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1.1 Vision: rods and cones 
 
Vision is mediated by the eye and is one of the five sense perceptions that evolved to 
receive and respond to environmental signals. The vertebrate eye primarily consists of 
the cornea, sclera, lens, retinal pigment epithelium and retina (Fig.1). Although all parts 
of the eye are important for generating a good image, the most vital layer for vision is 
the retina. The retina lines the posterior of the eye and contains the photoreceptors, 
which are highly specialized neuronal cells. There are two types of photoreceptors, rods 
and cones. They differ both in physiology and in morphology [1]. Rods mediate dim 
light or scotopic vision. Their detection treshold is about three orders of magnitude 
lower than that of cones, while cones have more rapid photoresponses and adaptation 
kinetics [2,3]. All rods in the retina have the same spectral sensitivity and the rod 
system therefore reports only in “grey levels”, so called "black and white" or scotopic 
vision. In contrast, three types of cones are present in the retina; blue, green and red 
light-sensitive cones, the spectral sensitivity of which lies at respectively 425 nm, 530 
nm and 560 nm [4-6]. The cone system therefore allows wavelength discrimination (so 
called colour or photopic vision). 
The spectral sensitivity is based on the presence of distinctive visual pigments in the 
retina, one rod pigment (rhodopsin) and three cone pigments. The cone pigments 
evolved long before the rod pigment [7-9]. The ancient photoreceptor thus probably was 
some type of cone from which the rods evolved. The photoreceptor cells consist of three 
cellular substructures: the outer segment, the inner segment and a synaptic region (Fig. 
2). The inner and outer segment are connected by a cilium. The gross anatomy of rods 
and cones is very similar except for the outer segment (Fig. 2). Rod outer segments have 
intracellular disks. These are flattened membranes which contain the photoreceptor 
protein rhodopsin. Cones have so called sacs, infoldings of the plasma membrane, 
instead of disks. The rationale for this difference is not yet understood [10]. The disks 
and sacs are tightly packed and a parallel array serves to align for optimal absorption of 
light. New disks/sacs are inserted from the ciliary region during the outer segment 
renewal process [11], in which old disks/sacs are daily removed from the tip of the outer 
1
2
7
6 5 4
3
Fig. 1: The vertebrate eye. Schematic presentation of the eye. The inset shows a detailed view of the retina. 1:
pigment epithelium, 2: rod and cones outer and inner segment, 3: rod and cone nuclei, 4: bipolar cells and
horizontal cells, 5: amacrine cells, 6: ganglion cells, 7: ganglion axons; optic nerve. Adapted from: Webvision
(http://retina.umh.es/webvision). 
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 9 
segment through phagocytosis by the pigment epithelial cells. The inner segment 
contains the nucleus, mitochondria and other intracellular organelles that are involved in 
cellular homeostasis. In the synaptic region, neurotransmitter release is modulated for 
transduction of the signal to second-order retinal neurons (bipolar cells) and eventually 
via the optic nerve to the brain. 
 
 
1.2 Structure and function of rhodopsin 
 
1.2.1 General features of rhodopsin 
Rhodopsin is a membrane-spanning protein containing seven transmembrane (TM) 
segments that belongs to the family of G protein-coupled receptors (GPCRs; Fig. 3). 
Rhodopsin is a special GPCR in that it consists of a protein, opsin and a covalently 
bound ligand, 11-cis retinal, that is responsible for the spectral properties of the 
pigment. Because 11-cis retinal is present in situ, photoactivation can occur very 
rapidly. 11-Cis retinal is bound to lysine 296 of opsin via a protonated Schiff base 
linkage. The counterion stabilizing the protonated Schiff base is provided by Glu113, 
which is highly conserved among all known vertebrate visual pigments [12-14]. Upon 
photoactivation, the retinal ligand isomerizes to the all-trans form and drives the protein 
through a series of transient photointermediates (Rhodopsin → Bathorhodopsin (Batho) 
↔ Blue-shifted intermediate (BSI)  →  Lumirhodopsin  (Lumi)  → Metarhodopsin I 
(Meta I) ↔ Metarhodopsin II (Meta II) → Metarhodopsin III (Meta III)) that within 
milliseconds leads to the generation of the active state (Meta II), which binds and 
activates the G protein transducin (GT; Fig. 4) [15]. 
Rhodopsin is synthesized on membrane-associated ribosomes and cotranslationally 
inserted into the endoplasmic reticulum (E.R.) membrane in the inner segment of the 
photoreceptor. Rhodopsin requires posttranslational modification (thiopalmitoylation, 
Fig. 2: The photoreceptor cells. Schematic presentation of a rod and a cone from the vertebrate retina. The
outer segment is specialized for visual transduction. Cone photopigment molecules are located on infoldings
of the plasma membrane, called sacs, rather than in the membrane of intracellular discs as in rods. From:
Zimmerman (1995) [10].
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Rhodopsin
Bathorhodopsin
BSI
Metarhodopsin IIIOpsin
Metarhodopsin II
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+
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Fig. 4: The photocascade of rhodopsin.
Fig. 3: Schematic representation of the two-dimensional structure of rhodopsin. The transmembrane
segments are numbered. Modified from Hargrave and McDowell (1992) [17] and Palczewski et al. (2000)
[18]. 
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disulfide bridge formation, glycosylation) and subsequently targeting to the rod outer 
segment membrane to fulfil its structural and functional tasks. These modifications take 
place in the E.R. and during passage through the Golgi membranes. In the Golgi 
membranes rhodopsin is sorted into distinct transport vesicles for transport through the 
trans-Golgi network [16]. After its passage through the Golgi, rhodopsin-containing 
vesicles move to the outer segment where they fuse to generate the disk membrane. 
Rhodopsin comprises more than 90% of the intrinsic protein content of the disk 
membranes. 
 
1.2.2. Crystal structure of rhodopsin 
Rhodopsin is one of the best studied GPCRs [17]. Recently, a 2.8 Å-resolution crystal 
structure of bovine rhodopsin finally provided a more detailed three-dimensional 
structure for rhodopsin (Fig. 5) [18]. About 97% of the whole opsin molecule could be 
identified in the electron density profile and the current structure lacks only part of the 
intracellular loops and the COOH-terminal region, but includes all 194 protein residues 
that form the seven transmembrane helices (Fig. 3) [18]. These are residue 35 to 64 for 
helix I, 71 to 100 for helix II, 107 to 139 for helix III, 151 to 173 for helix IV, 200 to 
225 for helix V, 247 to 277 for helix VI and 286 to 306 for helix VII. Helices I, IV, VI 
and VII are bent at proline residues, whereas helix V is almost straight. It is proposed 
that helix IV is involved in the stabilization of the dark-state rhodopsin through 
hydrophobic interactions with helixes II, III and V [19]. The chromophore is bound via 
a protonated Schiff base linkage to Lys296 in helix VII. Glu113 in helix III forms a salt 
bridge with the protonated Schiff base of the chromophore which keeps the protein 
constrained in its inactive conformation. Helix II is kinked around Gly89 and Gly90 
placing Gly90 close to Glu113, the residue that interacts with the protonated Schiff 
base. Helix III is the longest helix and the helix that is most tilted away from the 
membrane normal. The highly conserved sequence Glu134-Arg135-Tyr136 (E/(D)RY 
Fig. 5: The three-dimensional structure of rhodopsin. The helices are numbered. Modified from Palczewski et
al. [18]. 
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motif) that forms a potential binding site for a G protein, is located in the cytoplasmic 
terminal region of helix III surrounded by hydrophobic residues from helix II, 
cytoplasmic loop II (C-II), helix V and helix VI [18]. 
The extracellular region starts with residues 1-34 which are considered to form the N-
terminal tail. Residues 101 to 106 represent the extracellular loop I (E-I) which connects 
helix II and III, 174 to 199 form E-II which connects helix IV and V, and 278 to 285 
form E-III which connects helix VI and VII. The N-terminal tail is glycosylated at Asn2 
and Asn15. Glycosylation plays a role in the folding and maturation of rhodopsin 
[20,21]. The oligosacharides probably extend away from the extracellular domain and 
do not seem to interact with any part of the molecule [22]. Cys187 forms a disulfide 
bond with Cys110 at the extracellular end of helix III. Residues Cys110 and Cys187 are 
conserved in all known visual pigments [23] and many transmembrane receptors that 
are coupled to G proteins [23-26]. The disulfide bond forms an important determinant in 
the thermal stability of rhodopsin as well as its photointermediates and in coupling to G 
protein activation [27]. 
The cytoplasmic region is formed by residue 65 to 70 for cytoplasmic loop I (C-I) 
which connects helix I and II, 140 to 150 for C-II which connects helix III and IV, 226 
to 235 and 240 to 246 have been assigned to C-III which connects helix V and VI and 
307 to 327 and 334 to 348 to the COOH-terminal region. The missing residues have not 
yet been determined in the 3D crystal structure but form part of the cytoplasmic loops. 
C-II and C-III are known to participate in the interaction with the G protein transducin 
[28-30]. Residue 310 to 323 of the cytoplasmic domain appear to form a helix (helix 
VIII or C-IV). This eighth helix is of particular interest because of its putative 
interaction with GT [31]. This short amphipatic helix is clearly distinct from TM helix 
VII and lies nearly perpendicular to it. Rhodopsin undergoes palmitoylation at residues 
Cys322 and Cys323 [32,33] and these acyl chains provide anchor sites to the membrane 
[34]. Sequence conservation implies a similar structure in most other seven 
transmembrane receptors of the rhodopsin-like family [35]. The amino-terminal part of 
the C-IV loop contributes to the binding site for the carboxyl terminus of the α-subunit 
of GT and plays a role in the regulation of βγ-subunit binding [31,36]. Studies using 
transgenic animals show that the carboxyl-terminal domain is necessary for vectorial 
transport of rhodopsin from the inner to the outer segment of the rod photoreceptor cell 
[37]. The highly conserved C-terminal sequence QV(S)APA is thought to be critical in 
this rhodopsin trafficking [38]. 
Since this detailed crystal structure of rhodopsin has become available, directed and 
systematic efforts can be designed, using a combination of recombinant DNA, 
biochemical, cell biological and biophysical approaches, to unravel the receptor 
mechanism of rhodopsin leading to activation of the G protein, i.e. to map the 
underlying conformational changes and to understand the structural and/or functional 
role of contributing protein residues and motifs. 
 
1.2.3 Photocascade 
As was already described in paragraph 1.2.1. the photoactivation of rhodopsin leads to a 
cascade of photo-induced transitions including the Batho ↔ BSI → Lumi → Meta I ↔ 
Meta II → Meta III transitions [39,40]. Fourier Transform Infrared (FT-IR) difference 
spectroscopy (see paragraph 1.3.3) can be used to study the structural changes that 
occur during these major steps in photoactivation. FT-IR difference spectroscopy can 
measure small structural changes; it detects transitions between molecular rotational or 
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vibrational energy levels. Such data can provide direct information about the structural 
changes that occur during the individual steps of the photocascade (Fig. 6). 
 
 
Rhodopsin → Batho(rhodopsin) 
The first reaction in the photoactivation of visual pigments, the photo-induced 
isomerization of the ligand, triggers the cascade of structural transitions eventually 
producing the active receptor conformation Meta II (Fig. 6). Only the first step in the 
photocascade is light-dependent: the subsequent steps are thermodynamically driven. 
Hydrogen-out-of plane (HOOP) bands at 853, 877 and 921 cm-1 in the FT-IR difference 
spectrum are characteristic for the highly strained all-trans chromophore in Batho. 
Strong FT-IR difference bands near 1560 and 1535 cm-1 mainly reflect the changing 
electronic structure of the chromophore due to photoisomerization. The peptide 
backbone only undergoes small structural changes, reflected in small bands in the 
Amide I region (1620-1680 cm-1), that are restricted to protein residues lining the 
chromophore binding site [41,42]. The very small bands in the 1730-1775 cm-1 region 
have been assigned to Asp/Glu carboxyl group stretch modes [43]. 
 
Blue-shifted -intermediate (BSI) 
Although low temperature data do not provide clear evidence for the existence of an 
intermediate between Batho and Lumi in native rhodopsin, time-resolved studies 
suggest that the formation of BSI involves the first structural rearrangements in the 
protein and the initial relaxation of the all-trans chromophore [44]. Batho and BSI form 
an equilibrium, with BSI decaying to Lumi [45,46]. This equilibrium is strongly 
0.000
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Fig. 6: FT-IR difference spectra of the various transitions in the rhodopsin photocascade. The spectra were
taken at the indicated temperature to arrest the cascade at that specific intermediate. The rhodopsin spectrum
was subtracted from the photoproduct spectrum and negative bands thus represent vibrational bands originally
present in rhodopsin and positive peaks represent bands originating from the photointermediate. FT-IR
difference spectroscopy data are not yet available for BSI. 
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temperature dependent and at the low temperatures where Batho is trapped, the BSI 
component fraction is very small. Structural information is therefore very limited [44]. 
 
Lumi(rhodopsin) 
The retinal chromophore shows relatively large conformational changes upon the 
formation of Lumi as a result of major relaxation of the chromophore strain [42,44]. 
This is supported by the disappearance of the intense bathorhodopsin HOOP modes at 
921, 874 and 851 cm-1 and the appearance of a new band at 946 cm-1 in the FT-IR 
difference spectrum [39]. The first significant protein changes also occur upon Lumi 
formation. This is indicated by the appearance of prominent new bands near 1655 and 
1635 cm-1 in the amide I region (1600-1700 cm-1) [39]. 
 
 
Meta(rhodopsin) I 
Upon formation of the Meta I intermediate, additional changes occur in the protein 
structure as indicated by peaks that appear in the amide I region in the FT-IR difference 
spectrum [39]. Most prominent is a positive peak at 1664 cm-1, consistent with 
alterations in α-helical structure or orientation. New bands also appear above 1700 cm-1, 
representing alterations in the carboxyl groups of Asp and/or Glu residues [40,47,48]. 
Chromophore bands characteristic of Meta I appear at 950 cm-1 and 1537 cm-1. 
 
Meta(rhodopsin) II 
The Meta I → Meta II transition is accompanied by deprotonation of the Schiff base and 
uptake of a proton from the cytosol [49]. The Schiff base deprotonation is accompanied 
by protonation of its counterion Glu113 [50,51]. The major conformational changes 
occur in the protein upon formation of meta II [39,48]. An intense band appears at 1686 
cm-1, characteristic of β-turns [52]. Several bands appear in the region above 1700 cm-1, 
most prominently at 1767 (-)/1748 (+), 1729 and near 1710 cm-1 which have been 
assigned to Asp83, Glu122 and Glu113 respectively [43,53]. 
 
Meta(rhodopsin) III and opsin 
Decay of Meta II is accompanied by a nearly complete loss of signaling activity. The 
protein largely refolds into a conformation resembling that of rhodopsin as indicated by 
the decay of bands assigned to protein backbone and carboxyl group C=O stretch [54]. 
During the meta II decay the retinal is released from its binding pocket and opsin can 
bind 11-cis retinal to form a pigment with spectral properties identical to rhodopsin 
[55,56]. FT-IR studies also showed that Meta III and opsin share very similar protein 
structures distinct from both the Meta II and the rhodopsin state [54,57]. 
 
 
1.2.4 Phototransduction 
In the present model of vertebrate phototransduction, a dark current carried by Na+ and 
Ca2+ ions maintains the cytoplasmic membrane of the rod photoreceptor in a 
depolarized state (-35 mV). A cGMP-gated channel plays a central role in 
phototransduction by controlling the flow of Na+ and Ca2+ ions into the outer segment in 
response to light-induced changes in intracellular cGMP concentrations [2,58,59]. 
Briefly, in dark-adapted rod cells, Na+ and Ca2+ ions flow into the rod outer segment 
through cGMP-gated channels maintained in their open state by a relatively high 
concentration of cGMP. The balanced efflux of Ca2+ through the Na+/Ca2+ exchanger in 
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the plasma membrane of the outer segment maintains an intracellular Ca2+ concentration 
of ~ 400 nM. Na+ ions flow out of the inner segment through a Na+-K+ ATPase, thereby 
completing a dark current loop. In dark there is a constant release of neurotransmitter 
from the synaptic region of the photoreceptor cell [60]. 
Upon photoactivation, the 11-cis retinal chromophore of rhodopsin is converted to its 
all-trans isomer and this isomerization leads to the formation of the active form of 
rhodopsin (Meta II) [61-63]. The probability for the photoreceptor rod cell to catch a 
photon is very high due to the density of the rhodopsin molecules embedded in the disk 
membranes, which is about 106 molecules per disk [64]. Meta II catalyses the activation 
of the GTP-binding protein transducin via the exchange of GDP for GTP on its α-
subunit (GT,α). The high rate of the interaction between Meta II and transducin is 
explained by the high mobility of the rhodopsin molecule in the plane of the disk 
membrane. Within a fraction of a second, one molecule of Meta II is able to contact 
hundreds of transducins. GTP-GT,α on its turn activates a phosphodiesterase (PDE) to 
hydrolyse cGMP to 5’-GMP (Fig. 7). One molecule of the complex GTP-GT,α activates 
one PDE molecule by removing its inhibitory γ-subunits. PDE can catalyse the 
hydrolysis of about 1000 molecules of cGMP per second [65,66]. The decrease in 
intracellular cGMP causes the cGMP-gated channels to close and the rod cell to become 
hyperpolarized. Under this condition, neurotransmitter release at the synaptic region of 
the rod cell is inhibited and this signal is eventually processed to the brain. 
After photoactivation, the photoreceptor cell returns to its dark state by the shutdown of 
the visual cascade and resynthesis of cGMP [61,67]. The decrease of the calcium level 
due to the closure of the cGMP-gated channels and the ongoing extruding of Ca2+ ions 
by the Na+/Ca2+ exchanger stimulates the activity of guanylate cyclase which 
synthesizes cGMP for the reopening of the cationic channels. This causes the decrease 
of the electrical signal and the dark current is restored. In the same time, different 
shutoff reactions contribute to the recovery of the dark conditions. The shutdown of the 
visual cascade already starts when the first rhodopsin molecule is activated. Meta II is 
inactivated by ATP-dependent phosphorylation by rhodopsin kinase at its C-terminus, 
first predominantly at Ser334, Ser338 and Ser343 [68] and next on threonine residues 
Fig. 7: The cyclic nucleotide cascade. The enzyme cascade controlling visual transduction in rods.
Abbreviations: A: arrestin, channel: cGMP-gated channel, GC: guanylate cyclase, PDE: cGMP-specific
phosphodiesterase (*, active form), Rh: rhodopsin (*, photoexcited, active form), T: G-protein transducin.
From: Zimmerman (1995) [10]. 
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such as Thr335, Thr336, Thr340 and Thr342 [68-71]. The major role of rhodopsin 
phosphorylation is to promote high affinity binding of arrestin and inhibit transducin 
binding [72]. Arrestin binds to the C-terminal region (residue 331-348) of 
phosphorylated Meta II [73] to inactivate Meta II. By binding to the phosphorylated 
region arrestin becomes "activated" and next binds to residues in the cytoplasmic loops 
C-1, C-II and C-III [74,75]. Meta II phosphorylation is regulated by recoverin, a 
calcium sensitive protein that decreases the catalytic activity of rhodopsin kinase 
[76,77]. Phosphorylated opsin will be recycled to opsin by a phosphatase [78,79]. 
Active Tα is shut off by its own GTPase activity, accelerated by PDEγ en RGS9 [80,81], 
while PDE activity returns to dark state levels when it recombines with its inhibitory γ 
subunits. 
Finally, in order to regain photosensitivity opsin needs to be regenerated with 11-cis 
retinal. Exposure to light eventually results in hydrolysis of the Schiff base linkage 
between retinal and opsin and release of all-trans retinal. Regeneration requires 
isomerization of all-trans retinal to generate 11-cis retinal (visual cycle). The visual 
cycle takes place in the photoreceptors and in the adjacent retinal pigment epithelium 
(RPE; Fig. 8). In short, all-trans retinal released from activated rhodopsin is converted 
in the rod outer segment into all-trans retinol [82]. In the main pathway all-trans retinol 
is transported by the interphotoreceptor retinoid-binding protein (IRBP) to the RPE 
where it is isomerized to 11-cis-retinol by a retinol isomerase [83-87]. An alcohol 
dehydrogenase in the RPE is then required in order to produce 11-cis retinal [88-91] 
which is temporarily stored bound to the cellular retinal binding protein (CRALBP) 
[92]. In addition, there is evidence that the rhodopsin-like retinal G protein-coupled 
Fig. 8: The visual cycle. Schematic model of the visual cycle which takes place in the photoreceptor cell and
the RPE. LRAT: lecithin:retinol acyltransferase. Adapted from: Driessen (1999) [119]. 
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receptor (RGR) plays a role in the visual cycle. RGR has been shown to bind all-trans 
retinal and to function as a photoisomerase to produce 11-cis-retinal [93,94]. From 
transgenic studies it is indicated that RGR contributes by light-dependent synthesis of 
11-cis-retinal to but is not necessary for maintaining normal state levels of both 11-cis 
retinal and rhodopsin in the visual cycle [95]. Once 11-cis-retinol is formed it is 
esterified to generate a retinyl ester stock of the 11-cis isomers in the RPE or it is 
transported back as 11-cis retinal from the RPE to the rod outer segment with help of 
IRBP for regeneration with opsin to form rhodopsin [88-91]. 
 
 
1.3 Cysteine scanning mutagenesis 
 
Since the publication of the 2.8 Å resolution crystal structure of rhodopsin by 
Palczewski and coworkers in 2000 [18], a wealth of information has been revealed on 
the structure of rhodopsin. However, the role of individual protein residues in the 
photoactivation cannot be deduced from this structural model, since the crystal structure 
was obtained in the dark configuration and is difficult to extrapolate to rhodopsin in the 
activated state. There are several techniques which can be used to study the function of 
individual protein residues in the photoactivation of rhodopsin. One of these techniques 
is cysteine scanning mutagenesis and this approach will be further discussed in this 
thesis. 
Cysteine scanning mutagenesis is a technique which uses cysteine as a reporter group to 
study the structural and functional properties of a protein. Single amino acids are 
replaced by a cysteine residue. This is used to analyse structural and functional 
properties for which a variety of methods is available. Site-directed spin labeling is a 
technique that uses nitroxide spin labels to study the mobility and accessibility of 
individual protein residues and their environment. Site-directed chemical labeling is 
based on the chemical reaction of cysteines with a sulfhydryl reagent. Both techniques 
have been applied to rhodopsin and will be discussed in short in paragraph 1.3.1 and 
1.3.2. In paragraph 1.3.3. the combination of cysteine scanning mutagenesis and FT-IR 
spectroscopy will be discussed as a novel approach to map conformational changes. 
 
1.3.1 Site-directed spin labeling 
The general strategy of site-directed spin labeling (SDSL) is to introduce a nitroxide 
side chain at selected sites created by site-directed mutagenesis. First, a cysteine is 
introduced by means of cysteine-substitution mutagenesis in a base mutant in which all 
reactive native cysteines have been replaced by a suitable non-reactive residue. This is 
followed by derivatization of the reactive cysteine with a sulfhydryl-selective nitroxide 
reagent [96]. Next, an electron paramagnetic resonance (EPR) spectrum of the nitroxide 
is recorded to study the local environment of the nitroxide side chain [97]. 
In the last decade site-directed spin labeling has revealed information on the 
cytoplasmic loops of rhodopsin concerning accessibility and mobility of residues, loop 
structure and conformational changes upon photoactivation, and distances between 
residues. Due to the sterical constraints of the nitroxide label, mainly residues outside 
the transmembrane domain have been studied [98]. The hydrophobic-water interfaces of 
the cytoplasmic loops have been determined using SDSL and appear to agree very well 
with the crystal structure of rhodopsin [18,99-101]. According to SDSL the structure of 
loops C-I, C-II and C-IV displays a more ordered loop structure than C-III which forms 
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an extended, mobile loop [102]. The C-terminus (residue 324-348) is a highly 
disordered and dynamic structure [103]. From the crystal structure of rhodopsin, the 
structure of the cytoplasmic loops could only partly be determined because the 
cytoplasmic loops are almost certainly flexible and mobile in the physiological 
environment [103,104]. In addition, the crystal structure is based upon a non-natural 
conformation and thus may provide inaccurate information about the structure of the 
cytoplasmic loops. So far, the secondary structure of the cytoplasmic loops C-I and C-
III and the C-terminus predicted from SDSL experiments correspond very well with the 
crystal structure of rhodopsin [18]. SDSL has also been used to probe conformational 
changes upon photoactivation. Meta II formation results in conformational changes in 
cytoplasmic loops C-I, C-II, C-IV and the N-terminal region of C-III [99-102,105,106]. 
In addition to structural information about the cytoplasmic loops, the EPR-spectra of 
labeled cytoplasmic residues can be extrapolated to the conformational changes of the 
transmembrane helices upon photoactivation of rhodopsin. Measurements using 
nitroxide labeled cysteines 140 and 316 located at the cytoplasmic termination of helix 
III and VII respectively indicate that Helix III and VII show conformational changes 
upon photoactivation [102]. Labels at residue 65 in Helix I and varying residues in 
Helix VII show that the cytoplasmic portion of helix VII moves away from helix I upon 
photoactivation [107,108]. Helix III contains the Glu113 counterion that forms a salt 
bridge with the protonated Schiff base of retinal. Upon Meta II formation, the salt 
bridge is broken and this might cause the movement of helices III and VII 
[102,106,109]. Helix II moves away from C-IV and toward helix IV due to backbone 
rotations at the Gly89/Gly90 pair. Helix VI displays a robust displacement outward 
toward helix V, probably caused by rotation at Pro267 [105]. Helix VI and III that are 
located close to each other seem to be the most mobile helices in the rhodopsin 
structure. After photoactivation helix III displays an outward movement relative to helix 
II, IV, V, VI and VII. This is thought to be the result of a rigid body movement 
[106,110]. Helix V shows no detectable movement upon stimulation of rhodopsin by 
light [101]. 
 
1.3.2 Site-directed chemical labeling 
Relative comparable structural information, as achieved with site-directed spin labeling, 
can also be obtained using site-directed chemical labeling [104,111-113]. In site-
directed modification the structure of proteins can be studied by measuring the 
reactivity and accessibility of amino acids by chemically labeling cysteines with a 
(fluorescent) sulfhydryl reagent. Again a cysteine is introduced by means of cysteine-
substitution mutagenesis in a base-mutant in which all reactive native cysteines have 
been replaced by a suitable non-reactive amino acid. The sulfhydryl reagents can be 
either membrane-permeant or membrane-impermeant and provide a handle to study the 
cysteine environment. The reactivity of the sulfhydryl reagent is determined by the 
accessibility of the residue and hence by the local structure of the protein. Using two 
labeled cysteines the spatial proximity of two residues can be measured by energy 
transfer. In contrast to site-directed spin labeling it is possible to label amino acids 
located in the transmembrane domain provided that the amino acid is not buried too 
deep inside the protein [112,113]. While e.g. for transporter proteins this approach has 
been quite successful [114], it has offered only limited information on rhodopsin. 
Residues 136-150 of the intracellular C-II loop were found to be located in an ordered 
and sterically restricted environment [115] which indicates that the C-II loop has an 
ordered structure. This is in agreement with SDSL experiments (see § 1.3.1). Part of the 
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C-III loop (residue 240-250) is considered to be α-helical [104] in contrast to the crystal 
structure which indicates that only residue 243-246 exhibit helical structure [18]. 
 
1.3.3 FT-IR difference spectroscopy 
The nature of the above discussed techniques implies that preferentially protein residues 
of the intracellular and extracellular loops can be properly adressed. In addition, in site-
directed chemical or spin labeling the dynamics of the label have to be taken into 
account which need to be extrapolated to structure or structural changes of the protein, 
and this technique thus only indirectly reports on the dynamics of the residue they 
probe. Since nitroxide and chemical labels are invasive, the labels may perturb the 
tertiary structure of the protein studied and thus provide inaccurate information. On the 
other hand, Fourier transform infrared (FT-IR) spectroscopy does not need any labels 
and therefore this approach does not disturb the structure of the protein. It is a non-
invasive technique and can adress both the protein residues located in the intracellular 
and extracellular loops and those that are located in the transmembrane domain. 
FT-IR spectroscopy is a very sensitive technique that can measure small structural 
changes. It detects transitions between molecular rotational or vibrational energy levels 
[116] during which the electrical dipole moment changes. In the spectrum of 
electromagnetic radiation, the infrared region begins at about 800 nm (the near infrared 
region), followed by the mid infrared region (between 2500 and 25000 nm) and the far 
infrared (> 25000 nm). Usually, frequencies are expressed in wavenumbers, i.e. 
reciprocal wavelengths (cm-1). Thus the mid infrared region, which in practice is the 
most important, lies between 4000 and 400 cm-1. Most absorption bands, associated 
with stretching and bending vibrations, occur in the mid infrared region. Of particular 
importance are the amide I and amide II vibrations in the 1700-1500 cm-1 region 
representing the amide backbone of peptides and proteins. They are sensitive to 
hydrogen bonding and thus to the secondary structure of the protein. Hydrogen bonding 
causes a down-shift in frequency and broadening of the stretching bands. Bands around 
2900, 1740, 1400 and 1230 cm-1 represent (phospho)lipids and several bands around 
1100 and below 1000 cm-1 can be attributed to carbohydrates or nucleic acids. 
Infrared spectra of biomolecules consist of many bands which contain information 
about structural aspects of the molecule under study. The band positions are highly 
sensitive to molecular structure as well as to the micro-environment. The observed 
spectral bands have to be assigned to distinct components of the molecule. In many 
cases, comparison with infrared spectra of analogues is necessary but often not 
sufficient to assign the spectral features. Site-directed mutagenesis or stable-isotope 
labeling can help in the assignment of the spectral features. The combined efforts of 
both techniques might eventually result in detailed knowledge of structure-function 
relationships of the protein under study. 
In the work presented in this thesis, we aim to use cysteine scanning mutagenesis in 
combination with FT-IR difference spectroscopy to study the structural and functional 
role of residues located in the second transmembrane domain in the photoactivation of 
rhodopsin. Activation of rhodopsin often involves small structural rearrangements in the 
active site(s) that will be accompanied by changes in vibrational band position, width or 
intensity. These structural changes can be visualized in infrared difference spectra. In 
earlier experiments it was shown that vibrational changes in cysteine sulfhydryl groups 
(-SH) can be detected in the FT-IR difference spectrum around 2550 cm-1 [117,118]. 
The -SH group is very sensitive to changes in local structure and polarity and small 
structural changes can be observed. Furthermore, the 2500-2600 cm-1 region is an 
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isolated region in the FT-IR difference spectrum without interference from other 
biomembrane components. Hence, local protein conformational changes are reflected in 
small changes in -SH vibrational activity which makes the sulfhydryl group an excellent 
reporter group. The background of native cysteines should preferentially be eliminated 
and a base mutant created in which all native cysteines are replaced by a suitable amino 
acid, except for Cys110 and Cys187 that form the disulfide bridge. Subsequently, single 
residues can be mutated into a cysteine and -SH vibrational activity in the photocascade 
measured by means of FT-IR difference spectroscopy. In this way the role of individual 
residues in the photoactivation of rhodopsin can be studied. 
 
 
1.4 Aim and outline of this thesis 
 
Rhodopsin is a complex integral membrane protein and a member of the large family of 
G protein-coupled receptors. The recently determined 3-D crystal structure of ground-
state rhodopsin gives detailed information on the structure of rhodopsin and its three-
dimensional arrangement. However, it does not show which elements of the protein are 
involved in its photoactivation. The role of most individual protein residues during the 
photoactivation of rhodopsin, including the residues located in the transmembrane 
domain, has not yet been elucidated. From earlier experiments it is known that Asp83 
participates in the formation of Meta II. Since Asp83 is located in the second 
transmembrane helix of rhodopsin the aim of the work presented in this thesis was to 
study the role of the protein residues located in the second transmembrane helix in the 
photoactivation of rhodopsin. 
Chapter 2 investigates the contribution of Asp83 to structure and function of rhodopsin 
in more detail. It shows that the function of Asp83 can be largely maintained by a 
cysteine residue. The H-bonding changes involving Asp83 upon Meta II formation can 
also be probed by Cys83 as changes in the vibrational activity of its -SH group. This 
provides an experimental validation for mapping residues participating in 
photoactivation of rhodopsin by cysteine scanning mutagenesis. Chapter 3 describes the 
development of a cysteine-free base-mutant that can be used in cysteine scanning 
mutagenesis to study single protein residues of the second transmembrane helix of 
rhodopsin. Chapter 4 describes the construction, production and analysis of single 
cysteine mutants in the second transmembrane domain of rhodopsin on the background 
of a cysteine-free base-mutant. Serious production problems were encountered with 
production of sufficient quantities of functional mutants. In chapter 2 it was shown that 
changes in sulfhydryl vibrations of an introduced cysteine residue can be measured on a 
background of native cysteines. To allow purification and further study we constructed 
the same mutant rhodopsins as studied in chapter 4 in wild type rhodopsin. The results 
of this approach are described in chapter 5. 
Rhodopsin contains three native transmembrane domain located cysteines. Single 
mutations of these cysteines (C167R, C222R, C264del) result in a retinitis pigmentosa 
phenotype. Chapter 6 provides a biochemical characterization of these three retinitis 
pigmentosa prone cysteine mutants.  
The work presented in this thesis is summarized and discussed in chapter 7. 
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Abstract 
Asp83 is a highly conserved residue in the second transmembrane domain of visual 
pigments and many members of other G protein-coupled receptor subfamilies. Upon 
illumination, the rod visual pigment rhodopsin proceeds through various intermediate 
states (Batho ↔ BSI → Lumi → Meta Ι ↔ Meta II →Meta IΙΙ). Meta II represents the 
active state of rhodopsin, which binds and activates the G protein transducin. Evidence 
has been presented that Asp83 participates in the formation of Meta II and undergoes a 
change in H-bonding. To investigate whether this role of Asp83 requires its proton-
donating capacity and/or its H-bonding capability, we constructed the mutants D83C 
and D83N. Both mutants appear to effectively activate transducin, indicating that Asp83 
is not essential for signal transduction. Differential effects of the mutations D83C and 
D83N are observed in the spectral properties and the pH sensitivity of the Meta I → 
Meta II transition. In general, D83C behaves much more like wild-type than D83N. We 
conclude that the structural role of Asp83 also involves the acidic nature of its carboxyl 
group. In addition, the participation in Meta II formation of Cys83 in D83C manifests 
itself as a change in the vibrational properties of the sulfhydryl group, demonstrating 
that the –SH group can be used as a non-invasive probe for local structural changes. 
 
 
2.1 Introduction 
Rhodopsin, the rod visual pigment of the vertebrate eye, belongs to the super-family of 
G protein-coupled receptors (GPCRs)  [1]. Members of this membrane protein family 
all contain seven transmembrane spanning segments (Fig. 1). Rhodopsin consists of a 
protein, opsin, and a light-sensitive ligand or chromophore, 11-cis retinal. The 
chromophore is covalently linked through a Schiff base to lysine residue 296 of opsin 
[2-4]. Absorption of a photon by the chromophore induces a conformational change of 
the 11-cis to the all-trans configuration. This photo-isomerization triggers a cascade of 
distinct conformational steps (photointermediates: Batho ↔ BSI → Lumi → Meta Ι ↔ 
Meta II →Meta IΙΙ), eventually generating Meta ΙΙ, the active intermediate that can bind 
and activate the G protein transducin [5]. Meta ΙΙ exists in a pH-dependent equilibrium 
with Meta Ι [6-10]. 
Rhodopsin is one of the best studied GPCRs and represents a paradigm for this 
ubiquitous protein family [11]. Recently, a 2.8 Å-resolution crystal structure of bovine 
rhodopsin has become available [12], that displays the major structural features of the 
protein. An important task now has become to unravel the receptor mechanism of 
rhodopsin leading to activation of the G protein, e.g. to map the underlying 
conformational changes and to understand the structural and/or functional role of 
contributing protein residues and motifs [13]. In this report we further investigate the 
role of D83, a residue, that by a combination of site-specific mutagenesis and FT-IR 
spectroscopy has been shown to participate in the formation of Meta II [14-16] and that 
also seems to play a functional role in G protein activation by other aminergic GPCRs 
[1]. 
The aspartic acid at position 83 is a highly conserved residue located in the second 
transmembrane domain. The crystal structure of rhodopsin [12] suggests potential H-
bond interaction with residues in the seventh transmembrane domain, with putative 
involvement of H2O molecules. On basis of FT-IR studies H-bonded coupling, possibly 
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2
formation of Meta II and undergoes a change in H-bonding [14,16,17]. In addition, 
preliminary data indicated that the mutation D83N results in a change in the pKa of the 
Meta Ι ↔ Meta ΙΙ equilibrium [15,18]. Presently it is completely unclear whether this 
role of Asp83 depends on the acidic nature (proton donating capacity) of its carboxyl 
group, and/or on its potential to donate or accept H-bonding interactions, or whether a 
structural size factor comes into play as well. We have further addressed this question in 
a detailed investigation of the mutants D83N (the side-chain of Asn is non-acidic, a 
good H-bond acceptor, strong H-bond donor) and D83C (the side-chain of Cys is 
weakly acidic and a weak H-bond donor and acceptor).  
In this report we present conclusive evidence that the mutant D83C much more closely 
function the acidic nature of the side-chain at position 83 is an important supplement to 
its H-bonding potential. Quite interestingly, the participation of Cys83 in Meta II 
formation also manifests itself in a change in the vibrational properties of the sulfhydryl 
sensitive non-invasive probe for local structural changes [19]. Our results also clearly 
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Fig. 1: Schematic representation of the two-dimensional structure of rhodopsin.
The transmembrane segments are numbered. Modified from Hargrave and
McDowell [1] and Palczewski et al. [2]. 
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also through H O molecules, of Asp83 to residues in the third transmembrane segment 
has been proposed [17].  Evidence has been presented that Asp83 is active during 
resembles wild-type rhodopsin than D83N, suggesting  that for wild-type rhodopsin 
group, demonstrating that the -SH group indeed can be used in FT-IR studies as a 
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confirm that Asp83 participates in the determination of the pKa of the Meta Ι ↔ Meta ΙΙ 
equilibrium. This suggests that the pKa of this transition is not determined by a single 
residue, but rather by a complex of several residues, possibly interacting through a H-
bonded network. 
 
 
2.2 Materials and methods 
 
2.2.1 Cloning and expression of rhodopsin mutants 
The rhodopsin mutants D83N and D83C were constructed by means of site-directed 
mutagenesis using the approach developed by Kunkel [20], incorporated into the 
BioRad Mutagene kit (BioRad Laboratories, Veenendaal, The Netherlands). All 
constructs were extended with a 6x his-tag to allow rapid purification by immobilized 
metal affinity chromatography (IMAC) [21]. Cloning, isolation and propagation of 
recombinant baculovirus were performed as described before [22,23]. D83C was 
directionally subcloned from the pAcRP23 vector [24] into the transfer vector 
pFastbacdual (Life Technologies, Inc., Breda, The Netherlands) with help of BamHI 
and NotI (Promega, Leiden, The Netherlands). This transfer vector was used to generate 
recombinant baculovirus in the Spodoptera frugiperda derived cell line (IPLB-Sf9) as 
described before [25]. Recombinant virus was checked for the presence of the correct 
mutation by cycle-sequencing using appropriate rhodopsin primers [23,26]. Sf9 cell 
culture, expression and purification of recombinant protein were performed as described 
before [26,27]. 
 
2.2.2 Analysis of recombinant rhodopsins 
Recombinant protein was regenerated into photosensitive pigment by incubation of total 
cellular membrane preparations with a five-fold excess of 11-cis retinal, as described 
before  [27], and was subsequently purified by means of IMAC [21,27]. For analysis of 
photointermediates by UV-VIS or FT-IR spectroscopy, the purified pigments were 
reconstituted into retina lipids as described previously [28]. PH-dependence of the Meta 
I - Meta II transition was measured according to DeLange et al. [29]. Fourier transform 
infrared difference spectra of the Rho → Meta I and the Rho → Meta II transition were 
recorded on a Mattson Cygnus 100 FT-IR spectrometer, using set-up and settings 
similar to those previously reported [30]. Activation of the bovine G protein transducin 
(GT) by recombinant rhodopsin was measured by the intrinsic fluorescence 
enhancement of the G protein α-subunit upon binding of GTPγS (Roche, Almere, The 
Netherlands) as earlier described [25,31]. Initial rates were determined to assess 
activation capacity of the mutants relative to wild type (wt) rhodopsin. 
 
 
2.3 Results and discussion 
 
2.3.1 Expression and spectral properties of D83 mutants 
The his-tagged single mutants D83N and D83C were produced in Sf9 insect cells at 
functional levels comparable to his-tagged wt rhodopsin (12-16 pmol/106 cells, versus 
15-20 pmol/106 cells). Purification of the mutants was achieved through immobilized 
metal chromatography over Ni2+-agarose with a similar efficiency as wt rhodopsin 
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[21,27]. The profile of the absorbance bands of D83C and D83N is very similar to that 
of wt rhodopsin, as is obvious from the difference spectra (dark minus illuminated; Fig. 
2). However, their λmax show a blue-shift (Table 1) relative to wt rhodopsin (λmax: 498 ± 
1 nm), that is smaller in D83C (λmax: 495 ± 2 nm) than in D83N (λmax: 492 ± 1 nm). The 
small downshift of D83C suggests that the cysteine side-chain affects the electronic 
properties of the chromophore not much different from the wt Asp side chain. 
Apparently, the substitution of Asp at position 83 by Cys causes little structural and 
electronic perturbation of the chromophore. 
It has been reported, that at high pH (11) and ionic strength (4M KCl) the λmax of bovine 
rhodopsin exhibits a blue-shift of 5-6 nm, while that of frog rhodopsin is not affected 
[32]. Since frog rhodopsin carries an asparagine residue at the equivalent position of 83 
[33], we investigated the behaviour of the three position 83 variants up to pH 11.5 and 
up to 4 M KCl. Indeed, wild-type D83 showed the expected blue-shift at pH 11 and 4 M 
KCl (Table 1). No shift was observed, however, for D83N and D83C. This 
demonstrates, that an Asp residue at position 83 is essential for this phenomenon. As an 
Rhodopsin λmax (nm) Meta I → Meta II transition Transducin activation 
Half-life Meta II 
(min) 
D83 
variants 
pH 5-11 
(isotonic) 
pH 11 
(4 M KCl) pKa 
Relative area 
-SH vibration (wt ≡ 1) (10 °C, pH 6.5) 
  wt 498 ± 1 493 ± 2 6.5 ± 0.2 100 1 33 ± 4 
  D83N 492 ± 1 492 ± 2 7.3 ± 0.3 95 ± 15 0.8 ± 0.3 28 ± 4 
  D83C 495 ± 2 495 ± 2 6.6 ± 0.3 170 ± 20 1.0 ± 0.1 27 ± 3 
Wavelength (nm)
A
bs
or
ba
nc
e
250 350 450 550 650
-0.20
-0.10
0.00
0.10
0.20
0.30
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D83C
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Fig. 2: Absorbance dark-minus-light difference spectra of wt rhodopsin, D83N and D83C. Spectra were
obtained by subtracting a spectrum obtained after illumination in the presence of 50 mM hydroxylamine
from the original spectrum before illumination. Illumination then produces the all-trans-retinoxime
absorbing at 365 nm. The dotted line indicates the position of the λmax of wt rhodopsin. 
Table 1: Spectral, photochemical and functional properties of wt rhodopsin and D83 mutants. The area of the
-SH vibration was ratioed relative to the chromophore vibration at 1230 cm-1, and this ratio was set at 100 for
wt rhodopsin. The transducin activation rate was calculated from the initial velocity from curves as presented
in Figure 4. The activation rate for wt rhodopsin was set at 1. N = 2-5. 
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increase in ionic strength also has a dramatic effect on the pKa of the Meta Ι ↔ Meta ΙΙ 
equilibrium [29,34] and this pKa also shifts upon substitution of D83 (see below), we 
assume that these phenomena are connected through an extended H-bonded network in 
which Asp83 participates, as will be discussed below.  
 
 
2.3.2 Meta I ↔ Meta II equilibrium 
The late photointermediates Meta I and Meta II are in a pH-dependent equilibrium [6-
10] and hence determine the level of activated receptor (Meta II state). The Meta I ↔ 
Meta II equilibrium was analyzed for the three position 83 variants at the pH range 5.2 – 
8.8. (Fig. 3). At higher pH values Meta I becomes very unstable and cannot be reliably 
determined. The assay was performed at 10 °C, where Meta II is sufficiently stable. The 
half life of Meta II at pH 6.5 and 10 °C was slightly, but not significantly lower in the 
mutants compared to wt rhodopsin (Table 1). The resulting data are fit with a Michaelis-
Menten equation and the apparent pKa is determined from the mid-transition (Fig. 3). 
Evidently, the D83C mutation does not significantly affect the pKa of the Meta I ↔ 
Meta II equilibrium (6.6 ± 0.3 in D83C versus 6.5 ± 0.2 in wt). However, a significant 
upshift was observed for this pKa in the D83N mutant (Table 1), where it shifts to a 
value of 7.3 ± 0.3. This agrees with earlier reports, that the mutation D83N produces 
less Meta I than wild-type [15,18]. 
The pKa of the Meta I ↔ Meta II equilibrium is also markedly upshifted by an increase 
in bulk ionic strength, with the strongest effects induced by ions with more lipophilic 
character [29]. This suggests a connection between this phenomenon and the high 
pH/KCl effect on the λmax. Since the D83N mutant mimicks the effects of high KCl on 
pKa and of high pH/KCl on λmax, we propose, that in this mutant the side chain of 
residue 83 is uncoupled from an extended H-bonded network, that contributes to 
wavelength regulation and Meta I → Meta II transition. In our view, extreme conditions 
of pH and ionic strength will induce proton loss and/or transfer in this network, leading 
to deprotonation of the Asp83 carboxyl group. This would uncouple the latter from the 
network, accompanied by a blue-shift similar to that observed for the D83N mutant. In 
this view, we would also expect a high pH/KCl effect on the D83C mutant. Due to the 
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Fig. 3: pH-Dependence of the Meta I ↔ Meta II equilibrium of wt rhodopsin (‚), D83N (•) and D83C ().
Solid lines represent best fits with a Michaelis-Menten equation.
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require an even higher bulk pH to achieve this. Such conditions are not experimentally 
accessible, since rhodopsin rapidly denatures at a pH above 11.5.  
The participation of a larger network of residues controlling the Meta I → Meta II 
transition would also explain earlier reports, that mutation of a variety of residues does 
affect the pH dependence of this transition [15,18,35,36].  
 
2.3.3 G protein activation 
The signaling activity of the Asp83 mutants was compared with the wild type by the 
kinetics of GTP exchange in the α-subunit of transducin, that can be monitored as an 
increase in the fluorescence quantum yield of an intrinsic Trp residue [31,37,38]. Again 
the D83C mutant is very similar to wt rhodopsin, while D83N exhibits slightly reduced 
activity (Fig. 4, Table 1). Apparently, the presence of an Asp residue at this position is 
less critical for the signaling activity of rhodopsin than reported for other GPCRs [1]. 
This also explains, why the substitution D83N is a natural variant in aquatic animals, 
and appears to be exploited to blue-shift the absorbance spectrum of visual pigments in 
adapatation to the spectral profile of the ecotope [39-42].  
 
2.3.4 Structural studies using FT-IR difference spectroscopy  
FT-IR difference spectroscopy is very sensitive to changes in protein structure, even at a 
very local level. We have used this technique to probe whether mutation of Asp83 leads 
to long-range structural perturbation. In addition, we have shown previously that 
vibrational changes in cysteine sulfhydryl (-SH) groups can be detected in the FT-IR 
difference spectrum around 2550 cm-1 [19]. This is an isolated region in the FT-IR 
difference spectrum that would allow to detect small changes in -SH vibrational 
activity, which is quite sensitive to changes in local structure or polarity. Since the 
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Fig. 4: G protein activation capability of wt rhodopsin and D83 mutants. Intrinsic fluorescence enhancement
(excitation: 295 nm; emission: 337 nm) of the G protein α-subunit upon GTP binding was used to monitor
activation by either wild-type rhodopsin (trace 1) or mutants D83C (trace 2) and D83N (trace 3). As a control
the activation rate in the presence of the apoprotein opsin was measured (trace 4). The measuring sample
contained 100 nM of transducin and 5 nM of pigment. The sample was illuminated and after an equilibration
period the reaction was initiated by the addition of guanosine 5’-O-(3-thiotriphosphate) (GTPγS) to a
concentration of 2.5 µM (arrow). 
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carboxyl group of Asp83 reports local changes upon Meta II formation [14,16], we 
would expect that these changes would also be reflected in the Cys83 -SH vibration.  
The FT-IR difference spectra of the Rho → Meta I transition of the D83 mutants are 
nearly identical to wt rhodopsin (Fig. 5). The FT-IR difference spectra of the Rho → 
Meta II transition of both mutants also are highly similar to wt rhodopsin (Fig. 6 and 
[14], accurately copying all positive and negative peaks in the 1700-800 cm−1 range. 
This is conclusive evidence that these Asp83 mutations do not induce long-range 
structural perturbation, and presents a structural basis for our observation that these 
mutations do not significantly affect receptor activity.  
In addition, the Rho → Meta II difference spectra present a highly reproducible pattern 
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Fig. 6: FT-IR difference spectra of the Rho → Meta II transition of wt rhodopsin and D83C. The 2300 - 800
cm-1 region is shown. The 2300 - 1900 cm-1 region shows band shifts (arrow heads), that indicate changes in
proton continua, typical for H-bonded networks. Arrows point at the bilobal bands of the Asp83 carboxyl
group, that are absent in the Asp83 mutants. Spectra were taken at 10 °C and pH 6.0 and within 5 minutes of
illumination, so as to minimize interference by the slow decay of Meta II (half life of ca 30 min under these
conditions). 
Fig. 5: FT-IR difference spectra of the Rho → Meta I transition of wt rhodopsin, D83N and D83C. The 1800 -
800 cm-1 region is shown, where the major changes occur. Spectra were taken at -20 °C, where the Meta I
intermediate is stable. 
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of relatively weak, broad bandshifts in the 2300-1900 cm-1 region (Fig. 6, arrowheads). 
Such broad changes typically reflect rearrangements in extended H-bonded networks, 
that include water molecules (“proton continua”) [43-45]. This will be discussed 
elsewhere in more detail, but these data provide independent evidence for the presence 
of such networks in rhodopsin. The bandshifts are accurately reproduced in the D83C 
mutant, demonstrating that this mutation does not significantly affect the network 
rearrangements accompanying formation of Meta II. 
Changes in the Rho → Meta II difference spectrum of the mutants in comparison to the 
wt are obvious in the 1800-1700 cm-1 range (Fig. 6, arrows) and the 2600-2500 cm-1 
range (Fig. 7). As reported previously [14,16], mutation of the Asp83 residue abolishes 
the corresponding carbonyl (C=O) stretch vibration of its β-carboxyl (COOH) group 
(arrows in Fig. 6, wt spectrum). This vibration exhibits bilobal bands, representing a 
significant frequency shift between rhodopsin (1767 cm-1) and Meta II (1748 cm-1), that 
can be interpreted as an increase in H-bonding interaction. The cysteine -SH group of 
course lacks carbonyl vibrations, explaining why these bilobal bands are absent from 
the D83C spectrum. The asparagines carboxamide group (CONH2) does contain a 
carbonyl group, but its stretch vibration is shifted into the 1700-1600 cm-1 region [46]. 
However, new bands representing this carboxamide group are not apparent in the D83N 
spectrum [14]. This supports our view, that the side chain of Asn83 does not participate 
in a H-bonded network, and is not structurally involved in Meta II formation. 
In the 2600-2500 cm-1 range, the mutants do contain a distinct band near 2550 cm-1 that 
can be assigned to -SH stretch vibrations [19]. However, the difference spectrum of the 
D83C mutant presents a significant increase in the sulfhydryl peak, with a slight shift in 
frequency (Fig. 7, Table 1). These effects can only be produced by the additional 
sulfhydryl group of Cys83. Hence, similar to the Asp83 carboxyl group, the Cys83 -SH 
group also reports on the local changes occurring upon formation of Meta II. Because 
the -SH peak is located in a very uncrowded spectral region and vibrational changes of a 
single residue can be measured on a background of native cysteines, the -SH peak 
reporter group can be exploited as a very sensitive, non-invasive reporter group for the 
analysis of local conformational changes using FT-IR difference spectroscopy . 
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Fig. 7: FT-IR difference spectra of the Rho → Meta II transition of wt rhodopsin and D83C. The 2600 - 2500
cm-1 region is shown where the stretch vibration of the sulfhydryl group absorbs. Spectra were scaled on the
chromophore peaks at 1230 and 970 cm-1 (cf. Figure 6). The -SH band of the D83N mutant is very similar to
wt and left out for clarity. The -SH band peaks at 2548 cm-1 (wt) and 2550 cm-1 (D83C), respectively.   
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Obviously, the spectral region between 1800 and 1740 cm-1 is nearly flat in the absence 
Siebert and coworkers [47,48] which show a distinct bandshift in the Rho → Meta II 
transition (1727 → 1743 cm-1) in rhodopsin reconstituted in dioleoyl-PC. This bilobal 
pair is insensitive to H-2H exchange, but does shift in dioleoyl-PC 13C-labeled in the 
ester group. The authors conclude that these bands reflect a structural change in one 
strongly bound lipid residue upon Meta II formation. Remarkably, we have never 
observed these bands in Asp83 or Glu122 mutants prepared in our laboratory (Fig. 6 
and [14,15]. Since we routinely reconstitute our recombinant rhodopsin preparations in 
retina lipid extracts that closely resemble the native rod outer segment lipids in 
composition and degree of unsaturation, we assume that this lipid interaction is much 
weaker in a highly unsaturated lipid environment. This might relate to an abundance of 
observations, that a less unsaturated lipid environment affects several rhodopsin 
properties, including the kinetics of Meta II formation and the equilibrium of the Meta I 
↔ Meta II transition [13]. 
 
 
2.3.5 Conclusions 
In order to investigate the role of aspartic acid 83 in the photoactivation of rhodopsin, 
we constructed the mutants D83C and D83N. The λmax and the pH dependence of the 
MI ↔ MII equilibrium of D83C (495 nm; pKa = 6.6) are very close to those of wt 
rhodopsin (498 nm; pKa = 6.5). However, D83N shows a significant blueshift (492 nm) 
and the corresponding pKa is strongly upshifted. This agrees with earlier observations 
that Asp83 contributes to spectral tuning [39-42]. Our observation that at high pH and 
ionic strength the λmax of wt (Asp83) downshifts to that of D83N suggests that the 
carboxyl proton of Asp83 is involved in wavelength regulation, and that this effect is 
uncoupled by deprotonation. Uncoupling is also effectuated by the D83N mutation 
which abolishes the acidic nature of the side chain. The D83N mutation likewise 
provokes a strong upshift of the pKa of the Meta I → Meta II transition, suggesting that 
both phenomena are mediated by the same mechanism. FT-IR data [14,16] indicate that 
in rhodopsin the Asp83 carboxyl group (absorbing at 1767 cm-1) is weakly H-bonded, 
and that this H-bond interaction becomes stronger in Meta II (1748 cm-1). Furthermore, 
Asp83 may have H-bonding interaction probably through intermediate water molecules 
with Gly120, and possibly Glu113, in TM III [17]. In adition, the crystal structure of 
rhodopsin [12] suggests weak H-bonding interaction of Asp83 with residues in TM VII. 
Finally, the FT-IR data provide direct evidence for the presence of extended H-bonded 
networks in rhodopsin.  
On basis of these data, we propose that Asp83 participates, through its β-carboxyl 
proton, in an extended H-bonding network that contributes to spectral tuning as well as 
to setting the pKa of the Meta I ↔ Meta II equilibrium. These effects are based upon 
long-range interactions and represent global protein properties. Hence, this cannot only 
involve local H-bonding interaction, but requires the contribution of a larger network. 
The D83N mutation, which abolishes the acidic nature of the side-chain, uncouples 
residue 83 from this network, leading to shifts in λmax and pKa that in wt can only be 
effectuated by high pH and/or ionic strength [29,32]. Our FT-IR results show that in the 
mutant D83C, on the other hand, the still weakly acidic sulfhydryl group of Cys83 does 
participate in the H-bonding network, and apparently is able to largely maintain its wild-
type properties. The acidic nature of the side-chain at postion 83 might for instance be 
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required to allow partial deprotonation, or to allow rapid proton-transfer with a 
transient, deprotonated state. 
The FT-IR difference spectra of the Rho → Meta I transition of both mutants are nearly 
identical to that of wt rhodopsin. The FT-IR difference spectra of the Rho → Meta II 
transition are also very similar to wt rhodopsin except for the bilobal Asp83 carboxyl 
peaks which disappear upon mutation of this residue. These structural observations 
agree with the functional analyses, showing that the mutations do not significantly 
affect receptor activity. 
The participation of the sulfhydryl group in Meta II formation of D83C also manifests 
itself in a change in the vibrational properties of the sulfhydryl group, demonstrating 
that the -SH group can be used as a sensitive, non-invasive probe for local structural 
changes. 
In summary, our results demonstrate that Asp83 does not play an essential role in signal 
transduction of rhodopsin, but provides a more structural contribution involving spectral 
tuning and photointermediate propagation. This requires participation in an extended H-
bonded network where the proton-donating capacity of its side-chain are an important 
supplement to its H-bonding capacity.  
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Abstract 
 
The contribution of most individual protein residues of rhodopsin to the photoactivation 
process, especially of those located in the transmembrane domain, is not or only poorly 
understood. Our first target was to study the involvement of residues in the second 
transmembrane helix in the activation mechanism of rhodopsin using cysteine scanning 
mutagenesis in combination with Fourier transform infrared (FT-IR) difference 
spectroscopy. Hereto single protein residues need to be replaced by a unique cysteine 
the –SH group of which is used as a reporter group. To prevent a large background in 
the introduced signal by native cysteines and possible reciprocal interactions of the 
introduced cysteine with native cysteine residues, we aimed to create a base-mutant in 
which all potentially active cysteine residues are substituted without major functional 
side-effects. We constructed a recombinant baculovirus expressing a cysteine-free 
mutant (SOH ∆C) in which all cysteines were replaced by serine except for the 
cysteines involved in the disulfide bridge. However, this construct yielded significant 
less functional protein than the corresponding wild type rhodopsin. Attempts to increase 
the amount of functional recombinant base-mutant by alternative cysteine substitutions 
were not successful, so far, and the properties of the Cys-Ser base-mutant SOH ∆C were 
further explored. This species could be purified with reasonable recovery, showed no 
significant free cysteine residue activity, and retained wild type-like functional activity 
according to FT-IR analysis. These properties would make it a suitable base-mutant. 
 
 
3.1 Introduction 
 
Recently, the 3D-crystal structure of ground-state rhodopsin was determined with a 
resolution of 2.8 Å [2]. The crystal structure gives detailed information on the structure 
of rhodopsin and its three-dimensional arrangement. However, it does not show which 
elements of the protein are involved in the photoactivation of rhodopsin. The role of 
most individual protein residues, especially of those located in the transmembrane 
domain, during the photoactivation of rhodopsin is not yet known. Chapter 2 describes 
that the carboxyl group of Asp83 as well as the sulfhydryl group of a cysteine residue at 
the same position report local changes upon Meta II formation. Asp83 forms part of a 
H-bonded network [2,4]. Since during Meta II formation major rearrangements occur in 
the H-bonded networks of rhodopsin [5,6] it is most likely that the second 
transmembrane domain (TM II) of rhodopsin is involved in and hence undergoes 
structural changes during photoactivation. Our first target will therefore be to study the 
involvement of second transmembrane helix residues in the activation mechanism of 
rhodopsin. 
To investigate the contribution of residues of the second transmembrane helix we aim to 
use cysteine scanning mutagenesis in combination with Fourier transform infrared (FT-
IR) difference spectroscopy. In cysteine scanning mutagenesis single protein residues 
are replaced by a cysteine, that then is used as a reporter group to analyse the structural 
and functional properties of a protein, here rhodopsin. FT-IR spectroscopy is a non-
invasive technique; it uses no labels and therefore protein residues located in the 
intracellular and extracellular loops as well as those that are located in the 
transmembrane domain can be studied with minimal disturbance of the structure of the 
protein. In FT-IR difference spectroscopy the spectrum after illumination is subtracted 
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from the spectrum before illumination and thus only shows changes that occur during 
this phototransition. The -SH stretch vibration of the cysteine sulfhydryl groups can be 
detected in the 2500-2600 cm-1 region of the FT-IR difference spectrum [5,7]. This is an 
isolated region that allows to detect small changes in -SH vibrational activity, which is 
quite sensitive to local structural changes, without interference from other membrane 
components. However, the cysteine peak will appear on a background of native 
cysteines. This will require double-difference spectroscopy introducing additional errors 
and possibly obviating subtle changes in the newly introduced -SH group. To prevent a 
large background in the introduced signal by native cysteines and possible reciprocal 
interactions of introduced cysteines with native cysteine residues, we aimed to create a 
base-mutant in which all potentially active cysteine residues are substituted. The 
disulfide bond forms an important determinant of the stability of rhodopsin as well as 
the Meta II conformation [8] and is therefore retained. Next, the protein residues to be 
studied can be mutated into a cysteine for cysteine scanning mutagenesis studies. 
This chapter describes the development of a suitable base-mutant that can be used in 
cysteine scanning mutagenesis using FT-IR difference spectroscopy. We started with a 
mutant in which all potentially reactive cysteines were replaced by a serine except for 
the cysteines 110 and 187 that form the disulfide bridge. Base-mutants in which most of 
the cysteines are replaced by serines have been used before in studies of other 
membrane proteins without disturbing their structural and functional properties [9,10]. 
Database analysis shows that serine is the most frequently occuring natural substitution 
for cysteine [11]. Valine is the second natural preference, but because valine is larger 
than serine and cannot engage in H-bonding interactions we preferred to use serine in 
our base-mutant. Alanine is a good alternative [11]. Alanine conserves the hydrophobic 
character, is smaller than cysteine and is in general structurally and functionally very 
well tolerated [12]. Computational data also suggest serine and alanine as suitable 
substitutes for cysteine [13]. Cysteine to methionine changes are less likely to occur in 
natural substitution [11], probably since methionine is sterically more demanding than 
cysteine, but it preserves the sulfur atom of cysteine, and hence could be an alternative 
to serine or alanine. Since previous single mutation of Cys167 and Cys264 into a serine 
on a wild type background resulted in lower functional yields and a decrease in stability 
(M.J.M. Portier-VandeLuytgaarden, unpublished results), we therefore also considered 
substitution of cysteine 167 and 264 for alanine or methionine. 
 
 
3.2 Materials and methods 
 
3.2.1 Cloning and expression 
Synthetic, cysteine-free cDNA of bovine opsin (Synthetic Opsin His-tagged; SOH ∆C) 
was kindly provided by D. Oprian (Brandeis University, Waltham, USA) in the PMT 
vector. In SOH ∆C all cysteines have been replaced by a serine except for the cysteines 
of the disulfide bridge (Cys110 and Cys187). Unique restriction sites were introduced as 
silent mutations to allow modification by cassette mutagenesis and analysis by means of 
restriction enzymes. All constructs were extended with a 6X his-tag to allow rapid 
purification by immobilized metal affinity chromatography (IMAC) [14]. Mutants SOH 
∆C/C167A and SOH ∆C/C167M were constructed by means of QuikChange Site-
Directed Mutagenesis according to the manufacturer’s instructions (Stratagene). The 
primers used for site-directed mutagenesis are described in Table 1. The PCR was 
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performed on SOH ∆C in the pBluescript II SK− vector as described in the 
manufacturer’s manual with the following modifications: annealing temperature was 
75°C and the reaction was run for 18 cycles with an extension time of 13 minutes at 
72°C. Next, the SOH ∆C/C167 mutants were subcloned into the pFastbac DUAL vector 
under control of the polyhedrin promotor (Life Technologies Inc.) by means of 
restriction sites for BamH I and Not I. Mutants SOH ∆C/C264A and SOH ∆C/C264M 
were constructed by means of cassette mutagenesis (Fig. 1). For this purpose SOH ∆C 
was cloned into the pFastbac DUAL vector under control of the polyhedrin promotor by 
means of restriction sites for BamH I and Not I. The pFastbac DUAL vector was chosen 
since it can subsequently be used to generate recombinant baculovirus as will be 
discussed below. Part of the rhodopsin cDNA containing the mutation target was cut out 
of the SOH ∆C base-mutant using the restriction enzymes Mlu I and Nde I (Life 
Technologies Inc.). Next, a cassette containing the mutation and the corresponding 
restriction enzyme overhang was ligated into the base-mutant. The cassettes consist of a 
sense and an antisense oligo (Eurogentec), containing the desired mutation(s) (table 1). 
An Eppendorf cup containing the oligos (ratio forward: reverse = 1:1) was put in 100°C 
water and left to slowly cool down to room temperature (RT) to anneal the oligos and 
form the cassette. The cassettes contained a silent mutation to allow identification by 
means of restriction enzyme analysis. The mutants were checked by cycle-sequencing 
using primer 5'-cagttttgtaataaaaaaacctataaat-3' located in the polyhedrin region of the 
pFastbac DUAL vector or appropriate rhodopsin primers [15]. 
The Bac-to-bac Baculovirus recombination system (Life Technologies Inc.) was used to  
Fig. 1: Mutation scheme from cDNA to recombinant protein. This figure shows the different stages in the
generation of recombinant baculovirus from cDNA, suited to produce recombinant protein. A: two oligos,
both containing the mutation of interest, are annealed to form a cassette which will be used in cassette
mutagenesis. The cassette is exchanged with the target region in rhodopsin by means of restriction enzymes to
obtain recombinant rhodopsin cDNA. B: The recombinant rhodopsin is transformed into DH10Bac E.Coli
cells to obtain recombinant bacmid DNA. With this DNA Sf9 insect cells will be transfected. These cells will
produce recombinant baculovirus containing the recombinant rhodopsin cDNA. After isolation of pure
recombinant baculovirus, the virus titer is scaled up and determined by a plaque assay. C: Sf9 cells are
infected with the recombinant baculovirus in order to produce recombinant protein. 
Mutant forward reverse 
SOH ∆C/C167A 5'−GTCATGGCGCTAGCCGCTGCGGCCCCGCCGCTC−3’ 
5’−GAGCGGCGGGGCCGCAGCGGCT
AGCGCCATGAC−3’ 
SOH ∆C/C167M 5’−ATGGCGCTAGCCATGGCGGCCCCGCCGCTCGTCGGC−3’ 
5’−CGGCGGGGCCGCCATGGCTAGC
GCCATGACCCAGGT−3’ 
SOH ∆C/C264A 
5'−CGCGCATGGTTATCATCATGG
TCATCGCTTTCCTAATCGCTTGGC
TGCCA−3' 
5'−TATGGCAGCCAAGCGATTAGGA
AAGCGATGACCATGATGATAACCA
TG−3’ 
SOH ∆C/C264M 
5'−CGCGTATGGTTATCATCATGG
TCATCGCTTTCCTAATCATGTGGC
TGCCC−3' 
5'−TAGGGCAGCCACATGATTAGGA
AAGCGATGACCATGATGATAACCA
TA−3' 
 
Table 1: Oligo nucleotides used for QuikChange Site-Directed Mutagenesis (C167 mutants) and cassette 
mutagenesis (C264 mutants). SOH ∆C/C167: the cysteine → alanine and the cysteine → methionine 
mutations respectively are underlined; substitution of C167 disrupts a Sfi I-site; the silent mutation introduced 
to create a Nhe I-site is indicated in italic. SOH ∆C/C264: the cysteine → alanine and the cysteine → 
methionine mutations respectively are underlined; the silent mutation introduced to remove the Mlu I-site 
(C264A) is indicated in bold; the silent mutation introduced to remove the Nde I-site (C264M) is indicated in 
italic. 
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generate recombinant baculovirus for expression of recombinant rhodopsin in the 
Spodoptera frugiperda Sf9 cell line. First, the transfer vector pFastbac DUAL 
containing our cDNA of interest was transformed into DH10Bac competent cells which 
contain a helper plasmid and bacmid DNA (containing the baculovirus genome) with an 
attachment site for the bacterial transposon Tn7 (mini-attTn7). The transfer vector 
contains a mini-Tn7 element flanking the promoter-insert region. After transformation, 
the mini-attTn7 site on the bacmid DNA that contains part of the lacZα gene is 
exchanged with aid of a transposase expressed by the helper plasmid for the mini-Tn7 
element containing the rhodopsin cDNA. Colonies containing recombinant bacmid are 
identified by disruption of the lacZα gene. Next, high molecular weight mini-prep DNA 
was prepared from selected E. Coli clones containing the recombinant bacmid DNA. 
The selected colonies were inoculated into Luria-Bertani (LB) medium containing 
appropriate antibiotics and grown overnight at 37°C shaking at 250 to 300 r.p.m.. After 
centrifugation at 13,000 r.p.m. for 1 minute in an Eppendorff centrifuge the pellet 
containing the DH10Bac cells was resuspended in 0.3 ml solution I (15 mM Tris-HCl 
pH 8.0, 10 mM EDTA, 100 µg/ml RNase A) and lysed in 0.3 ml solution II (0.2 N 
NaOH, 1% SDS) for 5 minutes at room temperature. Subsequently, proteins and E. Coli 
genomic DNA were precipitated with 0.3 ml 3 M potassium acetate (pH 5.5) and the 
samples were put on ice for 5-10 minutes. After centrifugation at 13,000 r.p.m. for 10 
minutes the supernatant was transferred to a tube containing 0.6 ml absolute 
isopropanol, gently mixed and put on ice for 5-10 minutes to precipitate the bacmid 
DNA. Next, the sample was centrifuged at 13,000 r.p.m. for 15 minutes and the pellet of 
bacmid DNA was rinsed with 70% ethanol, air dried and dissolved in TE pH 8.0 (10 
mM Tris, 1 mM EDTA). This DNA was used to transfect Sf9 insect cells using 
CellFECTIN according to the manufacturer’s instructions (Life technologies, Inc.) 
except for the culturing media used: instead of Sf-900 II SFM, InsectXpress medium 
(Cambrex) was used for incubation with the CellFECTIN-bacmid DNA mixture and 
subsequently the InsectXpress medium was replaced by TNM-FH medium (Grace's 
basal insect cell medium, plus 3.3 g/l yeastolate, 3.3 g/l lactalbumin hydrolysate and 5.5 
g/l fraction V bovine serum albumin supplemented with 10% (v/v) fetal calf serum 
(PAA Laboratories GmbH), 50 units/ml penicilline and 50 µg/ml streptomycin (Life 
technologies, Inc.)). Generation and amplification of the isolated recombinant 
baculovirus was performed in a cell monolayer, cultured in TNM-FH, from which 
baculovirus was harvested at 4 days after transfection. To obtain pure recombinant 
baculovirus a plaque assay was performed. Sf9 insect cells were seeded in a 6 well 
plate, infected with a dilution series of the viral stock solution and covered with agarose 
(SeaPlaque, Biozym) to obtain single, monoclonal virus colonies. At 6-10 days post 
infection (d.p.i.) a single colony was picked and the virus was eluted from the agarose 
into TNM-FH medium. With this monoclonal virus Sf9 insect cells, seeded in a 6 well 
plate, were infected and the pure, recombinant virus was harvested at 6 d.p.i.. After 
harvesting, the recombinant virus (P1) was tested for production of recombinant opsin 
by SDS-PAGE of total cellular protein followed by immunoblotting with an anti-
rhodopsin antibody. Cells were harvested and lysed in milli-Q by freeze-thawing. After 
centrifugation at 13,000 r.p.m. for 10 minutes the pellet was resuspended in 200 µl 
milli-Q. 50 µl sample was solubilized for 10 min at RT in 2% SDS, 15 mM DTE, 15 
mM Tris-HCl buffer pH 6.8, 10% glycerol, 0.006% bromophenol blue and milli-Q 
added to a final volume of 100 µl. SDS-polyacrylamide gel electrophoresis was 
performed in 12% (w/v) slab gels (0.7 mm thickness) using the (mini)ProteanII 
Datawyse
Development of a rhodopsin base-mutant 
   
 
47
 
equipment (Bio-Rad). 10 µl of the solubilized sample was analyzed on gel. After 
separation by gel electrophoresis the proteins were electrophoretically transferred to 
nitrocellulose paper (Amersham) in blotting buffer (25 mM Tris, 200 mM glycine, 20% 
methanol) using the (mini)Trans-blot (Bio-Rad). Subsequently free protein binding sites 
on the nitrocellulose filter were blocked with 5% BSA in PBS. The blots were incubated 
with the first antibody (CERN922 1:10.00) diluted in PBS during the night at RT or for 
2 hours at 37°C. After rinsing twice in excess PBS, primary antibody was localized via 
incubation with a second antibody (SAR, 1:300) (Dako) followed by incubation with a 
third antibody conjugated to peroxidase (RPAP, 1:500 in PBS) (Dako). After rinsing 
twice in excess PBS, the blots were incubated with the peroxidase substrate 4-chloro-1-
naphtol (0.3% w/v in PBS containing 16.5% v/v methanol and 0.02% v/v H2O2). 
Incubation was stopped by rinsing with excess milli-Q when the desired staining 
intensity had been achieved. 
The viral DNA was tested for the correct sequence of the rhodopsin insert by restriction 
enzyme analysis and sequencing of viral DNA. Isolation of viral DNA from the nucleus 
of Sf9 cells was performed as follows: infected Sf9 cells were lysed with lysis buffer 
(0.03 M Tris pH 7.5, 0.01 M MgAc, 1 % Nonidet P-40) and centrifuged briefly at 
13,000 r.p.m.. The pellet, containing the nuclei, was resuspended in extraction buffer 
(100 mM Tris pH 7.5, 100 mM EDTA, 100 mM KCl) and incubated for 1 hour with 
100 µg/ml proteinase K and subsequently 1 hour with 1% SDS which dissolves the 
proteins and stimulates the activity of proteinase K. Next, the viral DNA was extracted 
from the solution by means of phenol/chloroform extraction, precipitated with 3 M 
NaAc and 100% ethanol and after centrifugation at 13,000 r.p.m. the pellet was 
dissolved in TE pH 8.0. The rhodopsin insert was amplified by means of polymerase 
chain reaction (PCR) with an annealing temperature of 60°C. The primers used were: 5'-
cagttttgtaataaaaaaacctataaat-3' (forward) and 5'-caaatgtggtatggctgattatg-3' (reverse). The 
PCR product was analyzed by means of restriction enzyme analysis or sequencing. 
The recombinant virus was amplified by inoculating Sf9 insect cells seeded in a T182 
culture flask with 10 µl P1 virus and was harvested at 6 d.p.i. (P2). To determine the 
virus titer a plaque assay was performed with 105x-, 106x- and 107x-diluted virus. For 
expression of recombinant protein Sf9 cells were adapted to serum-free InsectXpress 
medium for suspension culture in 250-ml spinner flasks (Bellco) or in mono-layer 
culture in T182 culture flasks. The cells were infected in mid log phase with a 
multiplicity of infection of 0.05-0.1, and finally harvested at 4 or 5 d.p.i. as described 
before [16,17]. 
 
 
3.2.2 Analysis of recombinant rhodopsins 
The capacity of the recombinant opsins produced by Sf9 cells to bond with 11-cis 
retinal to form a photosensitive pigment was assayed by incubation of total cellular 
membrane preparations with a five-fold excess of 11-cis retinal in darkness or under 
dim red light (Schott 610 long pass filter), as described before [17]. Formation of 
photosensitive pigment was analyzed by recording UV-VIS spectra before (1) and after 
(2) illumination in the presence of 20 mM hydroxylamine [18] and is presented as 
difference spectra (1-2). 
Total recombinant protein production was analyzed by SDS-PAGE (12% acrylamide) of 
total cellular protein as described earlier in this paragraph, except that after transfer of 
the proteins to nitrocellulose paper free protein binding sites on the nitrocellulose filter 
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were blocked in 5% BSA, 0.1% Tween-20 in PBS (w/v) for 15 min at RT. The blots 
were incubated with the first antibody (CERN922 1:20.000) diluted in PBS, 0.05% 
Tween-20 over night at RT or for 2 hours at 37°C. After rinsing twice in excess PBS, 
0.05% Tween-20, detection was accomplished using a second antibody (GARPO 
1:10.000). The blots were incubated with GARPO for 1-2 hours at RT. Next, the blots 
were rinsed in excess PBS, 0.05% Tween-20 and incubated for 5 min at RT with a 10 
times diluted solution of Lumino/Enhancer solution - Stable Peroxide Solution (1:1) 
(Pierce). The signal was transferred to an autoradiographic film by incubation for 10-60 
sec with the nitrocellulose blot in the dark. Finally, the film was developed in a Kodak 
x-Omat 2000 processor. 
SOH ∆C and wild type (wt) rhodopsin were purified by means of IMAC as described 
before [14,16] except that SOH ∆C was extracted in CHAPS/nonylglycose (1% w/v) 
and purified in nonylglycose. After purification the pigment was reconstituted into 
retina lipids as described previously [19]. 
FT-IR analyses were performed on a Bruker IFS 66v/S spectrometer equipped with a 
liquid nitrogen-cooled MCT detector. Spectra were taken at 8 cm-1 resolution. Sample 
temperature was computer-controlled using an ADP cryostat (Advanced Research 
Systems Inc.). Samples, prepared by isopotential spin-drying 2-3 nmol of pigment on an 
AgCl window (Fisher Scientific Co.), were rehydrated with 1 µl of buffer and sealed 
using a second AgCl window and a rubber O-ring spacer as described [1,20,21]. 
Samples were illuminated in the spectrometer using a 150 W halogen lamp equiped 
with a fiber optical ring (Schott). Each spectrum consists of 2560 scans taking about 2 
min to record in the dark, followed by similar blocks of spectra after illumination. 
Difference spectra were calculated by subtracting these blocks of spectra. Meta I was 
analyzed by cooling to 253 K and irradiation with yellow light (OG530, 2 min). Meta II 
was generated in the same way and analyzed at 283 K. 
The -SH content of rhodopsin and mutants was determined by reaction with DTNB in 
1% SDS as described in [22].  
 
 
3.3 Results 
 
The capacity of the recombinant opsins to bond with 11-cis retinal to form a 
photosensitive pigment was analysed by measuring the UV-VIS spectrum before and 
after illumination. Subtraction of the spectrum after illumination from the spectrum 
before illumination gives a difference spectrum, where interference with e.g. sloping 
 % of wt  
wt 100 
SOH ∆C 26 ± 12 (n = 5) 
SOH ∆C/C264A 20 ± 7 (n = 3) 
SOH ∆C/C264M n.d. 
Table 2: Production of functional protein of various base-mutants. The amount of functional protein
produced by wild type rhodopsin (wt) is set at 100%. n.d.: not detectable. Average of at least three
independent assays are given with SD. 
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baselines is cancelled out. This allows a better estimation of the λmax and the amount of 
recombinant protein that is produced. Figure 2 shows the spectra of wild type rhodopsin 
and SOH ∆C. The spectrum of SOH ∆C is similar in bandshape to that of wild type 
rhodopsin but shows a blue-shift (λmax: 498 nm → 492 nm). The recombinant proteins 
were analysed for production of functional rhodopsin at several d.p.i.. Relative to the 
amount of wild type rhodopsin produced (≡ 100%) SOH ∆C only produced 26% ± 12 
functional pigment (Table 2).  
Figure 3 shows total protein production analyzed by SDS-PAGE and immunoblotting. 
SOH ∆C yielded a protein product represented by a band near 38 kDa similar to wild 
type rhodopsin that as demonstrated before [23] corresponds to fully glycosylated opsin 
(Fig. 3, thick arrow). In contrast to wild type rhodopsin which yields large quantities of 
glycosylated protein, SOH ∆C produced significantly more non-glycosylated protein 
[23] (Fig. 3, thin arrow). It is also clear that non-glycosylated protein is only poorly 
extracted into detergent solution (+ lanes). 
Because of the low amount of functional protein, production of SOH ∆C was not very 
satisfactory. We decided to test whether A/M mutation of C167 and C264 would 
improve functional levels. Unfortunately, the SOH ∆C/C264 mutants behaved even 
worse. SOH ∆C/C264A produced only 20% ± 7 functional protein relative to wild type, 
whereas for SOH ∆C/C264M no functional protein could be detected. Both SOH 
∆C/C264A and SOH ∆C/C264M produced even larger quantities of non-glycosylated 
protein than SOH ∆C. Again, non-glycosylated protein was poorly (C264A) or hardly 
(C264M) solubilized. At this stage, we were not able to test mutants SOH ∆C/C167A 
and SOH ∆C/C167M for either production of functional rhodopsin or total opsin 
production. 
In view of these results we decided to select SOH ∆C as base-mutant for cysteine 
scanning. Since this would also require proper purification and retention of functional 
properties very similar to wild type, these aspects were addressed subsequently. 
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Fig. 2: Absorbance dark-minus light difference spectra of wild type rhodopsin and SOH ∆C after purification.
Spectra were obtained by subtracting a spectrum after illumination in the presence of 20 mM hydroxylamine
from the original spectrum before illumination. Illumination then produces the all-trans-retinoxime absorbing
at 365 nm. Note that SOH ∆C shows a blue-shift (λmax: 498 → 492 nm). Insert: absorbance spectrum of
purified SOH ∆C. 
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Purification was based on the approach developed for wild type rhodopsin [14,24]. In 
short: regenerated rhodopsin was purified by means of IMAC using a Ni2+-
nitrilotriacetic acid (NTA) column. The pigment was dissolved in Dodecylmaltose 
(DOM), applied to the column (10 µl matrix per nmol rhodopsin) and purified using the 
same buffer containing nonylglucoside and increasing concentrations histidine to 
eventually elute rhodopsin from the column. In contrast to wild type rhodopsin, 
extraction of SOH ∆C in DOM was poor and a CHAPS/nonylglucose (1:1) mixture was 
selected as detergent to extract the pigment. Elution was performed in nonylglucose 
since this detergent is easier removed for reconstitution. SOH ∆C was purified with 
40% ± 14 (n = 2) recovery, with a purity of 60 – 70% (ratio 280/492 = 2.8) and gave a 
spectrum that is very similar to wild type (Fig. 2). Wild type rhodopsin was purified 
with 40 - 70% (n = 10) recovery and a purity of 70 – 90% After purification, SOH ∆C 
was reconstituted into a native bovine retina lipid environment using a method based 
upon cyclodextrin extraction [14,24]. SOH ∆C was reconstituted with about 50% 
recovery where wild type was reconstituted with at least 80% recovery. Reconstitution 
further improved the purity to over 80%. 
Next, SOH ∆C was tested on functional properties. We estimated the number of -SH 
groups per mole of pigment by their reactivity with DTNB. We found 5.6 ± 0.2 per 
mole of pigment for wild type rhodopsin (n = 4) and 0.08 for SOH ∆C, in agreement 
with the six cysteines in wild type rhodopsin and the lack of cysteines in SOH ∆C. This 
also demonstrates that at least 96% of the Cys110 and Cys187 residues have generated a 
disulfide bond. To analyse the photoinduced structural changes in SOH ∆C, FT-IR 
difference spectroscopy was performed. Figure 4 shows the 1800-1500 cm-1 region of 
the FT-IR difference spectrum of the rhodopsin → Meta II transition. This region 
defines Meta II and is very similar between SOH ∆C and wild type rhodopsin. In 
particular the bilobal peak of the Asp83 carboxyl group at 1767 and 1748 cm-1 [1] and 
the band at 1712 cm-1 reflecting Glu113 protonation [3] are typical for a functional 
C264A SOH WTC264M SOH ∆C
KDa+- - ++- +-
50
37
25
75
100
150
250
Fig. 3: Immunoblot analysis of total protein production of Sf9 cells infected with recombinant baculovirus
expressing wild type rhodopsin, SOH ∆C, SOH ∆C/C264A and SOH ∆C/C264M. Blots were screened with
primary antibody CERN922 (polyclonal). Each lane was loaded with 1000 cells. The lanes indicated with -
show samples before solubilization (4 d.p.i.), lanes indicated with + show (rhod)opsins after extraction in
DoM (5 d.p.i). The thick arrow indicates glycosylated opsin, the thin arrow non-glycosylated opsin. The
bands at MW > 50 kD represent oligomers, mainly of non-glycosylated species, artificially produced upon
solubilization in SDS [22,33].
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rhodopsin to Meta II transition. Figure 5 shows the 2600 - 2500 cm-1 region of the 
rhodopsin → meta II transition which contains the sulfhydryl (-SH) vibration of 
cysteine. Wild type rhodopsin shows a -SH vibration pattern around 2548 cm-1, while 
SOH ∆C only exhibits base-line noise in this region 
 
 
3.4 Discussion 
 
3.4.1 Novel application of cysteine scanning mutagenesis: 
combination with FT-IR difference spectroscopy 
To investigate the involvement of protein residues of the second transmembrane 
segment in the photoactivation mechanism of rhodopsin we aim to use cysteine 
scanning mutagenesis in combination with FT-IR difference spectroscopy. Cysteine 
scanning mutagenesis is a technique which uses cysteines as a reporter group to study 
the structural and functional properties of a protein, here rhodopsin. Single amino acids 
are replaced by a cysteine residue and a variety of methods is available as described in 
Chapter 1, to probe the properties of this cysteine residue. FT-IR spectroscopy can 
directly probe the cysteine sulfhydryl group, hence does not need chemical 
modification, which only indirectly reports on the dynamics and microenvironment of 
the residue. Another important advantage of the no-modification requirement is that all 
protein residues are accessible, including buried or highly constrained ones. In FT-IR 
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Fig. 4: The 1800-1500 cm-1 region of the FT-IR difference spectra of the rhodopsin → Meta II transition of
wild type rhodopsin and base-mutant SOH ∆C. This region e.g. shows the bilobal peak of the Asp83 carboxyl
group (*) at 1767 and 1748 cm-1 [1] and E113 protonation (↓) at 1712 cm-1 [3]. Note that the difference
spectrum of SOH ∆C is very similar to that of wild type rhodopsin: Although intensities may differ somewhat,
most peak frequencies are accurately reproduced. Slight changes in Amide I and II peaks (∇) indicate very
small, hence subtle differences in secondary structure. Spectra were scaled on the chromophore peaks at 1230
and 970 cm-1. 
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difference spectroscopy the spectrum of a photointermediate is subtracted from the 
“dark” spectrum, which highlights the changes that occur during this transition. 
Vibrational changes in cysteine sulfhydryl (-SH) groups can be detected in the FT-IR 
difference spectrum around 2550 cm-1 [5,7]. The -SH group is very sensitive to changes 
in local structure and polarity and small structural changes can therefore easily be 
observed. The 2500-2600 cm-1 region is an isolated region in the FT-IR difference 
spectrum. This, in combination with the environmental sensitivity of the -SH group of 
cysteine, makes it possible to detect relatively small changes in -SH vibrational activity. 
Protein residues that are replaced by a cysteine and that are structurally active, i.e. 
undergo a change in their micro-environment during the rhodopsin photocascade, will 
give rise to a difference peak in the 2500-2600 cm-1 region of the FT-IR difference 
spectrum. However, this peak will appear on a background reflecting changes in native 
cysteines. To avoid this background as well as possible reciprocal interactions with 
native cysteine residues, we wanted to create a base-mutant in which all potentially 
active cysteine residues are substituted. Subsequently, protein residues to be probed can 
be mutated into a cysteine for cysteine scanning mutagenesis studies. 
 
3.4.2 Base-mutant 
In SOH ∆C all cysteine residues were replaced by serine except for the cysteines 
involved in the disulfide bridge. The disulfide bridge is formed by residues Cys110 and 
Cys187 and is conserved in all known visual pigments and many transmembrane 
receptors that are coupled to G proteins [25-28]. The disulfide bond forms an important 
determinant in the thermal stability of rhodopsin as well as its photointermediates and in 
coupling to G protein activation [8]. 
Cysteine and serine differ only in the hetero-atom in the side chain and replacement of 
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Fig. 5: The –SH stretch region in the FT-IR difference spectra of the rhodopsin → Meta II transition of
wild type rhodopsin and base-mutant SOH ∆C. In this region the stretch vibration of sulfhydryl groups
appears around 2550 cm-1. Spectra were scaled on the chromophore peaks at 1230 and 970 cm-1. 
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cysteine by serine involves the exchange of two relatively small side chains. 
Unfortunately, we observed that baculovirus expression produced SOH ∆C in 
significant less functional yield than wild type rhodopsin. In fact, in a previous study 
using COS cells for expression of SOH ∆C-like mutants production of functional 
protein was also lower than that of wild type protein [29]. In addition, the absorbance 
band of SOH ∆C was blue-shifted relative to wild type (λmax: 498 nm → 492 nm). The 
shift in λmax is probably due to the C176S mutation, since the single C167S mutant 
exhibits the same blue shift (M.J.M. Portier-VandeLuytgaarden, unpublished results). 
Rhodopsin requires posttranslational modifications like palmitoylation, disulfide bridge 
formation and glycosylation to fulfil its structural and functional activities. Analysis of 
total protein production on Western blot showed that SOH ∆C produced much less 
glycosylated and much more non-glycosylated protein than wild type rhodopsin. The 
relatively high amount of non-glycosylated protein in SOH ∆C probably reflects the 
presence of large amounts of incorrectly folded protein [30], which would explain the 
relative low yield of functional protein for SOH ∆C (26%) in comparison to wild type 
rhodopsin. Incorrect folding will enhance aggregation of the protein that also may 
explain the much lower solubility of the non-glycosylated protein in solutions of mild 
detergents (Fig. 3).  
To obtain sufficient amounts of functional SOH ∆C protein for purification and further 
experiments, large culture volumes will be necessary. Apart from the costs, the 
relatively large amount of non-functional protein will also hamper protein purification, 
which will lead to lower recovery of functional protein (P. Bovee-Geurts, unpublished 
results). We therefore attempted to increase the amount of functional recombinant base-
mutant by alternative cysteine substitutions. Some cysteine to serine mutants of the 
platelet activating factor were not delivered to the plasma membrane and failed to 
demonstrate ligand binding in contrast to the corresponding cysteine to alanine mutants 
[8,31]. Base-mutants in which cysteine residues were replaced by alanine have 
successfully been used before in studies of membrane proteins [32] in agreement with 
evolutionary studies showing that alanine is a relatively frequent occuring substitute for 
cysteine [11]. Methionine is not a natural substitute and is larger than cysteine but it also 
carries a hydrophobic side chain and retains the sulfur atom. Therefore, we tested 
whether selected replacement by alanine and methionine would improve base-mutant 
expression. Residues Cys167 and Cys264 form part of the retinal binding site and are 
shown to be structurally active during photoactivation (DeGrip et al., unpublished 
results). The single mutants C167S and C264S on a wild type background already 
showed lower levels of functional protein and reduced stability during purification 
(M.J.M. Portier-VandeLuytgaarden, unpublished results). Mutation of cysteine into a 
serine involves the replacement of a relatively hydrophobic side chain by a relatively 
hydrophylic side chain and might disturb subtle elements in chromophore binding or 
binding site organization and thus impair formation of functional protein. Hence, we 
aimed to examine whether substitution of cysteine 167 or 264 by an alanine or a 
methionine would increase the expression level of functional recombinant base-mutant. 
So far, we have not yet been able to test production of SOH ∆C/C167 mutants. The 
C264A/M mutants generated total levels of recombinant protein comparable to SOH ∆C 
and wild type. However, the production level of functional recombinant protein by 
mutant SOH ∆C/C264A was even less than that of SOH ∆C, whereas SOH ∆C/C264M 
mainly generated intact but non-glycosylated protein with very little production of 
functional protein. Non-glycosylated C264A again demonstrated much lower solubility 
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in mild detergent solution, while non-glycosylated C264M was hardly detected. SOH 
∆C/C264M probably displays a serious folding defect leading to a very aggregation-
prone protein. The relatively large side chain of methionine apparently severely disturbs 
proper folding. 
We conclude that substitution of Cys264 by an alanine or a methionine does not 
improve the production of functional protein relative to SOH ∆C. Since the highest 
functional expression levels of cysteine-free rhodopsins were still obtained for SOH ∆C 
and this species could be purified with reasonable recoveries (40% ± 14), showed no 
significant free cysteine residue activity, and retained wild type-level functional activity 
according to FT-IR analysis, we decided to use SOH ∆C as a base-mutant for our 
subsequent cysteine scanning mutagenesis studies. 
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Abstract 
 
A Cys → Ser-mutant of rhodopsin (SOH ∆C) was selected as base-mutant for cysteine 
scanning mutagenesis. Previously we showed that this base-mutant shows wild-type 
functional behaviour according to FT-IR analysis. Here, this is complemented with G-
protein activation studies, demonstrating that it retains full activity in this respect, as 
well. 
Earlier experiments indicate that residue Asp83, located in the second transmembrane 
domain of rhodopsin, contributes to spectral tuning and photoactivation, the two major 
functional elements of visual pigments. Our first target was therefore to study the 
involvement of residues of the second transmembrane segment in these processes. In 
this chapter we describe the construction, production and analysis of single cysteine 
mutants of residues 74-90 of this transmembrane segment of rhodopsin. Unexpectedly, 
most mutants produce little or no functional protein, show poor glycosylation and are 
largely retained intracellularly, suggesting major folding defects. The reason for this 
remains largely unclear. A relationship may appear between the extent of conservation 
of a protein residue and the amount of glycosylated, functional rhodopsin mutant 
produced. However, this needs further investigation. Remarkably some single-cys 
mutations resulted in relatively high levels of functional protein. One of these, mutant 
L77C , could already be purified and partially analyzed. It exhibits similar properties as 
the base-mutant and no evidence for contributon of residue 77 to the photoactivation 
process. This is plausible, since according to the crystal structure, L77 is located in the 
lipid face of TM II and hence probably inserted in the lipid matrix. 
 
 
4.1 Introduction 
 
Rhodopsin is a membrane-spanning protein containing seven transmembrane segments 
(TM), which requires posttranslational modification (thiopalmitoylation, disulfide 
bridge formation, glycosylation) and subsequently targeting to the rod outer segment 
membrane to fulfil its structural and functional tasks. Rhodopsin belongs to the family 
of G protein-coupled receptors and is a unique member of this family because its ligand, 
11-cis retinal, is covalently bound to the protein, opsin. The visual process begins with 
the absorption of light by rhodopsin inducing ultrafast cis/trans isomerization of the 
ligand after which photoexcited rhodopsin relaxes via a series of transient 
photointermediates (Rhodopsin → Bathorhodopsin (Batho) ↔ Blue-shifted-
intermediate (BSI) → Lumirhodopsin (Lumi) → Metarhodopsin I (Meta I) ↔ 
Metarhodopsin II (Meta II) → Metarhodopsin III (Meta III)) that within milliseconds 
leads to the generation of the active state (Meta II), which binds and activates the G 
protein transducin (GT) [1]. 
The 3D-crystal structure of ground-state rhodopsin (2.8 Å resolution) [2] gives detailed 
information on the three-dimensional structure of rhodopsin but does not show which 
elements of the protein are involved in the photoactivation of rhodopsin. Earlier 
experiments suggest that residue Asp83, located in the second transmembrane domain 
of rhodopsin, is involved in this process. This residue reports local changes upon Meta 
II formation and participates in a H-bonded network [2,3] that shows major 
rearrangements during Meta II [4,5]. Our first target will therefore be to study the 
involvement of residues of the second transmembrane domain in rhodopsin activation. 
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For this purpose we aim to use cysteine scanning mutagenesis in combination with FT-
IR difference spectroscopy as described in Chapter 3. To prevent a large background in 
the introduced signal by native cysteines and possible reciprocal interactions of 
introduced cysteines with native cysteine residues we use SOH ∆C, in which all 
potentially active cysteine residues were removed (see Chapter 3), as base-mutant to 
substitute single residues by a cysteine. In this chapter we will describe the production 
and analysis of single cysteine mutants of residue 74-90 of the second transmembrane 
segment of rhodopsin (Fig. 1). 
 
 
4.2 Materials and methods 
 
4.2.1 Cloning and expression 
Synthetic, cysteine-free cDNA of bovine rhodopsin (SOH ∆C) was kindly provided by 
D. Oprian (Brandeis University, Waltham) in the PMT vector. In SOH ∆C all cysteines 
have been replaced by a serine except for the cysteines of the disulfide bridge (Cys110 
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Fig. 1: Schematic representation of the two-dimensional structure of rhodopsin. The transmembrane segments
are numbered. Modified from Hargrave and McDowell [34] and Palczewski et al. [2]. Black circles indicate
the mutated residues discussed in this chapter, grey circles indicate the Cys → Ser mutations of base-mutant
SOH ∆C. 
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and Cys187). Unique restriction sites were introduced as silent mutations to allow 
modification and analysis by means of restriction enzymes. All constructs were 
extended with a 6x his-tag to allow rapid purification by immobilized metal affinity 
chromatography (IMAC) [6]. The mutant rhodopsins were constructed by means of 
cassette mutagenesis. For this purpose SOH ∆C was cloned either into a modified 
pBluescript II SK- vector (mutants Y74C-F85C and G90C) or into the pFastbac DUAL 
vector (Life Technologies Inc.) under control of the polyhedrin promotor (mutants 
M86C-G89C). The pBluescript II SK- vector was manipulated and lacks part of the 
multiple cloning site between restriction enzyme sites Dra II and BamH I. Part of the 
rhodopsin cDNA containing the mutation target was cut out of the SOH ∆C base-
mutant using the restriction enzymes (Life Technologies Inc.) Hind III and Bgl II for 
mutants SOH ∆C/Y74C-A82C, Hind III and Nco I for SOH ∆C/D83C, Bgl II and Nco I 
for SOH ∆C/L84C-G90C. Next, a cassette containing the mutation and the 
corresponding restriction enzyme overhang was ligated into the base-mutant. The 
cassettes consist of two oligos (Eurogentec), a sense and an antisense oligo (Table 1), 
containing the desired mutation(s). An Eppendorf cup containing the oligos (ratio 
forward: reverse = 1:1) was put in 100°C water and let slowly cool down to room 
temperature to anneal the oligos and form the cassette. The cassettes were provided with 
a restriction site created by a silent mutation to allow identification by means of 
restriction enzyme analysis. After cloning of the cassette into the base-mutant, the 
recombinant opsins generated in the pBluescript II SK- vector were subcloned into the 
pFastbac DUAL vector under control of the polyhedrin promotor using restriction 
enzymes BamH I and Not I. The construct was checked by cycle-sequencing using 
primer 5’-cagttttgtaataaaaaaacctataaat-3’ located in the polyhedrin promotor site of 
pFastbac DUAL or appropriate rhodopsin primers [7]. 
The Bac-to-bac Baculovirus Recombination system (Life Technologies Inc.) was used 
to generate recombinant baculovirus for expression of recombinant rhodopsin in Sf9 
Spodoptera frugiperda cells as described in Chapter 3. In short, the pFastbac DUAL 
transfer vector containing the recombinant opsin cDNA was transformed into DH10Bac 
competent cells to obtain recombinant bacmid DNA through transposition of the 
promoter-cDNA insert in the transfer vector. This DNA was used to transfect Sf9 insect 
cells in order to produce recombinant baculovirus. The recombinant virus (P1) was 
tested for production of (recombinant) opsin by means of immunoblotting and viral 
DNA was tested for the correct rhodopsin insert by restriction enzyme analysis or 
sequencing of viral DNA as described in Chapter 3.  
The recombinant virus was amplified (P2) and the virus titer was determined by means 
of a plaque assay (see Chapter 3). For expression of recombinant protein Sf9 cells were  
Table 1: List of sense and antisense oligos used to construct the SOH ∆C-mutants. The cysteine substitutions 
are indicated in bold. The silent mutations introduced to identify a mutant by means of restriction enzyme
analysis are underlined. 
 
1 Mutation V81C creates a Fsp I-site. 
2 Mutation A82C removes the Bgl II- site. 
3 Mutation D83C removes the Bgl II-site and creates a Sph I-site. 
4 Mutation L84C-mutatie removes the Bgl II-site. 
5 Mutation V87C creates a Hinf I-site. 
6 Mutation F88C creates a Hinf I-site and removes the Nco I-site. 
7 Mutation G89C creates a Hinf I-site. 
Datawyse
Cysteine scanning on SOH ∆C background 
   
 61
Table 1 
Mutant forward oligo reverse oligo 
SOH ∆C/Y74C 5’−AGCTGCGCACACCGCTCAACT
GCATCCTGCTCAACCTGGCCGTGG
CA−3’ 
5’−GATCTGCCACGGCCAGGTTGAGCA
GGATGCAGTTGAGCGGTGTGCGC−3’ 
SOH ∆C/I75C 5’−AGCTGCGCACACCGCTCAACT
ACTGCCTGCTCAACCTGGCCGTG
GCT−3’ 
5’−GATCAGCCACGGCCAGGTTGAGCA
GGCAGTAGTTGAGCGGTGTGCGC−3’ 
SOH ∆C/L76C 5’−AGCTTCGCACACCGCTCAACTA
CATCTGCCTCAACCTGGCCGTGGC
T−3’ 
5’−GATCAGCCACGGCCAGGTTGAGGC
AGATGTAGTTGAGCGGTGTGCGA−3’ 
SOH ∆C/L77C 5’−AGCTACGCACACCGCTCAACT
ACATCCTGTGCAACCTGGCCGTG
GCA−3’ 
5’−GATCTGCCACGGCCAGGTTGCACA
GGATGTAGTTGAGCGGTGTGCGT−3’ 
SOH ∆C/N78C 5’−AGCTACGCACACCGCTCAACT
ACATCCTGCTCTGCCTGGCCGTGG
CT−3’ 
5’−GATCAGCCACGGCCAGGCAGAGC
AGGATGTAGTTGAGCGGTGTGCGT−3’ 
SOH ∆C/L79C 5’−AGCTTCGCACACCGCTCAACTA
CATCCTGCTCAACTGCGCCGTGGC
A−3’ 
5’−GATCTGCCACGGCGCAGTTGAGCA
GGATGTAGTTGAGCGGTGTGCGA−3’ 
SOH ∆C/A80C 5’−AGCTGCGCACACCGCTCAACT
ACATCCTGCTCAACCTGTGCGTGG
CA−3’ 
5’−GATCTGCCACGCACAGGTTGAGCA
GGATGTAGTTGAGCGGTGTGCGC−3’ 
SOH ∆C/V81C1 5’−AGCTTCGCACACCGCTCAACTA
CATCCTGCTCAACCTGGCCTGCGC
A−3’ 
5’−GATCTGCGCAGGCCAGGTTGAGCA
GGATGTAGTTGAGCGGTGTGCGA−3’ 
SOH ∆C/A82C2 5’−AGCTTCGCACACCGCTCAACTA
CATCCTGCTCAACCTGGCCGTGTG
C−3’ 
5’−GATCGCACACGGCCAGGTTGAGCA
GGATGTAGTTGAGCGGTGTGCGC−3’ 
SOH ∆C/D83C3 5’−AGCTTCGCACACCGCTCAACTA
CATCCTGCTCAACCTGGCCGTGGC
ATGCCTCTTCATGGTCTTCGGTGG
CTTCACCACCACCCTCTACACCTC
TCTC−3’ 
5’−CATGGAGAGAGGTGTAGAGGGTGG
TGGTGAAGCCACCGAAGACCATGAAG
AGGCATGCCACGGCCAGGTTGAGCAG
GATGTAGTTGAGCGGTGTGCGA−3’ 
SOH ∆C/L84C4 5’−GATTGCTTCATGGTCTTCGGTG
GCTTCACCACCACCCTCTACACCT
CTCTC−3’ 
5’−CATGGAGAGAGGTGTAGAGGGTGG
TGGTGAAGCCACCGAAGACCATGAAG
CAATC−3’ 
SOH ∆C/F85C 5’−GATCTCTGCATGGTCTTCGGTG
GCTTCACCACCACCCTCTACACCT
CTCTG−3’ 
5’−CATGCAGAGAGGTGTAGAGGGTGG
TGGTGAAGCCACCGAAGACCATGCAG
A−3’ 
SOH ∆C/M86C 5’−GATCTGTTCTGCGTCTTCGGTG
GCTTCACCACCACCCTCTACACCT
CTCTG−3’ 
5’−CATGCAGAGAGGTGTAGAGGGTGG
TGGTGAAGCCACCGAAGACGCAGAA
CA−3’ 
SOH ∆C/V87C5 5’−GATCTCTTCATGTGCTTCGGTG
GATTCACCACCACCCTCTACACCT
CTCTC−3’ 
5’−CATGGAGAGAGGTGTAGAGGGTGG
TGGTGAATCCACCGAAGCACATGAAG
A−3’ 
SOH ∆C/F88C6 5’−GATCTCTTCATGGTCTGCGGTG
GATTCACCACCACCCTCTACACCT
CTCTG−3’ 
5’−CATGCAGAGAGGTGTAGAGGGTGG
TGGTGAATCCACCGCAGACCATGAAG
A−3’ 
SOH ∆C/G89C7 5’−GATCTGTTCATGGTCTTCTGCG
GATTCACCACCACCCTCTACACCT
CTCTC−3’ 
5’−CATGGAGAGAGGTGTAGAGGGTGG
TGGTGAATCCGCAGAAGACCATGAAC
A−3’ 
SOH ∆C/G90C 5’−GATCTCTTCATGGTCTTCGGTT
GCTTCACCACCACCCTCTACACCT
CTCTG−3’ 
5’−CATGCAGAGAGGTGTAGAGGGTGG
TGGTGAAGCAACCGAAGACCATGAA
GA−3’ 
Datawyse
Chapter 4 
 62
adapted to serum-free InsectXpress medium (Cambrex) in suspension culture in 250-ml 
spinner bottles (Bellco) or in monolayer culture in T182 culture flasks. For large-scale 
production in bioreactors (1 - 10 litre), InsectXpress medium-adapted cells were scaled 
up in spinner flasks to obtain a minimum cell density of 5·105 cells/ml in the bioreactor. 
The cells were infected in mid log phase with a multiplicity of infection of 0.05 - 0.1 
and harvested at 4 d.p.i. as described before [7-9]. 
 
4.2.2 Analysis of recombinant rhodopsins 
Total recombinant protein production was estimated by SDS-PAGE (12% acrylamide) 
of total membrane protein followed by immunoblotting with an anti-rhodopsin antibody 
as described in Chapter 3. 
The capacity of the recombinant opsins produced by Sf9 cells to bond with 11-cis 
retinal to form a photosensitive pigment was assayed as described before [7,10]. 
SOH ∆C, SOH ∆C/L77C and wild type (wt) rhodopsin were purified by means of 
immobilized metal chromatography (IMAC) over Ni2+ agarose as described before in 
[9] except that SOH ∆C and SOH ∆C/L77C were extracted in CHAPS/nonylglycose 
and purified in nonylglycose as described in Chapter 3. After purification the pigments 
were reconstituted into retina lipids as described previously [11]. 
The pH dependence of the Meta I → Meta II transition was measured according to 
DeLange et al., 1997 [12]. In short, rhodopsin proteoliposomes were resuspended in 
buffer with appropriate pH. A spectrum was recorded between 750 and 250 nm of the 
initial, unbleached sample (spectrum 1). After illumination, a second spectrum was 
recorded (spectrum 2). The relative amount of Meta I formed after illumination was 
derived from the linear relationship between the λmax of the difference spectrum 
(spectrum 1 – spectrum 2) and the percentage photoproduct formed [12]. 
Activation of the bovine G protein transducin (GT) by recombinant rhodopsin was 
measured by the intrinsic fluorescence enhancement of the G protein α-subunit upon 
binding of GTPγS (Roche) as earlier described [10,13]. In short, bovine transducin 
(final concentration 100 nM) was added to reconstituted recombinant rhodopsin (5 nM) 
in buffer containing 100 mM NaCl, 3 mM MgCl2, 1 mM dithioerythritol, 0.01% (w/v) 
DoM, 20 mM HEPES pH 7.4 in the dark. After illumination of the sample the 
fluorescence was measured using a Shimadzu RF-5301-PC spectrofluorometer with 
excitation at 295 nm and emission at 337 nm. Then GTPγS (final concentration 2.5 µM) 
was added and the subsequent increase in relative fluorescence intensity represents 
pigment-triggered activation of GTα. The same assay performed with opsin was used as 
a negative control. 
FT-IR analyses were performed on a Bruker IFS 66v/S spectrometer using set-up and 
settings as described in Chapter 3. The -SH content of rhodopsin and mutants was 
determined by reaction with DTNB in 1% SDS as described in [14]. 
Intracellular localization of the mutant rhodopsins was studied using confocal laser 
scanning microscopy. Cells were seeded on cover slips in 6 wells plates and grown to 
50% confluency. The cells were infected with (recombinant) baculovirus with a M.O.I. 
of 0.1 - 1.0 depending on cell density. At 4 d.p.i., the cells were washed in phosphate-
buffered saline (PBS), fixed with methanol at -20°C and permeabilized with 0.2% 
Triton X-100. After rinsing with PBS, the cover slips were incubated with PBS, 0.05% 
Tween-20, 1% gelatin, 2% Fetal calf serum (FCS) at RT to block non-specific binding 
sites. Next, the cells were incubated with anti-rhodopsin CERN886 antiserum (1:2000 
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rinsing twice in PBS, 0.05% Tween-20, the cells were incubated with the secondary 
antibody SAR-TRITC (1:200) in PBS containing 0.05% Tween-20, 1% gelatine and 
2% FCS. Again the cells were washed rinsing twice in PBS, 0.05% Tween-20. 
Finally the coverslips were brought to slides with a drop of PBS/glycerol and the 
edges were sealed with colourless nail-polish to avoid dehydration. To identify the 
localization of the endoplasmic reticulum (ER) in Sf9 insect cells, cover slips were 
incubated for 30 minutes to 2 hours with ER-tracker Blue-White DPX (Molecular 
Probes) under normal growth conditions. These coverslips were treated in a similar 
way as the coverslips containing infected Sf9 cells.  
 
% 
Conservation 
[32] 
Total protein production 
 
R C 
Localization: 
L(lipid face) 
P(protein face) 
λmax (nm) 
(purified) 
Functional 
protein 
(% ± SD) 
(wt ≡ 100%) Glycosylated Non-glycosylated 
SOH WT    498 ± 1 100 + + + +  + + + + 
SOH ∆C    492 ± 2 26 ± 12 (n= 12) + + + + + + 
Y74 18 68 L  2 ± 5 (n = 3) + + + + + 
I75 3 88 P  18 ± 1 (n = 2) + + +  
L76 37 85 P  14 ± 4 (n = 2) +  + + + + 
L77 31 48 L 492 66 ± 2 (n = 2) + + + + + 
N78 51 92 P  9 + + 
L79 91 98 P  < 1 + + + 
A80 74 80 P  < 1 - - 
V81 30 40 L  < 1 + + 
A82 58 63 P  < 1 +  + + + + 
D83 94 95 P  7 ± 12 (n = 3) + + + + + + 
L84 60 85 P  n.d. n.d. n.d. 
F85 7 77 L  44 (n = 1) + + + + + 
M86 7 55 P  19 ± 27 (n = 2) + + + + + 
V87 11 45 P  10 ± 9 (n = 3) + + + + + 
F88 7 58 L  38 ± 14 (n = 3) + + + + + + + 
G89 5 18 P  53 ± 4 (n = 2) + + + + + + + 
G90 3 22 P  11 ± 15 (n = 2) + + + 
Table 2: Protein production analysis: this table compiles localization and conservation of the mutated
residues, production of functional protein, λmax and conclusions from immunoblot analysis of wild type
rhodopsin, SOH ∆C and subsequent mutations SOH ∆C/Y74C to SOH ∆C/G90C. Y74 indicates mutant SOH
∆C/Y74C, I75 indicates SOH ∆C/I75C etc; % conservation: the percentage conservation within the GPCR
family; R (Residue) = percentage absolute conservation of a residue within the GPCR family, C (Class) = %
percentage conservation within the same residue subclass within the GPCR family. Classification of
subclasses of residues: apolar, large: Y/L/I/F/M, apolar, small: A/G/V/P, polar, non-charged: S/T/N/P/H,
polar, charged: D/E/K/R. Localization: localization of the amino acid residue in either the lipid face (L) or
protein face (P) of helix II, based upon the crystal structure [1-3]. Immunoblot analysis was performed on total
cellular protein of Sf9 cells infected with baculovirus expressing recombinant opsins. Blots were screened
with primary, polyclonal antibody CERN886 or CERN922. The plusses indicate the relative amount of
respectively glycosylated or non-glycosylated opsin relatively to wild type assessed by visual inspection.
Protein production by wild type was set at 100%. + = # 25%, ++ = 25 – 50%, +++ = 50 – 75%, ++++ ≥75%
compared to wild type (some mutants appear to produce larger amounts of protein than wild type). About 40%
of wild type protein production consists of glycosylated and about 60% consists of non-glycosylated opsin.
Functional protein was measured by UV-VIS spectra before (1) and after (2) illumination in the presence of
20 mM hydroxylamine [10]. n.d.= not determined, n = number of independent experiments. 
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4.3 Results 
 
4.3.1 Protein production 
The total amount of recombinant opsin produced was estimated by means of 
immunoblot analysis (Table 2). All mutants except SOH ∆C/A80C gave a protein 
product. Both glycosylated as well as non-glycosylated opsin were generated [15] (see 
Fig. 3, Chapter 3 for general glycosylation patterns). Most mutants produced amounts of 
non-glycosylated protein similar to or even higher than glycosylated protein, with the 
exception of SOH ∆C/L77C (Table 2). 
The capacity of the recombinant opsins to bond with 11-cis retinal to form a 
photosensitive pigment was analysed at 4 d.p.i. by measuring the resulting UV-VIS 
spectrum before and after illumination. Subtraction of the spectrum after illumination 
from the spectrum before illumination gives a difference spectrum, where interference 
with e.g. sloping baselines is cancelled out. This allows a better estimation of the λmax 
and the amount of recombinant protein that is produced. Base-mutant SOH ∆C 
produced 26% ± 12 ( n = 12) functional protein compared to wild type rhodopsin (wt) 
(≡ 100%). Functional protein production of SOH ∆C/L84C has not yet been determined. 
Mutants Y74C, I75C, L76C, N78C, D83C, M86C, V87C and G90C produced less 
Fig. 2: Typical patterns observed for intracellular localization of wild type and mutant rhodopsins in Sf9
insect cells analysed by confocal immunofluorescence microscopy. A: wild type rhodopsin; B: SOH ∆C; C:
SOH ∆C/L77C; D: SOH ∆C/I75C; E: localization of the E.R.. D is typical for pigments producing low
amounts of functional protein. Cells were seeded on coverslips, grown to 50% coverage of the coverslip and
infected with recombinant baculovirus. Opsins were localized with the anti-rhodopsin antiserum CERN886
(1:2000). The E.R. was localized using ER-tracker Blue-White DPX (Molecular Probes). The immunopositive
shell evident in (A) (B) and (C) represents staining of the plasma membrane. Similar staining was never
observed in condition (D).
A B
C D
E
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functional protein than SOH ∆C, while the mutants L79C, A80C, V81C and A82C even 
produced no detectable amount of functional protein (Table 2). On the other hand, the 
mutants L77C, F85C, F88C and G89C yielded more functional protein than the base-
mutant (30 – 66% of wild type, Table 2). Due to temporal and logistic restrictions only  
mutant SOH ∆C/L77C and base-mutant SOH ∆C could be analysed for their structural 
and functional properties.  
Confocal laser scanning microscopy was used to analyse the intracellular distribution of 
Fig. 4: G protein activation capability of purified pigments. Intrinsic fluorescence enhancement (excitation:
295 nm; emission: 337 nm) of the G protein α-subunit upon GTPγS binding was used to monitor activation by
wild type rhodopsin, SOH ∆C and SOH ∆C/L77C. The measuring sample contained 100 nM of transducin
and 5 nM of pigment. The sample was illuminated and after an equilibration period the reaction was initiated
by the addition of guanosine 5’-O-(3-thiotriphosphate) (GTPγS) to a concentration of 2.5 µM (arrow). The G
protein activation capability of SOH ∆C and SOH ∆C/L77C was higher but not significantly different from
wild type rhodopsin. n = 3.
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Fig. 3: Difference absorbance spectra of wild type rhodopsin, base-mutant SOH ∆C and mutant SOH
∆C/L77C. Spectra were obtained by subtracting a spectrum after illumination in the presence of 20 mM
hydroxylamine from the original spectrum before illumination. Note the blue shift of the λmax of both SOH ∆C
and SOH ∆C/L77C compared to wild type rhodopsin. The insert shows the spectrum of SOH ∆C after
purification by IMAC.
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wild type and mutant rhodopsins upon baculovirus expression in Sf9 insect cells (Fig. 
2). To distinguish between localization in the endoplasmic reticulum (ER) and other 
intracellular membranes we used a specific marker for the ER, ER-tracker Blue-White 
DPX (Molecular Probes) as shown in Figure 2.E. Base-mutant SOH ∆C was retained 
mainly in the E.R. and targeted to a smaller extent to the plasma membrane (Fig. 2.B) 
whereas wild type was preferentially targeted to the plasma membrane (Fig. 2.A) [16]. 
SOH ∆C/L77C was also present both in the plasma membrane and the ER, but showed 
stronger plasma membrane labeling than SOH ∆C (Fig. 2.C). The localization pattern of 
SOH ∆C/I75C is representive for the mutants that produced less than 20% of functional 
protein relative to wild type (Fig. 2.D). These mutants showed no detectable targeting to 
the plasma membrane but largely accumulated intracellularly in the E.R.. 
 
4.3.2 Purification and reconstitution 
Mutant SOH ∆C/L77C and base-mutant SOH ∆C were the only mutants that timely 
produced sufficient amounts of functional protein for purification by IMAC and further 
analysis. Purification was performed based on the approach developed for wild type 
rhodopsin as described before [6,9]. This method uses DoM for extraction. However, 
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Fig. 5: Photocascade of wild type rhodopsin, SOH ∆C and SOH ∆C/L77C measured at pH 6.5, 10°C. A1-A3:
overview photocascade; A1: SOH ∆C/L77C, A2: SOH ∆C, A3: wild type rhodopsin; B1-B3: spectrum 2-1
shows the formation of Meta I and Meta II, spectrum 10-2 reflects the Meta II to Meta III transition of
respectively SOH ∆C/L77C (B1), SOH ∆C (B2) and wild type rhodopsin (B3).
Datawyse
Cysteine scanning on SOH ∆C background 
   
 67
extraction of SOH ∆C and SOH ∆C/L77C in DOM was poor and 
CHAPS/nonylglucoside was eventually selected as optimal detergent mixture allowing 
extraction of the pigment as well as binding to the Ni2+-matrix. Washing and elution 
was performed with nonylglucose as detergent. In parallel experiments base-mutant 
SOH ∆C was purified with a recovery of 40% ± 14 (n = 2) (ratio 280/492 = 2.8 ± 0.2), 
wild type rhodopsin with 40% recovery (n = 1) (ratio 280/498 = 2.4) and SOH 
∆C/L77C with 75% recovery (n = 1, ratio 280/492 = 2.4). A ratio of 1.7 – 1.8 indicates 
highly purified rhodopsin. We also determined the amount of reactive -SH groups for 
SOH ∆C, SOH ∆C/L77C and wild type rhodopsin using the DTNB assay. We found 5.6 
± 0.2 (n = 4) for wild type rhodopsin, 0.08 for SOH ∆C and 0.8 for SOH ∆C/L77C, in 
agreement with the theoretical value of six free -SH groups in SOH WT, none in SOH 
∆C and one free -SH group in SOH ∆C/L77C. The spectra of SOH ∆C and SOH 
∆C/L77C were very similar in bandshape to wild type rhodopsin but show a blue-shift 
that is comparable for both mutants (λmax: 498 nm → 492 nm) (Fig. 3). The inset in 
Figure 3 shows the spectrum of purified SOH ∆C. After purification, SOH ∆C and SOH 
∆C/L77C were reconstituted into a native bovine retina lipid environment using 
detergent extraction with cyclodextrin as described in [6,9]. SOH ∆C was reconstituted 
with 50% recovery, SOH ∆C/L77C with 65% recovery and wild type was reconstituted 
with 77% recovery. 
 
 
4.3.3 Functional analysis 
The G protein activation capability was determined by measuring the intrinsic 
fluorescence enhancement of the G protein α-subunit upon GTP binding. Base-mutant 
SOH ∆C and mutant SOH ∆C/L77C showed a similar activation capacity that was 
higher than that of wild type rhodopsin but considering the limited number of 
experiments was not yet significantly different (Fig. 4). 
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Fig. 6: pH dependence of the Meta I ↔ Meta II equilibrium of wild type rhodopsin, SOH ∆C and SOH
∆C/L77C. Measurements were performed at 10°C or 20°C. The solid line represents best fits with a
Michaelis-Menten equation. The pKa of SOH ∆C and SOH ∆C/L77C could not be determined at 10°C. At
20°C and pH 6.5 the three species seem to coincide.
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Figure 5.A shows the photocascade of SOH ∆C/L77C (A1), SOH ∆C (A2) and wild 
type rhodopsin (A3). Rapid and slow changes are given as difference sp ectra in the B 
panel, highlighting the formation of Meta I and Meta II (spectrum 2 - 1) and the decay 
of Meta II and the formation of Meta III (spectrum 10 - 2). The photocascade of SOH 
∆C (Fig 5, A2) seems to be very similar to wild type rhodopsin (Fig. 5, A3) but more 
detailed analysis showed that SOH ∆C formed less Meta I and a reduced decay of Meta 
II to Meta III compared to wild type rhodopsin (Fig. 5, B2). SOH ∆C/L77C behaved 
even more aberrant than SOH ∆C. It again showed little Meta III formation but 
compared to SOH ∆C it produced more Meta I that however seems to decay fairly 
rapidly (Fig. 5, B1). In wild type rhodopsin the late photointermediates Meta I and Meta 
II are in a pH-dependent equilibrium [17-21] that determines the level of activated 
receptor (Meta II). The Meta I ↔ Meta II equilibrium was analysed for SOH ∆C, SOH 
∆C/L77C and wild type rhodopsin in the pH range 4.5 - 8.8 (Fig. 6). At pH values 
higher than 8.8 Meta I becomes very unstable and can not be reliably determined. The 
assay was performed at 10°C, where Meta II is sufficiently stable ( t½ > 20 min.). Wild 
type rhodopsin has a pKa of 6.5 ± 0.2 (n = 5) for this equilibrium but in SOH ∆C it was 
not very pH-dependent indicating that the pKa was outside this range or the pH-
dependence was lost. The pKa of SOH ∆C/L77C could not be accurately determined but 
seems to have shifted to lower pH. A single measurement at 20°C, pH 6.5 suggests that 
at this pH and this temperature SOH ∆C and SOH ∆C/L77C behave more similarly to 
wild type (Fig. 6). 
Figure 7 shows the FT-IR difference spectrum of the rhodopsin → Meta I transition of 
SOH ∆C, SOH ∆C/L77C and wild type rhodopsin. The spectra of both mutants showed 
marked similarity to that of wild type rhodopsin but exhibits more pronounced peaks at 
1767, 1748, 1686, 1500, 1204 and 830 cm-1. The FT-IR difference spectra of the 
rhodopsin → Meta II transition of both mutants were highly similar to that of wild type 
in the 1800-800 cm-1 range, accurately copying all positive and negative peaks except 
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Fig. 7: FT-IR difference spectra of the rhodopsin → Meta I transition of wild type rhodopsin, SOH ∆C and
SOH ∆C/L77C. The 1800-800 cm-1 region, where the major changes occur, is shown. Spectra were taken at -
20°C, where wild type Meta I intermediate is stable. Note that SOH ∆C and SOH ∆C/L77C display several
peaks typical for Meta II at respectively 1767, 1748, 1586, 1500 and 830 cm-1.
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for some minor changes around 1650 cm-1 (Fig. 8). However, the 2600-2500 cm-1 
region in the difference spectrum of the mutant rhodopsins is obviously different from 
that of wild type rhodopsin. Both SOH ∆C and SOH ∆C/L77C lack the band near 2550 
cm-1 that can be assigned to -SH stretch vibrations (Fig. 9) [22]. 
 
 
4.4 Discussion 
 
4.4.1 Expression of single TM II cysteine mutants 
Total levels of recombinant protein production were estimated from SDS-PAGE. About 
half of the mutants produced quantities of recombinant protein at least 50% of that 
observed for base-mutant SOH ∆C. Correctly folded and functional opsin will be 
transported to the plasma membrane. The intracellular distribution of the recombinant 
proteins was studied in Sf9 insect cells by means of confocal laser scanning 
immunofluorescence microscopy. Most mutants were retained intracellularly in the ER 
except for base-mutant SOH ∆C and mutant SOH ∆C/L77C which showed partial 
localization in the plasma membrane. Wild type rhodopsin on the other hand is 
preferentially targeted to the plasma membrane. These results suggest that the majority 
of the mutants displays folding and/or transport defects. 
In addition to targeting to the rod outer segment membrane, rhodopsin requires 
posttranslational modifications like palmitoylation, disulfide bridge formation and 
glycosylation to reach structural and functional maturity. Correct folding is thought to 
be necessary for proper glycosylation [23,24]. Most mutants showed poor glycosylation 
except for SOH ∆C/L77C which produced a relative amount of glycosylated protein that 
is comparable to wild type rhodopsin. This is in agreement with their intracellular 
localization pattern: mutant SOH ∆C/L77C showed targeting to the plasma membrane 
whereas most mutants were retained intracellularly. This supports the suggestion that 
Fig. 8: The 1800-800 cm-1 region of the FT-IR difference spectra of the rhodopsin → Meta II transition of
wild type rhodopsin, SOH ∆C and SOH ∆C/L77C. Spectra were taken at 10°C and pH 6.0 within 5 minutes
after illumination, in order to minimize interference by the slow decay of Meta II (half life of > 20 minutes
under these conditions). The spectra of SOH ∆C and SOH ∆C/L77C are nearly identical in this region and
highly similar to that of wild type rhodopsin.
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most mutants suffer from folding defects. SOH ∆C/A80C showed no protein product at 
all in initial experiments. This has not been investigated further. 
 
4.4.2 Functional properties of single TM II cysteine mutants 
The mutant rhodopsins were tested for production of functional protein in Sf9 insect 
cells. Base-mutant SOH ∆C produced about 75% less functional protein than wild type 
rhodopsin. While most of the cysteine mutants produced even less functional protein 
than SOH ∆C or no detectable amounts of functional protein at all, some (L77C, F85C, 
V87C, F88C and G89C) produced similar or even much higher amounts of functional 
protein. For technical reasons only SOH ∆C/L77C could be further analysed so far. 
Analysis of the relative amount of glycosylated species showed that base-mutant SOH 
∆C displayed poor levels of glycosylation compared to wild type rhodopsin, whereas 
SOH ∆C/L77C showed wild type-like levels of glycosylation. This supports the concept 
that glycosylation is an indication for the presence of functional protein.  
To obtain sufficient amounts of functional mutant rhodopsins for purification and 
further analysis, large culture volumes would be necessary. In addition, the relatively 
large amount of non-functional protein produced by most mutant rhodopsins will 
hamper protein purification and will significantly affect recovery of functional protein 
(P. Bovee-Geurts, unpublished results). Until now, only base-mutant SOH ∆C and SOH 
∆C/L77C could be purified sufficiently to allow analysis of structural and functional 
properties. Both mutants were purified with a recovery similar to or even higher than 
that of wild type rhodopsin, although their reconstitution into retina lipids was less 
efficient. These preparations allowed more detailed analysis of their spectral and 
photochemical properties. The UV/VIS difference spectra of the mutants showed a very 
similar bandshape to that of wild type except for a blue-shift in their λmax that was 
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Fig. 9: FT-IR difference spectra of the rhodopsin → Meta II transition of wild type rhodopsin, SOH ∆C and
SOH ∆C/L77C. The 2600-2500 cm-1 region is shown where the stretch vibration of the sulfhydryl group
absorbs. Spectra were scaled on the 1750 cm-1 band, typical for the Meta II state. Note that -SH band activity
is virtually absent in SOH ∆C and SOH ∆C/L77C.
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comparable for both SOH ∆C and SOH ∆C/L77C (498 nm → 492 nm, Fig. 3). The shift 
in λmax is probably due to the C167S mutation, since the single C167S mutant on a wild 
type background exhibits a similar blue shift (M.J.M. Portier-VandeLuytgaarden, 
unpublished results). Residue C167 participates in the lining of the retinal binding site 
and in the formation of the active state of Meta II (DeGrip et al., unpublished results), 
hence may be close enough to influence the electronic properties of the chromophore. 
The blue shift indicates that light of higher energy is required for the mutant to reach the 
activated state, indicating that the C167S substitution stabilizes the ground state and/or 
destabilizes the excited state. 
Estimation of the number of -SH groups per mole of rhodopsin by their reactivity with 
DTNB confirmed the phenotypes: 5.6 ± 0.2 per mole of pigment for wild type 
rhodopsin (n = 4) in agreement with the native six cysteines, 0.08 for SOH ∆C 
reflecting the lack of cysteines in SOH ∆C and 0.8 for SOH ∆C/L77C representing the -
SH group derived from the Leu → Cys mutation at position 77. The number of -SH 
groups of SOH ∆C also demonstrates that at least 96% of the Cys110 and Cys187 
residues in the purified pigment have generated a disulfide bond. 
The purified pigments SOH ∆C and SOH ∆C/L77C were tested for their functional 
properties. The photocascade of SOH ∆C, SOH ∆C/L77C and wild type rhodopsin was 
analysed at 10°C, pH 6.5 (Fig. 5). SOH ∆C formed similar amounts of Meta I as wild 
type rhodopsin where SOH ∆C/L77C formed more Meta I than wild type. Both showed 
only little decay of Meta II into Meta III. Analysis of the MI ↔ MII equilibrium at 10°C 
showed that the mutants displayed either no pH dependence in the range analysed (SOH 
∆C) or that the pKa seemed to be shifted to the left but this could not be exactly 
determined (SOH ∆C/L77C). The pKa of the Meta I ↔ Meta II equilibrium is largely 
determined by residues E134 and H211 that form part of an H-bonded network in 
rhodopsin [1,25,26]. There is strong evidence that residue Asp83 also forms part of an 
H-bonded network [1,4,27,28]. Mutation of Asp83 into a cysteine did retain wild type-
like properties and we concluded that cysteine –SH residues can also participate in this 
H-bonded network (Chapter 2) [4]. Cysteine 167 and 264 are structurally active during 
the photoactivation of rhodopsin (DeGrip et al., unpublished results) as indicated by 
changes in their –SH group vibration. This is strongly suggestive of a change in H-
bonding properties, and of participation in (a) H-bonded network(s). If these 
communicate with the pH-sensor of the Meta I ↔ Meta II equilibrium, it might explain 
why mutation of these cysteine residues could disturb the Meta I ↔ Meta II equilibrium 
and the lack of pH dependence of base-mutant SOH ∆C. This suggests that -SH residues 
might be involved in pH-sensing. Residue L77 is located close to a water molecule 
located in a cavity between helix II, VI and VII. Mutation of this residue into a cysteine 
introduces a –SH group at this position which may H-bond to and/or perturb the 
position of this water molecule. Whether such subtle conformational changes are 
sufficient to explain the different pH dependency of SOH ∆C/L77C relative to SOH ∆C 
presents a fascinating topic for further research.  
FT-IR difference spectroscopy is very sensitive to changes in protein structure. We used 
this technique first of all to probe whether substitution of the residues of the second 
transmembrane helix by a cysteine caused long-range structural perturbations and 
secondly to identify participation of the newly introduced –SH groups in rhodopsin 
activation. The difference spectra of the rhodopsin → Meta I transition of SOH ∆C and 
SOH ∆C/L77C were quite similar to that of wild type rhodopsin except for peaks 
around 1767, 1748, 1686, 1500 and 830 cm-1. These peaks reflect typical Meta II 
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vibrations indicating that the mutants show conformational changes that are typical for 
Meta II at a temperature where wild type Meta I is still fully stable. This suggests that 
the temperature dependence of the Meta I → Meta II transition has changed in the base-
mutant. The FT-IR difference spectrum of the rhodopsin → Meta II transition of SOH 
∆C was very similar to wild type rhodopsin accurately copying all positive and negative 
peaks in the 1700-800 cm-1 range except for some minor changes around 1650 cm-1. 
These data indicate that the cysteine mutants do not cause long-range perturbations in 
protein structure. As expected the 2600-2500 cm-1 region of SOH ∆C and SOH 
∆C/L77C clearly differs from that of wild type. This region can be assigned to -SH 
stretch vibrations which peak at 2548 cm-1 in wild type rhodopsin [22]. This peak is 
absent in the rhodopsin → Meta II FT-IR difference spectrum of SOH ∆C because in 
this base-mutant all (potentially) reactive cysteines have been replaced by a serine. The 
Rho → Meta II difference spectrum of mutant SOH ∆C/L77C was very similar to SOH 
∆C and also shows no -SH stretch vibration. This indicates that residue 77 is not 
structurally involved in the photoactivation of rhodopsin. 
The MI ↔ MII equilibrium measured at 10°C showed no pH dependency for SOH ∆C 
whereas the pKa for SOH ∆C/L77C could not be determined. At pH 7.4 and at 10°C, 
base-mutant SOH ∆C produced a higher percentage of Meta II than wild type. The FT-
IR difference spectra of SOH ∆C at -20°C, at which wild type Meta I is stable, show a 
mixture of Meta I and Meta II, also suggesting changes in the MI ↔ MII equilibrium in 
support of the higher level of Meta II evident in the UV/VIS spectral analysis. If this 
difference persists at 20°C it might explain the somewhat higher G protein activation 
capability of the mutant since higher levels of Meta II, the active state, are present. On 
the other hand, the FT-IR difference spectrum of Meta II of both mutants shows no 
indication for the presence of significant amounts of Meta I. This is in contradiction 
with the UV/VIS data showing an increased amount of Meta I in the L77C mutant at 
10°C. We have not yet been able to resolve this discrepancy. At 20°C and pH 6.5 the 
equilibrium constants of the MI ↔ MII equilibrium of the three species coincide again. 
Clearly, further experiments, both at various temperatures and pH values will be 
necessary to properly evaluate the photochemical changes induced by these mutations. 
The question remains why the majority of the mutants produced little or no functional 
protein. We chose to study the second transmembrane domain of rhodopsin because 
from earlier experiments we know that Asp83 forms part of a H-bonded network [2,3] 
that shows major rearrangements during photoactivation and hence most likely is 
involved in the photoactivation of rhodopsin. In order to prevent a large background in 
the introduced signal by native cysteines and possible reciprocal interactions of 
introduced cysteines with native cysteine residues, we used SOH ∆C as base-mutant to 
substitute single residues by a cysteine (Chapter 3). In this base-mutant all (potentially) 
active cysteines were replaced by a serine. Cysteine and serine differ only in the hetero-
atom in the side chain and replacement of cysteine by serine involves the exchange of 
two relatively small side chains. Although substitution of cysteine by serine involves the 
replacement of a non-polar by a polar residue, serine has been reported as a suitable 
substitute for cysteine in base-mutants of other membrane proteins without disturbing 
their structural and functional properties [29,30]. However, although total amounts of 
recombinant protein do not differ strongly, base-mutant SOH ∆C produces much lower 
quantities of functional recombinant protein than wild type rhodopsin. Cysteine 167 and 
264 form part of the retinal binding site and are structurally active during the 
photoactivation of rhodopsin. Single substitution of these residues by a serine on a wild 
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type background significantly reduced their stability during purification (M.J.M. 
Portier-VandeLuytgaarden, unpublished results). Since conformational stability is 
considered to be a positive factor in the protein folding process [31], reduced stability 
might be a cause for the less successful folding of the base-mutant under overexpression 
conditions. The observation that this is aggravated by certain cys-substitutions and 
partially rescued by others is a very intriguing phenomenon that deserves further 
studies. 
The residues of the second transmembrane helix analysed in this study show a varying 
extent of relative conservation of their position in this helix within the family of G 
protein-coupled receptors (Table 2) [32]. Mutation of residues with 30% or higher 
degree of residue conservation gave very low amounts of functional protein and showed 
little glycosylation except for SOH ∆C/L77C which gave 65% functional protein 
compared to wild type and showed wild type-like glycosylation (Table 2). Mutation of 
residues with less than 30% residue conservation within the family of G protein coupled 
receptors in general produced reasonable amounts of functional protein, sometimes even 
higher than SOH ∆C, except for mutant Y74C. Tyr74 contains an aromatic side chain 
and is located in the lipid face of TM II. Substitution by a cysteine introduces a smaller 
residue which might cause a local structural rearrangement, explaining the lower 
amounts of functional protein production. However, this is only speculative and further 
experiments are needed to resolve this question. Residues that play an important role in 
protein structure and/or function are in general well conserved. Thus, mutation of such 
residues might display a more pronounced effect on functional protein production than 
mutation of less conserved residues. This suggests that the degree of conservation can 
be an indication for the production of functional protein in cysteine scanning 
mutagenesis. Considering this, it is interesting to note that no relationship was evident 
between class-based conservation and production of functional and/or glycosylated 
protein (Table 2). The residues of TM II are either located in the lipid face or in the 
protein face of the transmembrane helix (Table 2). Residues that are located in the 
protein face are located in closer contact with residues from neighbouring helices and 
mutations of these residues might therefore more easily disturb rhodopsin structure and 
functionality. However, no clear relationship could be found between localization and 
the extent of functional protein production and/or glycosylation of the recombinant 
opsins. It should be noted that reduced production of functional protein can be caused 
either by reduced ability to fold, producing non-glycosylated protein, or by disturbance 
of ligand binding in spite of proper folding and glycosylation. In our experiments, 
ligand binding was primarily used as a marker for functionality. For instance, SOH 
∆C/G90C produced no detectable amount of functional protein. Residue G90 is located 
in the vicinity of E113, the counterion for the protonated Schiff base formed between 
retinal and K296. Mutation of this residue might therefore disturb the formation of the 
Schiff base. On the other hand, mutation G90D on a wild type background is known to 
produce functional protein in similar amounts as wild type rhodopsin [33]. 
Nevertheless, we cannot exclude that sterical hindrance interfering with ligand binding 
may account for several mutants yielding low protein functionality. 
In summary, there might be a relationship between the extent of conservation and the 
amount of glycosylated, functional rhodopsin protein production that should be further 
investigated. Nevertheless, it remains largely unclear why most mutants produce little or 
no functional protein. So far, the only conclusion we can draw from these cysteine 
scanning efforts is that residue L77 is not involved in structural or enzymatical changes 
underlying rhodopsin activation. Indeed, residue L77 is located in the lipid face of TM 
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II and hence probably inserted in the lipid matrix (Table 2) which makes it plausible 
that this residue does not participate in photoactivation.  
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Abstract 
 
Mutation of the residues of the second transmembrane domain of rhodopsin on a 
cysteine-free background appeared to cause major problems in functional expression. 
Hence, we modified our initial approach and decided to evaluate cysteine scanning 
mutagenesis of the second transmembrane segment on a wild type background. In 
contrast to the cysteine-free background most wild type-based single cysteine mutants 
produced total levels of recombinant protein equal to wild type rhodopsin, and similar 
amounts of glycosylated protein, as well. All mutants produced quantities of functional 
protein that would be sufficient for purification by IMAC and for further analysis. Until 
now, the mutants L76C, L79C, V81C, D83C, F85C, F88C, G89C and G90C have been 
partially analyzed. It was shown before that residue Asp83 does not play an essential 
role in signal transduction by rhodopsin, but that it contributes to structure and 
photochemistry by interaction with H-bonded networks. Our data so far indicate that 
residues Leu76, Val81 and Phe85 do not seem to be essential for signaling, but residues 
Phe88, Gly89 and Gly90 most likely participate in Meta II formation and receptor 
activation. Due to the prominent wild-type background in the –SH peak region of the 
FT-IR difference spectrum, the activity of the substituted cysteine residues is difficult to 
interpret. We therefore conclude that for an effective combination with FI-IR difference 
spectroscopy cysteine scanning mutagenesis is better performed on a background free of 
endogenous cysteine activity. 
 
 
5.1 Introduction 
 
Rhodopsin is a membrane spanning protein containing seven transmembrane segments 
(TM) that belongs to the family of G protein-coupled receptors. Rhodopsin is a unique 
member of this family because its ligand, 11-cis retinal, is covalently bound to the 
protein, opsin. Upon photoactivation, the retinal ligand isomerizes to the all-trans form 
and drives the protein through a series of transient photointermediates (Rhodopsin → 
Bathorhodopsin (Batho) ↔ Blue-shifted intermediate (BSI) → Lumirhodopsin (Lumi) 
→ Metarhodopsin I (Meta I) ↔ Metarhodopsin II (Meta II) → Metarhodopsin III (Meta 
III)) that within milliseconds leads to the generation of the active state (Meta II), which 
binds and activates the G protein transducin (GT) [1].  
The 3D-crystal structure of ground-state rhodopsin (2.8 Å resolution) [2] does not show 
what elements of the protein are involved in the photoactivation of rhodopsin. Results 
from earlier experiments indicate that the second transmembrane domain (TM II) of 
rhodopsin undergoes structural changes during photoactivation [2-6]. Our aim is to 
study the contribution of the protein residues of the second transmembrane domain to 
the photoactivation of rhodopsin by means of cysteine scanning mutagenesis in 
combination with FT-IR difference spectroscopy. However, the cysteine sulfhydryl 
peak will appear on the background of native cysteines and might interfere with native 
cysteine residues. Our initial goal therefore was to study the residues of TM II on a 
cysteine-free background (SOH ∆C) (see Chapter 3) but mutation of these residues on 
this background appeared to cause major production problems (see Chapter 4). In 
Chapter 2 of this thesis we showed that a change in the vibrational properties of a single 
cysteine sulfhydryl group can be measured on the background of native cysteines. With 
this knowledge in mind we modified our initial plan and decided to perform cysteine 
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scanning mutagenesis of TM II on a wild type (wt) background since this was likely to 
generate less severe functional expression problems. 
 
 
5.2. Materials and methods 
 
5.2.1 Cloning and expression 
Synthetic cDNA of bovine rhodopsin (SOH WT) was kindly provided by Oprian 
(Brandeis University, Waltham) in the PMT vector. Restriction sites were introduced by 
means of silent mutations to allow modification and analysis by means of restriction 
enzymes. All constructs were extended with a 6X his-tag to allow rapid purification by 
immobilized metal affinity chromatography (IMAC) [7]. Mutants SOH WT/Y74C – 
N78C and SOH WT/L84C – G90C were constructed by means of cassette mutagenesis 
as described in Chapter 4 using the same cassettes as used in the cysteine-free mutants. 
After cloning of the cassette into SOH WT, the recombinant SOH WT was cloned into 
the transfer vector pFastbac DUAL under control of the polyhedrin promotor. This 
transfer vector was used to generate recombinant baculovirus as described in Chapter 3. 
The cassettes were checked for the correct mutation by cycle-sequencing using primer 
5’-cagttttgtaataaaaaaacctataaat-3’ located in the polyhedrin promotor site of pFastbac 
DUAL or appropriate rhodopsin primers [8]. Mutants SOH WT/L79C – A82C were 
constructed by exchange of the corresponding mutation from the SOH ∆C-mutant 
(pBlueScript II SK- vector) to SOH WT (pFastbac DUAL vector) using restriction 
enzymes BamH I and Nco I (Life Technologies Inc.). To prevent digestion of the Nco I-
site located in the p10 promoter site of the pFastbac DUAL vector, this restriction site 
was first removed by digesting the vector with Nco I, after which the sticky ends of the 
restriction site were filled to create blunt ends using T4 DNA polymerase. Next, the 
vector was closed by ligation and SOH WT was subcloned from the pBlueScript II SK- 
vector into this modified pFastbac DUAL vector. The mutation of interest could now be 
excised of the SOH ∆C-mutant and cloned into SOH WT in the pFastbac DUAL vector 
using the BamH I and Nco I restriction sites. The cassettes were checked for the correct 
mutation by cycle-sequencing as described above. SOH WT/D83C was directly 
subcloned from the pAcRP23 vector [9] into the pFastbac DUAL vector. 
The Bac-to-bac Baculovirus Recombination system (Life Technologies Inc.) was used 
as described in Chapter 3 to generate recombinant baculovirus for expression of 
recombinant rhodopsin in Sf9 Spodoptera frugiperda cells. The recombinant virus (P1) 
was tested for production of (recombinant) opsin by means of Western blotting and viral 
DNA was tested for the correct rhodopsin insert by restriction enzyme analysis or 
sequencing of viral nuclear DNA as described in Chapter 3. 
The recombinant virus was amplified (P2) and the virus titer was determined by means 
of a plaque assay (see Chapter 3). For expression of recombinant protein Sf9 cells were 
adapted in monolayer culture in T182 culture flasks to serum-free InsectXpress medium 
(Cambrex). For large scale productions in the bioreactor (1 - 10 litre), InsectXpress 
medium-adapted cells were scaled up in spinner flasks to obtain a minimum 
concentration of 5·105 cells/ml in the bioreactor. The cells were infected in mid log 
phase with a multiplicity of infection of 0.05-0.1 and finally harvested at 4 d.p.i. as 
described before [8,10,11]. 
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5.2.2 Analysis of recombinant rhodopsins 
Total recombinant protein production was analyzed by SDS-PAGE (12% acrylamide) of 
total cellular protein followed by immunoblotting with an anti-rhodopsin antibody as 
described in Chapter 3. 
The capacity of the recombinant opsins produced by Sf9 cells to bond with 11-cis 
retinal to form a photosensitive pigment was assayed by incubation of total cellular 
membrane preparations with a five-fold excess of 11-cis retinal under dim red light 
(Schott 610 long pass filter) or in darkness, as described before [8]. Formation of 
photosensitive pigment was analyzed by recording UV-VIS spectra before (1) and after 
(2) illumination in the presence of 20 mM hydroxylamine [12] and is presented as 
difference spectra (1-2). 
The mutants and wild type rhodopsin were purified by means of immobilized metal 
chromatography (IMAC) over Ni2+ agarose as described before in [11] except that after 
regeneration with 11-cis retinal the samples were treated with 2 M dimethyl thiourea in 
20 mM Pipes, 130 mM NaCl, 10 mM KCl, 3 mM MgCl2, 2 mM CaCl2, 0.1 mM EDTA, 
pH 6.5 for 30 min at 4°C to remove non-intrinsic membrane proteins. After 
centrifugation (30 min, 92,000xg, 4°C) the supernatant could be used for IMAC. Not 
every mutant pigment was efficiently extracted in DOM and therefore alternative 
detergents were used. For SOH WT/L76C, SOH WT/G89C extraction was performed in 
DOM (10 mM)/CHAPS (10 mM) and SOH WT/F88C, SOH WT/G90C and wild type 
rhodopsin were extracted in nonylglycose (20 mM). After centrifugation (30 min, 
92,000xg, 4°C), the supernatant was treated on ice with ammonium sulphate to a final 
concentration of 1.79 M to remove part of contaminating protein. After incubation for 
120 min and another centrifugation step (30 min, 92,000xg, 4°C) the supernatant could 
directly be applied to a Ni2+ NTA agarose column. After washing, the bound pigments 
were eluted with 20 mM bis-trispropane, 150 mM NaCl, 15% glycerol, 5 mM β-
mercaptoethanol, 20 mM nonylglycose, 50 mM histidine, pH 6.5. After purification the 
pigments were reconstituted into retina lipids as described previously [13]. 
pH dependence of the Meta I → Meta II transition was measured according to DeLange 
et al., 1997 [14]. In short, rhodopsin proteoliposomes were resuspended in buffer with 
appropriate pH. A spectrum was recorded between 750 and 250 nm of the initial, 
unbleached sample. (spectrum 1). After illumination a second spectrum was recorded 
(spectrum 2). The relative amount of Meta I formed after illumination was derived from 
the linear relationship between the λmax of the difference spectrum (spectrum 1 – 
spectrum 2) and the percentage photoproduct formed. 
Activation of the bovine G protein transducin (GT) by recombinant rhodopsin was 
measured by the intrinsic fluorescence enhancement of the G protein α-subunit upon 
binding of GTPγS (Roche) as earlier described [12,15] (Chapter 3). 
FT-IR analyses were performed on a Bruker IFS 66v/S spectrometer using set up and 
settings as described in Chapter 3. 
 
 
5.3 Results 
 
5.3.1 Protein production 
The total amount of recombinant opsin produced was estimated by means of 
immunoblot analysis. Most mutants produced total amounts of recombinant protein of at 
least 75% compared to wild type but the ratio of glycosylated opsin [16] to non-
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glycosylated opsin varied (Table 1). Most mutants produced amounts of glycosylated 
protein in the same range as wild type. In addition, both wild type and mutants produced 
considerable quantities of non-glycosylated protein. 
The mutant rhodopsins were tested for production of functional protein in Sf9 insect 
cells on a small scale (T182 flasks). The capacity of the recombinant opsins to bond with 
11-cis retinal to form a photosensitive pigment was analysed by UV-VIS spectroscopy. 
Subtraction of the spectrum after illumination from the spectrum before illumination 
gives a difference spectrum, in which interference with e.g. sloping baselines is 
cancelled out. This allows a better estimation of the λmax and of the amount of 
recombinant protein that is produced. The quantity of functional protein (pmol/106 cells) 
produced by the mutant rhodopsins compared to wild type varied strongly per mutant 
(13 – 167%; Table 1) but was high enough to obtain sufficient amounts of purified 
functional protein for further analysis through large scale production and purification by 
IMAC. 
 
Total protein production Functional proteinSOH WT 
Mutant Glycosylated Non-glycosylated 
% ± SD 
(wt ≡ 100%) 
wild type ++++ ++++ 100 
Y74C ++ + 33 (n = 1) 
I75C +++ ++++ 67 (n = 1) 
L76C ++ + 167 (n = 1) 
L77C ++++ ++++ 92 ± 82 (n = 2) 
N78C ++++ ++ 25 (n = 1) 
L79C ++++ ++++ 44 (n = 1) 
A80C n.d. n.d. n.d. 
V81C ++++ ++ 88 (n = 1) 
A82C + ++++ 33 (n = 1) 
D83C +++ + 80 ± 2 (n = 2) 
L84C n.d. n.d. n.d. 
F85C ++ ++++ 100 (n = 1) 
M86C ++ +++ 40 ± 3 (n = 3) 
V87C +++ ++++ 13 (n = 1) 
F88C ++++ ++++ 63 ± 18 (n = 2) 
G89C ++++ ++++ 92 ± 12 (n = 2) 
G90C +++ ++++ 72 ± 24 (n = 2) 
Table 1: Protein production analysis of mutants and wild rhodopsin produced in T182 culture flasks.
Immunoblot analysis was performed on total cellular protein of Sf9 cells infected with recombinant
baculovirus expressing (recombinant) opsins. Blots were screened with primary, polyclonal antibody
CERN922 (1:10.000). The plusses indicate the amount of respectively glycosylated or non-glycosylated opsin
relative to wild type estimated by visual inspection of blots with cellular protein. Protein production by wild
type was set at 100%. + = # 25%, ++ = 25 – 50%, +++ = 50 – 75%, ++++ ≥ 75% compared to wild type
(some mutants appear to produce larger amounts of protein than wild type). About 40% of wild type protein
production consists of glycosylated and about 60% consists of non-glycosylated opsin. Functional protein was
measured by recording UV-VIS spectra before (1) and after (2) illumination in the presence of 20 mM
hydroxylamine [12]. n.d. = not determined, n = number of independent experiments.
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5.3.2 Purification and reconstitution 
The mutants SOH WT/L76C, L79C, V81C, D83C, F85C, F88C, G89C and G90C were 
timely produced on a large scale (1 – 10 litre) to allow further analysis. Although 
significant amounts of functional protein could be generated, substantial losses were 
encountered during purification and reconstitution (Table 2), and some mutants could 
only be partly analyzed. The relative quantities of functional protein production at a 
bioreactor scale were roughly similar to those obtained in culture flasks. To allow 
detailed functional analysis the mutant rhodopsins were purified by IMAC as described 
for wild type rhodopsin [7,11]. This method uses DOM for extraction in which, 
however, mutants SOH WT/L76C, F88C, G89C and G90C were poorly dissolved and 
gave turbid solutions. Extraction was best for L76C and G89C in a combination of 
DOM/CHAPS (1:1) and for F88C and G90C in nonylglycose. Direct application of the 
resulting supernatant to the IMAC matrix, however, resulted in poor purification due to 
low binding efficiency to the matrix and substantial contamination with other proteins. 
Several approaches for reducing protein contamination before IMAC were tested, and 
Total protein production Mutant 
(SOH WT-
based) 
Production of 
functional 
protein 
(pmol/106 cells) glycosylated non-glycosylated 
λmax (nm) 
(purified 
pigment) 
Recovery 
after 
purification 
(%) 
Purity 
index† 
(A280/Aλmax) 
wild type 9 ++++ ++++ 498 ± 1 40 2.4 
L76C 9 ++ + 495 27 3.5 
L79C 6 +++ ++++ 497* - - 
V81C 5 +++ ++++ 497 21 7.8 
D83C 14 n.d. n.d. 495 ± 2 75 2.3 
F85C 6 +++ ++++ 499 25 5.1 
F88C 5 +++ ++++ 497 67 2.8 
G89C 6 ++ ++++ 499 33 4.5 
G90C 11 n.d. n.d. 489 14 2.2 
Table 2: Large scale expression and purification of SOH WT-mutants. For purification single-step Ni2+-
affinity chromatography (IMAC) was used. Total protein production was estimated relative to wild type as
explained in the legend of Table 1. 
* Determined from non-purified spectrum. 
n.d.: not determined. 
† For highly purified rhodopsin this index = 1.8 ± 0.1
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incubation with 40-45% saturated ammoniumsulphate on ice for 30 min to precipitate 
part of the contamination usually gave satisfactory results. The resulting supernatant 
could be directly applied to the IMAC matrix. The mutants were purified in parallel 
experiments and recoveries varied from 14 – 67% (n = 1) with a recovery of 40% (n = 
1) for wild type rhodopsin (Table 2). The ratio A280/Aλmax represents a purity index and 
varied from 2.2 to 7.8. A ratio of 1.8 indicates highly pure rhodopsin. The spectra of the 
mutants were very similar in bandshape to that of wild type rhodopsin, but those of 
L76C, D83C, and G90C showed blue-shifts between 3 and 9 nm (Table 2). The purified 
pigments were reconstituted into a native bovine retina lipid environment using 
detergent extraction as described in [13] with recoveries of at least 90%. 
 
5.3.3 Functional analysis 
The G protein activation capability was determined by measuring the initial rate of the 
intrinsic fluorescence enhancement of the G protein α-subunit upon GTP binding under 
standardized conditions. Mutants SOH WT/L76C, V81C, D83C and F85C displayed a 
G protein activation capability similar to that of wild type rhodopsin, whereas the 
activity of mutants F88C, G89C and G90C was reduced (Fig. 1). 
Figure 2 shows representative difference spectra of the photocascade of mutants SOH 
WT/L76C, D83C, F85C, F88C, G89C and G90C measured at 10°C, pH 6.5. Rapid and 
slow changes are given as difference spectra highlighting the formation of Meta I and 
Meta II (spectrum 1) and the decay of Meta II and formation of Meta III (spectrum 2), 
respectively. In general terms, the photocascade of all mutants was very similar to that 
of wild type rhodopsin under these conditions. The late photointermediates Meta I and 
Meta II are in a pH-dependent equilibrium [17-21]. Hence, the pKa of this equilibrium 
will determine the level of activated receptor (Meta II) at a fixed pH. The Meta I ↔ 
Meta II equilibrium was analyzed for mutants SOH WT/D83C and F88C and wild type 
rhodopsin in the pH range 5.8 – 7.5 (Fig. 3). The assay was performed at 10°C, where 
Fig. 1: G protein activation kinetics of rhodopsin mutants. Initial rate of intrinsic fluorescence enhancement
(excitation: 295 nm; emission: 337 nm) of the G protein α-subunit upon GTPγS binding was used to monitor
activation by wild type and mutant rhodopsins. Wild type rate was set at 100%. Mutants SOH WT/L76C,
V81C, F85C and G89C do not differ significantly from wild type rhodopsin, whereas the mutants SOH
WT/F88C and SOH WT/G90C exhibit significant lower activity than wild type rhodopsin. Error bars reflect
standard deviation of a concentration range (n = 5) in a single experiment. 
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Fig. 2: Difference spectra representing major transitions in the photocascade of wild type rhodopsin and
mutants SOH WT/L76C, D83C, F85C, F88C, G89C and G90C measured at 10°C, pH 6.5. Spectrum 1
shows the loss of rhodopsin concomitant formation of Meta I (480 nm) and Meta II (380 nm). Spectrum
2 reflects the decay of Meta II to several products, including Meta III (450 nm). 
Datawyse
Cysteine scanning on wt background 
   
 85
Meta II is sufficiently stable ( t½ > 20 min.). The pKa of D83C and F88C was not 
significantly different from wild type rhodopsin (pKa = 6.6 ± 0.2). For the mutants 
L76C, F85C, G89C and G90C only one data point, measured at pH 6.5, could be 
obtained. These data points again do not significantly deviate from wild type rhodopsin. 
The structural changes in the rhodopsin → Meta II transition were analyzed by FT-IR 
difference spectroscopy. Figure 4 shows this transition for the mutants L76C, D83C, 
F85C, F88C, G89C and wild type rhodopsin. The difference spectrum of SOH 
WT/D83C has been thoroughly analyzed in Chapter 2 and is very similar to that of wild  
type, except for the absence of the Asp83 carboxyl vibrations. The overall pattern of the 
other mutants is quite similar to wild type as well, indicating that the mutation has not 
induced long-range structural perturbations. Nevertheless, these mutants all clearly 
differ in intensity or bandshape from wild type in the Amide I (1620-1680 cm-1) and 
Amide II (1520-1560 cm-1) region, indicating subtle differences in secondary structure 
changes accompanying Meta II formation. In addition, small individual differences are 
observed for F85C (1356 and 1170 cm-1), F88C (1160, 1150, 1134 and 1082 cm-1) and 
G89C (1780, 1060 and 1004 cm-1). SOH WT/D83C displayed a significant increase in 
the band near 2550 cm-1 that can be assigned to –SH stretch vibrations (Fig. 5) [22]. The 
FT-IR difference spectra of the other mutants show a large background noise in this 
region. Mutant L76C and F85C may have a –SH peak area comparable to wild type but 
seem to show a peak shift. In order to quantify this phenomenon, additional data are 
required in order to reduce the noise level. In F88C and G89C the –SH peak seems to be 
strongly decreased. 
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Fig. 3: pH dependence of the Meta I ↔ Meta II equilibrium of wild type rhodopsin and mutants SOH
WT/D83C and F88C (full analysis) and L76C, F85C, G89C and G90C (single data point at pH 6.5).
Measurements were performed at 10°C. The solid line represents best fit for wild type with a Michaelis-
Menten equation. Arrows indicate coinciding data points. We conclude that there is no evidence for
significant changes in the pKa of the Meta I ↔ Meta II equilibrium of these mutants. 
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Fig. 4: The 1800-800 cm-1 region of the FT-IR difference spectra of the rhodopsin → Meta II transition of
wild type rhodopsin and mutants SOH WT/L76C, D83C, F85C, F88C and G89C. Spectra were taken at 10°C
and pH 6.0 within 5 minutes after illumination, so as to minimize interference by the slow decay of Meta II
(half life of > 20 minutes under these conditions). Overall, the spectra are very similar to that of wild type
rhodopsin. The small individual differences, indicated by asterisks, could not yet be assigned.
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Fig. 5: FT-IR difference spectra of the rhodopsin → Meta II transition of wild type rhodopsin and mutants
SOH WT/L76C, D83C, F85C, F88C and G89C. The 2600-2500 cm-1 region is shown where the stretch
vibration of the sulfhydryl group absorbs. Spectra were scaled on the chromophore peaks at 1230 and 970 cm-
1. The –SH peak of SOH WT/D83C shows a significant increase compared to wild type rhodopsin. These first
data indicate that the –SH peak areas of mutants L76C and F85C are about similar to that of wild type,
whereas that of F88C and G89C show a significant decrease. More detailed analysis will require averaging
with additional spectra to improve signal to noise ratio. 
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5.4 Discussion 
 
In the previous chapter we aimed to study the residues of the second transmembrane 
domain of rhodopsin by substituting single residues by a cysteine on the background of 
a cysteine-free base-mutant (SOH ∆C). Most mutants failed to produce sufficient 
amounts of functional protein to study their structural or functional properties. Earlier 
experiments demonstrated that it is possible to measure strong sulfhydryl group changes 
by FT-IR difference spectroscopy on a background of native cysteines (Chapter 2). 
Therefore, we decided to take the risk of native –SH interference and study the residues 
of the second transmembrane domain using wild type rhodopsin as background. 
 
5.4.1 Expression and purification of single TM II cysteine mutants 
Small scale protein production (monolayer culture in T182 flasks) was initially used to 
estimate the level of total and functional protein of the rhodopsin mutants and the extent 
of glycosylation. In strong contrast to the cysteine-free based mutants, most wild type-
based mutants produced total levels of recombinant protein of at least 75% compared to 
wild type with similar amounts of glycosylated protein. Both wild type and mutants in 
general generated large quantities of non-glycosylated opsin. All mutants produced 
functional protein in amounts varying from 13% to 167% of that of wild type rhodopsin. 
No relationship was apparent between the quantity of glycosylated protein and the 
production of functional protein but the low number of experiments may obscure such a 
correlation. To obtain sufficient amounts of functional protein for structural and 
functional analysis, the recombinant rhodopsins were produced at a larger scale in 
bioreactors (1 – 10 litre). The total amount of protein produced was comparable to that 
in culturing flasks. Again a relatively high level of non-glycosylated protein product 
was generated (except for SOH WT/L76C). The relative amounts of functional protein 
produced in the bioreactor by the recombinant baculoviruses were roughly similar to 
those in culturing flasks. Several mutants could already be purified to a reasonable 
extent, although the recovery varied strongly (14 - 75%). The final purity also showed 
great variation (down to only 30% of wild type), but no correlation was observed with 
the recovery. 
The amounts of functional protein produced by the wild type-based mutants were 
significantly increased compared to those produced by the SOH ∆C-based mutants. As 
argued in Chapter 3 the SOH ∆C base mutant will be less stable than wild type, as 
cysteine 167 and 264 form part of the retinal binding site and play a structural role 
during the photoactivation of rhodopsin. The wild type-based mutants differ only in the 
mutated residue from wild type rhodopsin and this should have less effect on the 
stability of the protein and hence probably on its folding ability. In addition these data 
demonstrate that the single cys-mutations by itself do not seriously interfere with ligand 
binding.  
 
5.4.2 Functional properties of single TM II cysteine mutants 
To date, only mutants SOH WT/L76C, L79C, V81C, D83C, F85C, F88C, G89C and 
G90C could be obtained in sufficient purity to begin to study their structural and 
functional properties. Due to technical problems the other mutants could not yet be 
produced in sufficient quantities to allow even preliminary functional analysis. D83C 
has already been extensively analyzed in Chapter 2 and this mutant will only briefly be 
discussed here. The UV/VIS difference spectra of the mutants were very similar in 
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bandshape compared to wild type. L76C and D83C exhibit a small blueshift in λmax 
suggesting subtle electronic perturbation of the chromophore. This has already been 
discussed for D83C in Chapter 2 considering that the carboxyl proton of Asp83 is 
thought to participate in an extended H-bonded network that is involved in wavelength 
regulation [6]. Residue 76 is also located in the neighbourhood of a water molecule. 
This water molecule mediates interaction between helices I (Thr62) and II (Asn73) [5]. 
If this water participates in a more extended H-bonded network, substitution of the 
apolar leucine residue with a cysteine might induce small changes in charge distribution 
affecting the electronic properties of the chromophore to cause the blueshift. SOH 
WT/G90C showed a significant 9 nm blue-shift in its λmax compared to wild type 
rhodopsin. The electronic properties of the chromophore, that govern the absorbance 
maximum, partly depend on interactions between the chromophore and the protein. In 
avian UV/violet pigments the residue corresponding to Gly90 in bovine rhodopsin is 
reported to be a very strong spectral tuning site and the S → C substitution induces a 35 
nm blue-shift [23]. In bovine rhodopsin residue 90 is located close to Lys296 and 
Glu113, since in the mutant G90D D90 can substitute for Glu113 as a counterion [24]. 
This mutant shows a blueshift in its λmax to 483 nm, is affected in its photochemical 
properties and is constitutively active [24]. Interestingly, the G90C mutation in bovine 
rhodopsin also induces a blue shift and slows down G protein activation, but does not 
have substantial effects on the photocascade. Cysteine is only very weakly acidic and 
Cys90 can therefore probably not substitute for Glu113 as a counterion. However, the 
G90C mutation does affect the electronic properties of the chromophore (λmax 498 nm 
→ 489 nm), probably via a H-bonded network.  
The photocascades of mutants SOH WT/L76C, D83C, F85C, F88C, G89C and G90C 
were found to be very similar to wild type rhodopsin at 10°C and pH 6.5. Analysis of 
the MI ↔ MII equilibrium showed that D83C and F88C display a similar pH 
dependency at 10°C as wild type rhodopsin. For mutants L76C, F85C, F88C, G89C and 
G90C only one data point was yet available. These data points coincide with wild type 
and indicate that at 10°C these mutations also do not significantly affect the pKa of the 
Meta I → Meta II transition. The signalling activity of the mutants was compared with 
wild type rhodopsin by measuring the capacity of the mutants to activate the G protein 
transducin. Mutants L76C, V81C, D83C and F85C displayed a similar G protein 
activation capacity as wild type rhodopsin. Apparently the residues at position 76, 81, 
83 and 85 are not critical for signalling. Residue Leu76 points into the protein face in 
the neighbourhood of a water molecule that is positioned in a cavity between helix II, 
VI and VII. Mutation of this residue into a cysteine introduces minor conformational 
changes (see below) possibly since the –SH group may H-bond to and/or perturb the 
position of this water molecule. Apparently these changes do not affect the G protein 
activation capacity of this mutant. Residues Val81 and Phe85 point into the lipid bilayer 
and substitution of these residues by a cysteine is therefore not expected to cause 
significant functional perturbations. Asp83 is thought to participate structurally in an 
extended H-bonded network [6]. Because of the H-bonding potential of the cysteine 
sulfhydryl group, Cys83 might participate in this H-bonded network and largely 
maintain the wild type properties of Asp83 (Chapter 2). On the other hand, mutants 
F88C and G90C exhibit a respectively 50% and 40% reduced G protein activation rate 
compared to wild type, whereas results so far also indicate a reduced G protein 
activation rate for G89C. The 88-90 segment hence may have a role in receptor 
activation. In fact, Phe88 points into the lipid face but is located close to a water 
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molecule that is also situated close to residue Gly90. Potentially, Cys88 H-bonds with 
this water molecule and disturbs the local structure affecting the G protein activation 
kinetics of mutant F88C. Residue Gly89 and Gly90 are located close to Lys296 and 
Glu113 in close proximity to two water molecules. Cysteine may perturb local 
backbone mobility in the Gly-Gly region as well interact with the(se) water molecule(s) 
to induce local structural perturbations. Apart from this, mutation of a residue directly 
participating in Meta II formation may affect the activation kinetics by itself. In such 
conditions, structural perturbations in the rhodopsin to Meta II transition are expected 
and structural involvement of the cysteine side chain is anticipated. 
We used FT-IR difference spectroscopy first of all to analyse whether substitution of the 
residues of the second transmembrane domain of rhodopsin by a cysteine caused long-
range structural perturbations and secondly to identify participation of the newly 
introduced (–SH) groups in rhodopsin activation. Mutant D83C has been extensively 
discussed in Chapter 2. This mutation is quite exemplary since it abolishes the change in 
carboxyl group vibration of Asp83 upon Meta II formation (bilobal bands at 1767 and 
1748 cm-1) and shows participation of Cys83 in this transition by an increase of the –SH 
peak at 2550 cm-1, that must arise in the additional sulfhydryl group of Cys83. Clearly, 
like the Asp83 carboxyl group, this sulfhydryl group can report on local changes 
occuring upon formation of Meta II. Further, the rhodopsin → Meta II difference 
spectrum of D83C is very similar to wild type, confirming that this mutation has very 
few structural side-effects. This is reflected in its G protein activation capacity, which is 
very similar to that of wild type rhodopsin. The other mutants analyzed so far (L76C, 
F85C, F88C and G89C) indicate a slight structural perturbation. These mutants show 
small changes in the Amide I and II region upon Meta II formation, reflecting subtle 
changes in secondary structure during photoactivation. These changes might represent 
local structural perturbation as a consequence of the single amino acid substitutions and 
suggest that in these mutants a small loss in α-helical structure is less explicit. However, 
in spite of these structural changes, the signalling capacity of the mutants L76C and 
F85C was not affected, indicating that these structural effects here do not impair signal 
transduction and that Leu76 and Phe85 are not actively involved in this process. 
Mutants F88C and probably G89C on the other hand showed slower G protein 
activation kinetics. Since the small changes in the amide region observed in the F88C 
mutant are intermediate between those of F85C and G89C, it is not clear whether this is 
the cause of the decrease in signalling activity. More likely, if Phe88 participates in 
receptor activation, substitution for Cys cannot fully sustain this activity. In this case it 
is to be expected that the mutation also will induce small individual changes in the 
rhodopsin → Meta II infrared difference spectrum, that will either reflect the loss of the 
original residue or the gain of a cysteine residue. Additional analyses to verify their 
reproducibility and to assign these changes will be necessary for a detailed structural 
and functional interpretation of the corresponding mutation. The 2600-2500 cm-1 region 
of the FT-IR difference spectra of the mutant rhodopsins is expected to show additional 
–SH activity, if any, since this region can be assigned to -SH stretch vibrations which 
peak at 2548 cm-1 in wild type rhodopsin [22]. Unfortunately, the noise level is quite 
substantial in the single spectrum of the mutants obtained so far, and averaging of a 
population of spectra will be required for a more accurate estimation of peak absorbance 
and area. At this stage we can conclude that the -SH peak areas of L76C and F85C are 
roughly similar to wild type, which suggests that these positions do not structurally 
participate in Meta II formation and agrees with their native-like G protein activation 
capacity. On the other hand, we cannot exclude that in F85C a bilobal peak is 
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superpositioned on the wild type peak, but this also may reflect background noise. The –
SH peaks in F88C and G89C are strongly reduced. This could be interpreted as a 
suppression of wild type –SH activity by these mutations, reflecting decreased structural 
participation in Meta II formation which might explain the reduced G protein activation 
capability. On the other hand, participation of the cysteine residue of these mutants in 
the photoactivation is expected, as discussed above, and might be reflected by a 
negative peak in the FT-IR difference spectrum. On a background of wild type cysteines 
this would then be observed as a decrease in the –SH peak height. This confirms our 
concern that on a background of native cysteines any activity of the substituted cysteine 
residues is difficult to interpret, unless there is a considerable increase in peak area as 
was observed for the D83C mutant. 
In conclusion, all mutants on a wild type background produce sufficient amounts of 
functional protein to allow purification by IMAC and further analysis. As was already 
extensively discussed in chapter 2, Asp83 does not play an essential role in signal 
transduction by rhodopsin but does participate in a more structural role. Positions 76, 
81, 83 and 85 analyzed so far do not seem to be essential for signalling. On the other 
hand, mutants F88C, G90C and probably G89C showed reduced G protein activation 
kinetics. These mutants display a wild type-like photocascade and the pKa of F88C is 
very similar to that of wild type rhodopsin while the single datapoints for G89C and 
G90C suggest that this is also true for these mutations. The lower activation kinetics and 
apparent –SH activity upon Meta II formation of these mutants indicate that residues 
Phe88, Gly89 and Gly90 participate in Meta II formation and receptor activation. It is 
conceivable that substitution of a large aromatic side chain or a mobile Gly-Gly 
segment with a cysteine side chain by itself affects the activation kinetics. On the other 
hand, small adaptations in secondary structure also may play a role. Because the small 
changes in secondary structure observed upon Meta II formation in F88C are 
intermediate between those of F85C and G89C this need not to be a major cause of the 
decrease in signalling activity. Residue Phe88 and Gly90 are both located close to 
structural water molecules and Gly90 is also located close to the Schiff base and the 
counterion site (Lys296 and Glu113). Cysteine residues of mutants F88C, G89C and 
G90C for instance might be able to participate in H-bonded networks near the 
chromophore linkage site, causing slight structural changes that affect the signalling 
kinetics of these mutant rhodopsins [5]. The –SH peak area in the Meta II FT-IR 
difference spectrum of F88C and G89C is strongly reduced suggesting either an indirect 
negative effect of these mutations on the wild type –SH activity or a direct participation 
of the cysteines that reflects itself in a negative peak in the difference spectrum and is 
thus observed as a decrease in the wild type –SH peak area. Both interpretations are in 
agreement with our observation that the signalling activity of these mutants is affected. 
Nevertheless, it is evident that due to the large background noise observed in the –SH 
peak region of the FT-IR difference spectrum the activity of the substituted cysteine 
residues is difficult to interpret, except for the D83C mutant which shows a considerable 
increase in peak area. We conclude that effective cysteine scanning mutagenesis studies 
will first require adequate production of functional cysteine-free rhodopsin to perform 
cysteine scanning mutagenesis on a background free of endogenous cysteine activity. 
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Abstract 
A large number of mutations in rhodopsin are associated with autosomal dominant 
retinitis pigmentosa (ADRP). We analyzed the biochemical phenotypes of the ADRP-
associated cysteine mutants C167R, C222R and C264del. C222R behaved as wild type 
in every aspect testable and is classified as a class I mutant. C167R produced intact 
protein but did not regenerate with 11-cis retinal and was not transported to the plasma 
membrane. We confirm its classification as a class IIa mutant. C264del represents a 
novel phenotype, which we propose to call class III. It produced a truncated protein of 
27 kDa that failed to regenerate with 11-cis retinal and was not targeted to the plasma 
membrane. 
 
 
6.1 Introduction 
 
Rhodopsin is the visual pigment of the rod photoreceptor cell in the vertebrate eye. Like 
all members of the family of G protein coupled receptors it contains seven 
transmembrane spanning segments (Fig. 1). Rhodopsin consists of a protein, opsin and 
an internal ligand or chromophore, 11-cis retinal bound to lysine 296 of opsin. Upon 
R
Q
F
N
C
L
Q
G
K
K
DT
E V
S
S
S
P
A
- CIntracellular
N
M
V
Y
I
V
P N
Y
I
T
A
S
K A
F
F A
P
M
P
F
G
F
A
F
A Y
P
G
W
F
F A
L
V M
V
V
V M
RT V
E
K E
A
KQ
T
S
E
E
Q
Q
K
A
A
I
A
V
Q L
Y
V
I
I
S
LP
T
I
T
V
M
L
V
I Y
S
G
D
G
H
P
YR
P
G
C S
T
S
W
G
F I
PP A
T
VA
A I
W
G
V
I
A
L
A
F
R
N
G
F
P
K
C
V
V
M
RE
S
I
I
A
LS
W L
T
C
L
V
T
Y
G
E
L V
C
P
H
G
L
VF
G
Y
Q
I
T
S
A
V
T
A
EL D
AV
A LN
V
L I
N L
PH
RLK
K
F M
T
L
V
L
G
N
T
F
V
A
I
V
F
I
M
T
L
H
Y
Extracellular
W
P
A
P
P
G
R
T
SN N
T
Y
M
60
80
90
100
130
320
330
PE
L
Y
30
Y
Q
Q
A
E
F
F
S
V
20
V
K
P V
10
F
P
G
E
G
N
QF S M 40
A A
F L
LM
L
50G
F
Y
I
T
70
Y
L
F
G
F
T
L Y
T
L
G 110
FF
G
L
Y
140
E
N
H
M
M
160
170
E
M
190 Y
180
E
E
N
N
E
200
F210
F120
F
220
F
G
F
230
E
Q
240
I
I
260
Y
270
T
H
Q D
I
280
T
I 290
V
300
M
310
K
M
T
T
C C
N
L
G
D
T
T340
T
A
P
A
-
250
G
Fig. 1: Schematic representation of the two-dimensional structure of rhodopsin. The transmembrane segments
are numbered. Modified from Hargrave and McDowell [1] and Palczewski et al. [3]. Black circles indicate the
three cysteine residues addressed in this report. C167 is located in TM IV, C222 in TM V, and C264 in TM
VI. i3 indicates the third intracellular loop. 
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illumination, the retinal group isomerizes to the all-trans form and drives the protein 
through a series of transient photointermediates which within milliseconds leads to the 
generation of the active state (Meta II), that binds and activates the G protein transducin 
[2]. Rhodopsin is a complex integral membrane protein that requires posttranslational 
modification (thiopalmitoylation, disulfide bridge formation, glycosylation) and 
subsequently is targeted to the rod outer segment (ROS) membrane to fulfil its structural 
and functional properties.  
While rhodopsin is essential for dim-light (scotopic) vision in all mammals, including 
human [4] it also has an important pathological component [5]. In the human 
population, over hundred mutations have been identified in rhodopsin that inflict a 
dominant form of the retinal disease, retinitis pigmentosa [6]. Retinitis pigmentosa (RP) 
manifests itself by a black-spotted fundus appearance [7,8] that reflects a degenerative 
process affecting the rod photoreceptors in the retina. It usually results in night 
blindness and tunnel vision, but can also lead to overall loss of vision already at a young 
age [8]. RP is a hereditary disease (incidence 1:4000) [9], which can be transmitted in 
an autosomal dominant (ADRP), autosomal recessive (arRP) or X-linked (x1RP) form 
[5]. ADRP accounts for at least 25% of the RP cases in the Western world [10-14]. 
ADRP can be divided in two distinct types: type 1 and type 2 [5]. Type 1 represents a 
more severe phenotype and is characterized by earlier onset, diffuse localization and/or 
rapid progression. Type 2 is characterized by more regional occurrence and/or slow 
progression. The mutations currently identified in rhodopsin are not randomly 
distributed. Most mutations (± 60%) are found in the transmembrane domain. The 
extracellular loops account for 35% of the mutations and only a few mutations in the 
intracellular loops are RP-genic [8]. A large number of mutations in the transmembrane 
domain give rise to a charged residue that might destabilize the membrane domain and 
interfere with correct folding [15]. On the basis of expression in heterologous systems, 
mutations have been classified into three classes: class I mutants resemble wt rhodopsin 
in that they fold correctly, are targeted to the cell membrane, and bind 11-cis retinal to 
form a typical photosensitive pigment. Class IIa mutants do not fold correctly, do not 
leave the endoplasmic reticulum (ER) and fail to bind 11-cis-retinal. Class IIb mutants 
also show folding defects, but less severe than IIa and produce varying extents of folded 
protein capable of binding 11-cis-retinal [16,17]. It has therefore been proposed that 
class IIa and IIb mutants are RP-genic, since they encode an opsin, that exhibits folding 
defects, accumulates in the ER, and thereby may eventually produce protein overload 
that perturbs cellular homeostasis. Class I mutations do not perturb the basic properties 
of folding and binding of 11-cis-retinal, but may interfere with correct targeting or 
functional properties that cannot be assayed in heterologous systems [7,17]. 
In the course of our studies on the contribution of the transmembrane domain-located 
cysteine residues C167, C222, and C264 to structure and function of rhodopsin, a single 
mutation has been reported for every residue, that results in a RP phenotype: C167R 
[12], C222R [10], and C264del [15]. We have analyzed the biochemical phenotype of 
these mutants by heterologous expression using the insect cell/recombinant baculovirus 
system. Unexpectedly, mutant C222R exhibits a class I phenotype, while C167R 
belongs to class IIa. The ‘in-frame’ deletion C264del represents a novel phenotype, 
which we propose to define as class III. It does not seem to generate intact, completely 
translated protein. A major fragment of 27 kD was produced that was truncated 
downstream of the third intracellular loop and showed a complex intracellular 
distribution. 
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6.2 Materials and methods 
 
6.2.1 Cloning and expression of rhodopsin mutants 
The rhodopsin mutants C167S, C222S, C264S, C167R, C222R, and C264del were 
constructed by means of site-directed mutagenesis using the approach developed by 
Kunkel [18] incorporated in the Bio-Rad Mutagene kit. Cloning, isolation, and 
propagation of recombinant baculovirus producing the various mutants under control of 
the polyhedrin promoter were performed, as described before [19,20]. Recombinant 
virus was checked for the presence of the correct mutation by cycle sequencing using 
appropriate rhodopsin primers [20]. Sf9 cell culture and recombinant protein expression 
were performed as described before [20-22]. 
 
6.2.2 Analysis of recombinant rhodopsins 
The capacity of the recombinant opsins to bond with 11-cis retinal into a photosensitive 
pigment was assayed by incubation of total cellular membrane preparations with a five-
fold excess of 11-cis retinal under dim red light (Schott 610 long pass filter) or in 
darkness, as described before [21]. Formation of photosensitive pigment was analyzed 
by recording UV-VIS spectra before (1) and after (2) illumination in the presence of 20 
mM hydroxylamine [23] and is presented as difference spectra (1-2). Recombinant 
protein production was analyzed by SDS-PAGE (12% acrylamide) of total cellular 
protein followed by immunoblotting with several anti-rhodopsin antibodies, as 
previously described [24]. The blots were probed with the polyclonal antibody 
CERN858 [25] and the monoclonal antibodies K57-142C, directed against the C-
terminus [26], and K42-41L, directed against the i3 loop [27]. N-glycosylation was 
analyzed through incubation with N-glycosidase F as described before [24]. 
Intracellular localization of the mutant proteins was studied using confocal laser 
scanning microscopy (with CERN858 (1:1000) as primary antibody) according to [24], 
except that 1x105 cells were seeded on a coverslip and subsequently infected with 
recombinant baculovirus (MOI = 1). 
 
 
6.3 Results and discussion 
Correct protein folding is essential for proper function. Incorrect folding will lead to 
non-functional proteins that can disturb cellular homeostasis and may have severe 
pathological consequences [28]. In the course of our studies on the contribution of 
membrane domain-located cysteine side chains (C167, C222, and C264) to structure 
and function of rhodopsin [29,30], we were intrigued by clinical genetic studies linking 
a single mutation in each of these cysteine residues to ADRP [10,12,15]. We therefore 
constructed the corresponding mutants (C167R, C222R, and C264del) and expressed 
them in Sf9 cells using the recombinant baculovirus expression system [22,31]. As a 
control we used the corresponding C→S mutations. In agreement with an earlier report 
[32], the mutants C167S, C222S, and C264S produced mature, glycosylated opsin that 
was targeted to the plasma membrane and generated a photosensitive pigment upon 
incubation with 11-cis retinal. The λmax and bandshape of the absorbance bands of the 
C→S mutants are very close to that of wt rhodopsin, as is obvious from difference 
spectra (dark minus illuminated, Fig. 2). These rhodopsin mutants present a fully 
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functional, wild-type phenotype in every aspect testable [32] (P.H.M. Bovee-Geurts and 
W.J. DeGrip, unpublished). This demonstrates that mutation of these residues per se 
does not lead to an ADRP phenotype. 
 
6.3.1 C222R 
The clinical phenotype of the C222R ADRP mutation has not been reported in detail 
[10]. Without presenting any experimental evidence, this mutation was biochemically 
classified as a class IIa mutant by Kaushal and Khorana [17]. However, in full contrast 
our results indicate that C222R behaves like wild type and should be classified as a 
class I mutant. This was already indicated by immunoblot analysis. The major protein 
product for mutant C222R was represented by a band near 38 kDa (Fig. 3.a) that 
corresponds to fully glycosylated opsin (thick arrow) [33]. This band actually runs as a 
doublet, probably due to slight differences in carbohydrate composition, as is also 
observed in recombinant wild-type rhodopsin (Fig. 3.a). Variable but smaller amounts 
of non-glycosylated opsin at 31 kDa were also observed (thin arrow), similar again to 
wild-type expression [33]. Upon treatment with N-glycosidase F only the non-
glycosylated species remains (Fig. 3, lanes designated with +). A positive immuno-
reaction with antibodies against the C-terminus and the i3-loop (Fig. 3b and 3c) 
demonstrates that an intact protein was produced. This was also reflected in its 
interaction with 11-cis retinal that resulted in a photosensitive pigment: the profile of 
the absorbance band of C222R was very similar to that of wt rhodopsin, with only a 
slight blue shift in λmax (Fig. 4; wt λmax: 498 ± 1 nm, C222R λmax: 496 ± 2 nm). Finally, 
the C222R mutant showed a similar intracellular distribution upon baculovirus 
expression as wild type [20] with clear evidence of targeting to the plasma membrane 
(Fig. 5.a). Hence the C222R mutation produces a protein with wild-type-like 
biochemical properties, but it nevertheless is RP-genic [10]. 
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Fig. 2: Absorbance dark-minus-light difference spectra of wt rhodopsin and the mutants C167S, C222S, and
C264S. Spectra were obtained by subtracting a spectrum obtained after illumination in the presence of 20 mM
hydroxylamine from the original spectrum before illumination. Illumination then produces the all-trans-
retinoxime absorbing at 365 nm. 
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Fig. 3: Immunoblot analysis of Sf9 cells infected with recombinant baculovirus expressing wt or mutant
opsins. Blots were screened with primary antibodies; (A) polyclonal antibody CERN858; (B) monoclonal
antibody K57-142C (directed against the C-terminus) and (C) monoclonal antibody K42-41L (directed against
the i3-loop). + Indicates pre-incubation with N-glycosidase F. The – lanes were loaded with extracts of 50,000
cells. The thick arrow indicates the position of intact glycosylated opsin, the thin arrow that of intact non-
glycosylated opsin. The bands at Mw > 50 kDa represent oligomers, mainly of non-glycosylated species,
artificially produced upon solubilization in SDS [24,33]. 
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The wild type biochemical properties of C222R were surprising, as replacement of a 
neutral residue in a membrane-domain by a charged one usually results in folding 
defects [17]. However, according to the recently refined rhodopsin structure [34] C222 
is located in the lipid face of TM V close to the intracellular surface. The side chain of 
R222 would be able to reach the polar lipid interface and/or could be stabilized by 
interaction with Y136 and/or Q225. The RP-genic nature of C222R is difficult to 
explain on basis of these data. Interference of this mutation with the specific targeting of 
rhodopsin to the rod outer segment is unlikely, since the major targeting signals reside 
in the C-terminal tail [35]. Several other RP-genic mutations outside the C-terminal 
region have been reported, that behave as class I (F45L, R135G and D190N) [13,17]. 
Probably, such mutations perturb subtle properties of rhodopsin involved in structural 
maintenance of the highly organized rod outer segment or in photoreceptor adaptation 
[28]. For instance R135 mutants are light-sensitive but do not activate transducin [36]. 
To resolve such issues, transgenic studies must be undertaken. 
 
6.3.2 C167R 
The disease induced by the mutation C167R has been clinically classified as type 1 RP 
[37]. It shows early onset and the first symptoms comprise night blindness and visual 
field shrinkage. The fundus of the eye shows typical RP pigmentation and rod function 
is altered at an early stage, while cones are not affected until the age of about 18 years 
[37]. Biochemically, the C167R mutation has been classified as class IIa upon 
expression in COS cells [17]. Our results in Sf9 cells fully agree with this classification. 
This mutant did not generate detectable amounts of photopigment upon incubation with 
11-cis retinal (Fig 4). Nevertheless, intact recombinant protein was produced 
(immunoreaction with C-terminal antibody; Fig. 3.b) part of which was fully 
glycosylated (Fig. 3.a). The relative amount of non-glycosylated species was 
significantly larger however than in wild type and the C222R mutant. In addition, this 
mutant was not targeted to the plasma membrane but accumulated intracellularly in 
A
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Fig. 4: Absorbance dark-minus-light difference spectra of C167R, C222R, C264del, and wt rhodopsin.
Spectra were obtained by subtracting a spectrum obtained after illumination in the presence of 20 mM
hydroxylamine from the original spectrum before illumination. 
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organelles that with respect to distribution [38] (Chapter 4, Fig. 3) correspond to ER 
(Fig. 5B). 
Residue Cys167 is highly conserved in rod and green cone pigments, and is located in 
the protein face of TM IV [34]. This suggests that this residue is of structural or 
functional importance. Cys167 participates in the lining of the retinal binding site and in 
formation of the active state Metarhodopsin II (W.J. DeGrip, F. DeLange, C.H.W. 
Klaassen, P.H.M. Bovee and K.J. Rothschild, unpublished). Hence, replacement of the 
neutral cysteine at this position by the larger and charged side chain of arginine might 
by itself already perturb binding of the ligand, but will certainly lead to folding defects 
[15]. Prolonged residence in ER or Golgi will presumably lead to overload of synthetic 
and degradative pathways in the photoreceptor cell, which could explain the RP-genic 
nature of this mutation.  
 
6.3.3 C264del 
So far, no clinical or biochemical classification has been reported for the mutant 
C264del. Here, we provide evidence that C264del represents a novel biochemical 
phenotype that we propose to name class III. Although the in frame deletion of Cys264 
should theoretically result in a protein, one residue shorter than wt rhodopsin, this 
mutation seems to have much broader consequences. The product failed to regenerate 
with 11-cis retinal (fig. 4) and was not targeted to the plasma membrane (Fig. 5.c). In 
this respect it resembles class IIa mutations. However, immunoblot analysis revealed 
that the fully translated protein was not detectable (Fig. 3.b). Rather, the major product 
D
A
C
B
Fig. 5: Typical patterns observed for intracellular localization of wt and mutant rhodopsins in Sf9 cells
analyzed by confocal immunofluoromicroscopy. Cells (105) were seeded on coverslips and infected with
recombinant baculovirus. As primary antibody the polyclonal CERN858 was used in 1:1000 dilution.
(A) C222R, (B) C167R, (C) C264del and (D) wt opsin. The immunopositive shell evident in (A) and (D)
represents staining of the plasma membrane. Similar staining is never observed in condition (B) and (C).
The dense perinuclear staining in (B) is typical for ER localization. Intracellular staining in (C) is always
more diffuse than in (B). 
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was a truncated product with an apparent molecular weight of about 27 kDa (Fig. 3.a) 
that still contained the i3-loop (Fig. 3.c), but considering its molecular weight should 
lack the C-terminus, TM VII and probably most of TM VI, and indeed did not react 
with the C-terminal antibody (Fig. 3.b). This fragment was largely present as the 
unglycosylated species (Fig. 3.a). Also, the intracellular distribution was more diffuse 
than that of C167R (Fig. 5.c) and suggests its presence in a variety of intracellular 
structures. Truncation does not seem to be the result of direct proteolytic cleavage of a 
misfolded mature protein, since no trace of intact protein was observed in the presence 
of protease inhibitors either even very early after infection of the cells with baculovirus 
(1-2 days, not shown). In fact, proteolytically highly susceptible sites reside within the 
i3-loop [39]. 
In our view, the most straightforward interpretation of this phenomenon is mutation-
induced translational stalling with subsequent abortive release of the ribosome. In this 
view the deletion, which would twist the face of the extracellular half of TM VI, 
interferes with the function of a transfer signal and blocks further translocation by the 
TRAM complex. The cell has several mechanisms to rescue stalled ribosomes by 
aborting the unfinished bound protein chain [40]. The resulting translational abortion 
could also explain the low extent of glycosylation. 
Hence, we propose to classify this mutation with the biochemical phenotype class III: 
no photopigment formation, intracellular retention, and no apparent formation of intact 
protein. The RP-genic character may again result from an overload of synthetic and 
degradative pathways in the photoreceptor cell. This phenotype further demonstrated 
that truncated proteins can also be generated in the absence of premature stop codons. 
  
 
6.3.4 Conclusions 
We have studied the biochemical properties of mutants of three transmembrane-located 
cysteine residues (C167R, C222R, and C264del) that are involved in ADRP. The 
corresponding C→S mutants produced fully functional, wild-type-like protein. This 
demonstrates that mutation of these residues per se does not lead to an ADRP 
phenotype. The ADRP mutations C167R, C222R, and C264del represent three 
biochemically different phenotypes. Our results clearly indicate that C222R is a class I 
mutant. C222R resembles wild type in every aspect testable, but nevertheless is RP-
genic. We confirmed the classification of C167R as a class IIa mutant. C167R is known 
to cause type 1 ADRP [37]. C264del resembles the C167R mutation with respect to lack 
of regeneration with 11-cis retinal and of targeting to the plasma membrane. However, 
unlike class IIa a truncated product was formed and the mutant represents therefore a 
new biochemical phenotype that we propose to call class III. Different mutations in 
rhodopsin lead to different clinical parameters that correspond to a variation in severity 
of ADRP [41]. Mutations that share the same biochemical classification do not 
necessarily give rise to the same ADRP phenotype. Among class I mutations, for 
example, some mutations cause type 1 ADRP where other mutations give rise to type 2 
ADRP. About two-third of the class IIa mutants of which both the biochemical and the 
clinical phenotype have been established are known to cause type 1 ADRP [17]. Type 
IIb mutations on the other hand cause type 2 ADRP or are described as relatively mild 
[9,17]. It is therefore hard to predict the severity of the disease outcome solely from 
biochemical data. Insight into the relationship between biochemical features and disease 
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outcome would be very welcome, but does need a large body of additional biochemical 
and clinical data. 
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Signal transduction mediated by visual pigments has been extensively studied during 
the last 45 years and in this period the visual pigments have evolved into a model 
system for the G protein-coupled receptor family. This family contains receptors 
involved in all major signaling processes in the human body and represents a major 
target for pharmacological intervention. Detailed knowledge has meanwhile been 
obtained on the cell biology of the signaling pathways but much less is known about the 
structural details of signal generation by the receptors. The recent description of a 
crystal structure of bovine rhodopsin strengthens its position as the model protein for 
the GPCR family and provides the first atomic insight into the structure and activation 
mechanism of rhodopsin and GPCRs in general. 
As described in Chapter 1, rhodopsin is a membrane-spanning protein containing seven 
transmembrane segments, which undergoes posttranslational modification (disulfide 
bridge formation, thiopalmitoylation, glycosylation) and is subsequently targeted to the 
rod outer segment membrane to take up its cellular function. Rhodopsin is a unique 
member of the family of G protein-coupled receptors because its ligand, 11-cis retinal, 
is covalently bound to the protein, opsin. The visual process begins with the absorption 
of light inducing cis/trans isomerization of the ligand after which photo-excited 
rhodopsin relaxes via a series of transient photointermediates (Rhodopsin → 
Bathorhodopsin (Batho) ↔ Blue-shifted-intermediate (BSI) → Lumirhodopsin (Lumi) 
→ Metarhodopsin I (Meta I) ↔ Metarhodopsin II (Meta II) → Metarhodopsin III (Meta 
III)), that within milliseconds leads to the generation of the active state (Meta II), which 
binds and activates the G protein transducin (GT). 
The 3D-crystal structure of ground-state rhodopsin (2.6 Å resolution) gives detailed 
information on the three-dimensional structure of rhodopsin. Rhodopsin can be divided 
into three topologically distinct domains: 1) the transmembrane domain consisting of 
helix I – VII that accomodates 11-cis-retinal, 2) the extracellular region and 3) the 
cytoplasmic region where interaction with transducin occurs. Results from earlier 
experiments indicate that the second transmembrane domain (TM II) of rhodopsin 
undergoes structural changes during photoactivation [1-5]. Helix II runs from residue 71 
to 100 and is kinked around Gly89 and Gly90 placing Gly90 close to Glu113, the 
residue that interacts with the protonated Schiff base. Helix II displays hydrophobic 
interactions with other helices to stabilize the dark state of rhodopsin. In spite of our 
detailed knowledge about the three-dimensional structure of rhodopsin, the role of 
individual protein residues in the photoactivation cannot be deduced from this structural 
model since the crystal structure was obtained in the dark configuration and is difficult 
to extrapolate to rhodopsin in the activated state. We chose to study the structural and 
functional role of individual residues in the photoactivation of rhodopsin using cysteine 
scanning mutagenesis in combination with Fourier Transform-Infrared (FT-IR) 
difference spectroscopy. Cysteine scanning mutagenesis is a technique which uses 
cysteines as a reporter group to study the structural and functional properties of a 
protein. Single amino acids are replaced by a unique cysteine residue and analysed by 
FT-IR difference spectroscopy. This is a very sensitive technique that can measure 
small structural changes and can directly probe the cysteine sulfhydryl group without 
requiring additional modification. The –SH group of cysteine is very sensitive to 
changes in local structure and polarity and vibrational changes can be detected in an 
isolated region of the FT-IR difference spectrum where there is no interference from 
other biomembrane components. 
Evidence has been presented that Asp83 located in the second transmembrane domain 
of rhodopsin is active during formation of Meta II and undergoes a change in H-
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bonding. Our first target was therefore to study the structural and functional role of 
residues located in the second transmembrane domain in the photoactivation of 
rhodopsin using cysteine scanning mutagenesis in combination with FT-IR difference 
spectroscopy. In Chapter 2 the contribution of Asp83 to the structure and function of 
rhodopsin was investigated in more detail, using mutants D83N and D83C. The 
mutation D83C was selected to test the potential of the combination of cysteine-
scanning with FT-IR difference spectroscopy. FT-IR difference spectra show that these 
Asp83 mutations do not cause long-range structural perturbations. The absorbance 
bands of D83C and D83N display a small blue-shift relative to wild-type rhodopsin that 
is smaller in D83C than in D83N, showing that substitution of Asp83 by Cys causes 
little structural and electronic perturbation of the chromophore. Comparison of the 
photochemical properties of these species indicates that Asp83 participates in a H-
bonded network that contributes to spectral tuning and setting of the pKa of the Meta I 
↔ Meta II equilibrium. Our conclusion is that the proton-donating capacity of the 
aspartic carboxyl group forms an important supplement to its H-bonding capacity. Since 
FT-IR difference spectroscopy studies show that the carboxyl group of Asp83 reports 
local changes upon Meta II formation, we would expect that these changes would also 
be reflected in the D83C sulfhydryl vibration. Mutant D83C indeed shows a significant 
increase in the sulfhydryl peak, showing that the -SH peak can be exploited as a very 
sensitive reporter group for the analysis of local structural changes using FT-IR 
difference spectroscopy. 
This cysteine peak was observed on a background of native cysteines, however. To 
prevent a large background in the introduced signal by native cysteines and possible 
reciprocal interactions of introduced cysteines with native cysteine residues, we aimed 
in Chapter 3 at creating a base-mutant in which all potentially active cysteine residues 
are substituted. We started with SOH ∆C in which all potentially reactive cysteines were 
replaced by a serine except for cysteines 110 and 187 that form the disulfide bridge. 
Unfortunately, SOH ∆C produced significantly less functional protein than wild type 
rhodopsin. We attempted to increase the amount of functional base-mutant by 
alternative cysteine substitutions. Since previous single mutation of Cys167 and Cys264 
into a serine on a wild-type background resulted in lower functional yields and a 
decrease in stability, we tested whether substitution of cysteine 167 and 264 by alanine 
or methionine would improve base-mutant expression. However, the production levels 
of functional recombinant protein were even lower than that of SOH ∆C. Since the 
highest functional expression levels of cysteine-free rhodopsins were still obtained for 
SOH ∆C and this species could be purified with reasonable recoveries, showed no 
significant free sulfhydryl activity and retained wild type-level functional activity, we 
decided to use SOH ∆C as a base-mutant for our cysteine scanning mutagenesis studies. 
Now that we had developed a cysteine-free base-mutant (Chapter 3) and a probe to 
study local structural changes (Chapter 2) we aimed in Chapter 4 to study the role of 
the residues of the second transmembrane domain of rhodopsin in the photoactivation 
using cysteine scanning mutagenesis in combination with FT-IR difference 
spectroscopy. Unfortunately, the majority of the single rhodopsin mutants based upon 
SOH ∆C produced little or no functional protein, showed poor glycosylation and was 
retained intracellularly, suggesting folding and/or transport defects. Single substitution 
of Cys167 and Cys264, both structurally active during the photoactivation, on a wild 
type background is known to reduce the amount of correctly folded protein and this was 
aggravated by most mutations. On the other hand some mutations partially rescued the 
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corresponding mutant from incorrect folding. This is a very intriguing phenomenon. 
Residues that play an important role in protein structure and/or function are in general 
well conserved. The native residues of the rescueing mutations L77C, F85C, F88C and 
G89C, show a maximum conservation of 30% in the family of G protein-coupled 
receptors, indicating that these residues probably are not very important for structure 
and function of rhodopsin and substitution of these residues might therefore show no 
adverse effects. Enhanced structural ability of the functional species might improve the 
chance that upon translation a protein proceeds to the correctly folded state. We 
consider it unlikely that the single substitutions mentioned above would make such a 
major difference, and other factors, like chaperone-mediated processes, are likely to 
play a role as well. Until now, only base-mutant SOH ∆C and mutant SOH ∆C/L77C 
have been analysed for several structural and functional properties by UV/VIS 
spectroscopy, FT-IR difference spectroscopy and the GT activation assay. We conclude 
that residue Leu77 is not involved in structural or enzymatical changes underlying 
rhodopsin activation. Indeed, residue L77 is located in the lipid face of TM II and hence 
probably inserted in the lipid matrix, which makes it plausible that this residue does not 
participate in the photoactivation of rhodopsin. We could not yet determine the thermal 
stabilities of these mutants, but the higher recovery of SOH ∆C/L77C after purification 
by IMAC indicates that mutant L77C is more stable than the base-mutant. 
Since the SOH ∆C-mutants produced very low amounts of functional protein we 
searched for an alternative approach. In Chapter 2 of this thesis we showed that a 
change in the vibrational properties of a single cysteine sulfhydryl group can be 
measured on the background of native cysteines. We decided to risk possible 
interference of this large background in the introduced signal by native cysteines and 
proceeded to study the residues of the second transmembrane domain of rhodopsin by 
cysteine scanning mutagenesis on a wild type background. 
The first results of this approach are described in Chapter 5. Most wild type-based 
single cysteine mutants produced total levels of recombinant protein equal to wild type 
rhodopsin, and most mutants also produced amounts of glycosylated protein similar to 
wild type. All mutants produced amounts of functional protein that were sufficient for 
purification by IMAC and for further analysis. However, due to technical problems 
most mutants could not yet be produced in sufficient quantities to allow a 
comprehensive analysis. Until now, mutants L76C, L79C, V81C, D83C, F85C, F88C, 
G89C and G90C have been partially analyzed. Asp83 was already extensively discussed 
in Chapter 2, where it was shown that this residue does not play an essential role in the 
signal transduction of rhodopsin, but that it contributes to the structure and the 
photochemistry by interaction with H-bonded networks. Residues Leu76, Val81 and 
Phe85 so far do not seem to be essential for signaling, whereas mutants F88C, G90C 
and probably G89C show a reduced G protein activation rate. Nevertheless, the latter 
three mutants display a wild type-like photocascade, although the kinetics could not be 
firmly established yet. In addition, the results so far indicate that the pKa of the Meta I – 
II transition is close to that of wild type. Global properties of rhodopsin therefore do not 
seem to be affected. On the other hand, the reduced –SH peak area in the Meta II FT-IR 
difference spectrum of F88C and G89C suggests either an indirect negative effect of 
these mutations on the wild type –SH activity or a direct participation of the extra 
cysteine that is reflected in a negative peak in the difference spectrum and is thus 
observed as a decrease in the wild type –SH peak area. In our view, this justifies the 
conclusion that residues Phe88, Gly89 and Gly90 directly participate in Meta II 
formation and receptor activation, which could explain the lower activity upon 
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substitution of these residues. Upon photoactivation vectorial conformational changes 
occur, resulting in helix II moving away from C-IV and towards helix IV. Probably this 
is facilitated by backbone rotations at the Gly89/Gly90 pair [6], and it is expected that 
substitution of either of these residues by the cysteine side chain will affect the kinetics 
of the rotational outward movement. Unfortunately, different from the D83C mutant 
which shows a considerable increase in -SH peak area, the –SH peak region of the FT-
IR difference spectrum of these mutants is difficult to interpret. This is partly due to a 
relatively high noise level which needs to be reduced by averaging a set of independent 
experiments. Even then, the presence of a background of active native cysteine residues 
will seriously complicate the interpretation of the –SH vibration data. We conclude that 
effective cysteine scanning mutagenesis is better performed on a background free of 
endogenous cysteine activity. Hereto production of functional cysteine-free rhodopsin 
will have to be improved. 
Correct protein folding is necessary for proper functioning of rhodopsin. In the course 
of our studies on the contribution of membrane-located residues to structure and 
function of rhodopsin, our attention was drawn by clinical genetic studies linking a 
single mutation in a cysteine residue of rhodopsin to autosomal dominant retinitis 
pigmentosa (ADRP). In Chapter 6 we analyzed the biochemical phenotype of mutants 
of three transmembrane-located cysteine residues (C167R, C222R and C264del) that are 
involved in ADRP. ADRP can be divided into two clinical subtypes: type 1 and 2. Type 
1 represents a more severe phenotype and is characterized by earlier onset, diffuse 
localization, and/or rapid progression. Type 2 is characterized by more regional 
occurrence and/or slow progression. Biochemically, the mutations have been classified 
into three classes based upon heterologous expression: class I mutants resemble wild 
type rhodopsin in folding, targeting to the cell membrane and formation of 
photosensitive pigment, class IIa mutants do not fold correctly, are retained in the 
endoplasmic reticulum and do not form a photosensitive pigment and class IIb mutants 
show less severe folding defects as IIa and produce varying extents of folded protein 
capable of forming a functional photopigment. The corresponding C → S mutations of 
residue Cys167, Cys222 and Cys264 produce fully functional, wild type-like protein 
demonstrating that mutation of these residues per se does not lead to an ADRP 
phenotype. Our results indicate that the ADRP mutations C167R, C222R and C264del 
represent three different biochemical phenotypes. C222R is classified as class I: it 
resembles wild type rhodopsin in every aspect tested. Its RP-genic nature clearly is not 
expressed in a heterologous system. C167R is classified as class IIa in agreement with 
results described before in another expression system. Mutant C264del represents a new 
biochemical class that we propose to call class III and is described by class II-like 
characteristics (lack of formation of functional pigment and no targeting to the plasma 
membrane) but a truncated protein was formed. In general, the various mutations in 
rhodopsin lead to a variety of clinical parameters with variable severity of ADRP. 
Mutations that share the same biochemical classification do not necessarily give rise to 
the same ADRP phenotype. It is therefore hard to predict disease outcome solely from 
biochemical data on recombinant proteins. These results point at a similar phenomenon 
observed in our cysteine-scanning studies: subtle mutations in rhodopsin can have 
profound effects on the expression level of functional recombinant protein. Our present 
data are still very scattered and our insight in the mechanisms of membrane protein 
folding is still too limited to allow even a preliminary interpretation. 
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The work presented in this thesis shows that cysteine scanning mutagenesis in 
combination with FT-IR difference spectroscopy could be a promising, non-invasive 
technique to study individual, transmembrane-located residues. However, in the case of 
rhodopsin, the total amounts of recombinant protein produced did not differ much from 
wild type, but the cysteine-free base-mutant produced strongly reduced quantities of 
functional protein. Additional substitution of a single residue by a cysteine further 
reduced the production of functional protein in the majority of the mutants to such a 
level, that no adequate purification by IMAC, a prerequisite for further analysis, was 
achieved. The question remains why the SOH ∆C-based mutants showed such a strong 
reduction in functional protein production. Trouble-makers probably are residues 
Cys167 and Cys264 that are structurally active during photoactivation (DeGrip et al., 
unpublished results). Single mutants C167S and C264S on a wild type background 
already produced lower levels of functional protein and reduced stability during 
purification (M.J.M. Portier-VandeLuytgaarden, unpublished results). These effects 
seem to be aggravated in the cysteine-free base mutant (SOH ∆C). N-linked 
glycosylation is thought to accompany and improve protein folding and prevent 
aggregation of intermediate folding products [7]. SOH ∆C showed higher amounts of 
non-glycosylated protein than wild type rhodopsin. This indicates the presence of large 
quantities of incorrectly folded protein and agrees with the lower level of functional 
protein compared to wild type. Since conformational stability is considered to be a 
positive factor in the protein folding process [8], reduced stability might impair correct 
protein folding of the base-mutant under overexpression conditions. However, 
additional substitution of a residue of the second transmembrane domain of rhodopsin 
by a cysteine even further reduced the quantity of functional recombinant rhodopsin 
produced in the majority of the SOH ∆C-based mutants. This would suggest that a large 
number of residues in helix II fulfil an important structural or functional role. Indeed, 
helix I and II form a tight complex by ion pairs and multiple hydrophobic contacts and 
this combination is believed to play a structural and functional role in rhodopsin and as 
well as in other GPCRs [9,10]. In addition, residue Tyr74 and Asn78 link these helices 
with helices III, IV, VII and VIII by a more extended hydrogen bonded network [1]. 
Substitution of the residues of TM II by a cysteine might perturb interhelical contacts 
and/or hydrogen bonded networks and as a consequence decrease the stability of the 
apoprotein. Upon overexpression, the mutant rhodopsins thus might give lower amounts 
of correctly folded, functional protein at the time of harvesting because the folding rate 
of the mutants is much lower than that of wild type resulting in overload of the ER 
folding machinery and accumulation of incompletely or aberrantly folded protein. The 
observation that this is partially rescued by certain cys-substitutions is very intriguing. 
The residues exhibiting rescuing potential (L77, F85, F88 and G89) are not restricted to 
either the lipid or the protein face of helix II (Table 1). Hence, it is likely that apart from 
a possible positive influence on protein stability also other factors such as effects on 
pathway selection or kinetics in protein folding or on interaction with folding 
intermediates play a role. 
Because the D83C mutation on a wild type background showed that a change in 
cysteine sulfhydryl peak vibration can be observed on the background of native 
cysteines, we tried to study the residues of the second transmembrane domain by 
cysteine scanning mutagenesis on a background of wild type cysteines. On this 
background the mutants still produced sufficient amounts of functional protein to allow 
purification and further analysis. This demonstrates that the cysteine mutations do not 
-1  
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region of the FT-IR difference spectra we were able to record was quite substantial. The 
change in vibrational activity of the additional cysteine could therefore not be 
determined reliably, unless the change in peak height is considerable as was observed 
for the D83C mutant. The noise level can be improved by averaging a reasonable 
number of independent spectra, but even then the activity of the substituted cysteine 
residue would be difficult to interpret on a background of native cysteines. It therefore 
seems essential to perform cysteine scanning mutagenesis on a cysteine-free 
background. This requires development of a cysteine-free base-mutant that upon single 
cysteine substitutions still produces sufficient amounts of functional protein for 
purification and further analysis. One option would be to analyse additional mutations at 
“rescuing positions”. Preliminary tests with the L77A mutant however gave no 
indications for a “rescuing effect”. Another option would be to investigate the double 
mutant reported by Xie et al. [11] in which residue Asn2 and Asp282 were substituted 
by a cysteine to form a second disulfide bond. The thermal stability of this mutant 
improved substantially without significant effects on its signaling activity. As was 
discussed earlier this chapter, the thermal stability of the mutant protein is considered an 
important factor in protein folding. An additional disulfide bridge might improve the 
stability of the cysteine-free base-mutant and increase production of functional protein. 
Because the introduced cysteines form a disulfide bridge, they are expected not to 
interfere with the introduced cysteines in cysteine scanning mutagenesis. A third option 
would be to create a base-mutant in which only the cysteines that are active during the 
photoactivation are substituted. Although single substitution of the active cysteines 167 
and 264 reduced the stability of the protein on a wild type background, sufficient 
amounts of functional protein could still be obtained for purification and further 
analysis. However, this case has the major drawback that interactions between native 
and introduced cysteine residues cannot be excluded. 
 
The combined first results from our cysteine scanning mutagenesis studies are 
summarized in Table 1. We think that helix II can be roughly divided into an 
intracellular (residue 71 – 83) and an extracellular half (residue 84-100) based on the 
structural and funtional properties of their residues. Our analysis of some of the 
intracellular located residues (L76, L77, L79, V81 and D83) gave no indications that 
these residues display any significant structural and/or functional role in the 
photoactivation of rhodopsin, except for Asp83 that plays a more general structural role 
[5]. However, previous studies have shown that Tyr74 and Asn78 hydrogen bond with 
residues located in TM I, III, and IV [1,12]. Because they participate in an extended H-
bonded network, mutation of these residues could induce long range effects [4]. In 
addition, residues Ile75, Leu76, Asn78 and leu79 are considered to be generically 
important in the GPCR family because of their high conservation, and are thought to be 
involved in stabilizing transmembrane interactions and folding [13]. In addition, certain 
substitutions of residues Ile75, Leu76, Asn78 and Leu79 give a constitutively active 
protein [13]. Together, these results support the view that residues of the intracellular 
half of helix II in general play a role in establishing a correct protein structure. Our 
analyses of the residues of the extracellular half of helix II indicate that Phe88, Gly89 
and Gly90 participate in Meta II formation and receptor activation. Helix II is kinked 
around Gly89-Gly90 and brings the extracellular part of this helix, in particular Gly90, 
closer to helix III in which Glu113, the counterion for the protonated Schiff base, is 
located [1]. Mutations of Gly89 are observed in retinitis pigmentosa patients [14,15] 
while the Gly90 mutation is associated with congenital night blindness [16], confirming  
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the importance of these residues for rhodopsin. Bioinformatical studies propose that 
residues Phe85, Met86, Val87 and Phe91 are generally important in the GPCR receptor 
family. Mutation of these residues affects ligand binding, showing that these residues 
are of functional importance to rhodopsin [13]. However, in our experiments we found 
no effect of Phe85 mutation on the G protein activation capacity. So far, we can not 
explain this discrepancy. Phe91 forms part of a H-bonded network that lies at the 
extracellular side of the chromophore-binding site, and mutation of this residue might 
cause long range effects on the spectral properties of rhodopsin [4]. Together, these 
results suggest that the extracellular region of helix II plays a significant role both in 
structure and in function of rhodopsin. 
Until now, too little information is available to give a complete detailed description of 
helix II, both structurally and functionally. However, considering the nature of the 
information obtained from our preliminary results, we think that in principle cysteine 
scanning mutagenesis of rhodopsin in combination with FT-IR difference spectroscopy 
and functional studies should be able to provide detailed diagnostic information on 
involvement of particular residues in structure and/or receptor activation. 
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Het signaaltransductie pad geïnitieerd door visuele pigmenten is gedurende de laatste 45 
jaar uitgebreid bestudeerd en in deze periode hebben de visuele pigmenten zich 
ontwikkeld tot een modelsysteem voor de familie van G-eiwit gekoppelde receptoren. 
Deze familie omvat receptoren die betrokken zijn bij alle belangrijke signaal transductie 
processen in het menselijk lichaam en vertegenwoordigen een belangrijke doelgroep 
voor farmacologische interventie. Inmiddels zijn veel details bekend geworden van 
celbiologische aspecten van dit signaal transductiepad maar over de structurele 
principes achter de signaal transductie door de receptoren is nog weinig bekend. De 
recente publicatie van de eerste kristal structuur van runder rhodopsine heeft de positie 
van rhodopsine als model voor de familie van G-eiwit gekoppelde receptoren verder 
versterkt en de eerste inzichten op atomair niveau verschaft in structuur en activatie 
mechanismen van rhodopsine en G-eiwit gekoppelde receptoren in het algemeen. 
Hoofdstuk 1 beschrijft de belangrijkste eigenschappen van rhodopsine. Het is een 
membraaneiwit bestaande uit zeven transmembraan segmenten, dat posttranslationele 
modificatie ondergaat (disulfide brug, palmitoylering, glycosylering) en vervolgens naar 
het buitensegment van het staafje wordt getransporteerd om zijn cellulaire functie uit te 
oefenen. Rhodopsine is een uniek lid van de familie van G-eiwit gekoppelde receptoren 
omdat zijn ligand, 11-cis retinal, covalent gebonden is aan het eiwit, opsine. Het proces 
van het zien begint met de absorptie van lichtenergie waardoor er cis/trans isomerisatie 
van de ligand plaatsvindt waarna het geactiveerde rhodopsine via een aantal 
conformationele veranderingen (Rhodopsine (Rho) → Bathorhodopsine (Batho) ↔ 
Blue-shifted intermediate (BSI) → Lumirhodopsine (Lumi) → Metarhodopsine I (Meta 
I) ↔ Metharhodopsine II (Meta II) → Metarhodopsine III (Meta III)) binnen een 
tijdsbestek van milliseconden de actieve vorm (Metarhodopsine II) aanneemt die het G-
eiwit transducine bindt en activeert. 
De kristalstructuur van rhodopsine in de grondtoestand (resolutie 2.6 D) geeft 
gedetailleerde informatie over de driedimensionale structuur. Het rhodopsine kan 
worden onderverdeeld in drie verschillende domeinen: 1) het transmembraandomein 
bestaande uit helix I – VII waarbinnen het 11-cis retinal zich bevindt, 2) het 
extracellulaire domein en 3) het intracellulaire domein waar de interactie met het G-
eiwit transducine plaatsvindt. Resultaten van voorgaande experimenten duiden er op dat 
het tweede transmembraansegment (TM II of Helix II) van rhodopsine een structurele 
verandering ondergaat tijdens de fotoactivatie [1-5]. Helix II loopt van residu 71 tot 100 
en vertoont een knik ter hoogte van Gly89 en Gly90 waardoor Gly90 in de buurt van 
Glu113 komt, het residu dat een interactie aangaat met de geprotoneerde Schiffse base. 
Helix II staat in verbinding met andere helices via hydrofobe en H-brug interacties 
waarmee de grondtoestand van rhodopsine wordt gestabiliseerd. Ondanks onze 
gedetailleerde kennis van de driedimensionale structuur van rhodopsine kan de rol van 
de individuele eiwitresiduen in de fotoactivatie van rhodopsine niet afgeleid worden van 
dit structurele model, aangezien de kristalstructuur verkregen is in de grondtoestand en 
het zeer moeilijk is om dit te extrapoleren naar de geactiveerde toestand. Wij hebben er 
voor gekozen om de structurele en functionele rol van individuele residuen in de 
fotoactivatie van rhodopsine te bestuderen met behulp van cysteïne-scanning 
mutagenese in combinatie met Fourier transform-infrarood (FT-IR) 
verschilspectroscopie. Cysteïne scanning mutagenese is een techniek waarbij cysteïnes 
worden gebruikt als reporter groep om de structurele en functionele eigenschappen van 
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een eiwit te bestuderen. Individuele aminozuren worden vervangen door een uniek 
cysteïne residu en geanalyseerd door middel van FT-IR verschilspectroscopie. Dit is een 
zeer gevoelige techniek die kleine structurele veranderingen direct aan de -SH groep 
van het cysteïne residu kan meten zonder dat extra modificaties nodig zijn. De –SH 
groep van cysteïne is erg gevoelig voor veranderingen in locale structuur, polariteit en 
corresponderende veranderingen in vibratie frequentie kunnen worden gedetecteerd in 
een geïsoleerd gebied van het FT-IR verschilspectrum waar er geen verstoring optreedt 
door andere biomembraan componenten. 
Het is aangetoond dat Asp83, gelegen in het tweede transmembraandomein van 
rhodopsine, actief is tijdens de vorming van Meta II en een verandering ondergaat in H-
brug interactie (2,3,5). Ons eerste doel was derhalve om met behulp van cysteïne-
scanning mutagenese in combinatie met FT-IR verschilspectroscopie de structurele en 
functionele rol te bestuderen van residuen die gelegen zijn in het tweede 
transmembraandomein van rhodopsine. In Hoofdstuk 2 wordt de bijdrage van Asp83 
aan de structuur en functie van rhodopsine in meer detail bestudeerd met behulp van de 
mutanten D83N en D83C. De mutatie D83C was gekozen om de mogelijkheden van een 
combinatie van cysteïne scanning met FT-IR verschilspectroscopie te testen. FT-IR 
verschilspectra laten zien dat deze Asp83-mutaties geen “long-range” structuur 
veranderingen veroorzaken. De absorbtie spectra van D83C en D83N vertonen een 
kleine blauw-verschuiving ten opzichte van wild-type rhodopsine die kleiner is in D83C 
dan in D83N, daarmee aantonend dat substitutie van Asp83 door cysteïne zeer beperkte 
structurele en electronische verstoring van de chromofoor veroorzaakt. Vergelijking van 
de fotochemische eigenschappen van de mutanten duidt er op dat Asp83 participeert in 
een netwerk van H-bruggen dat bijdraagt aan golflengte regulatie en de pKa van het 
Meta I ↔ Meta II evenwicht. Onze conclusie is dat hiervoor de proton donerende 
capaciteit van de carboxyl groep van asparaginezuur 83 een belangrijke aanvulling 
vormt op zijn H-brug vormende capaciteit. Aangezien FT-IR verschilspectroscopie laat 
zien dat de carboxyl groep van Asp83 reageert op locale veranderingen bij Meta II 
vorming, zouden we verwachten dat deze veranderingen ook zichtbaar zijn in de –SH 
vibratie van D83C. Mutant D83C laat inderdaad een significante toename zien in de –
SH piek, daarmee aantonend dat de –SH piek gebruikt kan worden als een zeer 
gevoelige reporter groep voor de analyse van lokale structurele veranderingen door 
middel van FT-IR verschilspectroscopie. 
Deze cysteïne piek werd echter waargenomen op een achtergrond van natieve cysteïnes. 
Om een hoge achtergrond door natieve cysteïnes in het geïntroduceerde signaal en 
mogelijke wederzijdse interacties van geïntroduceerde cysteïnes met natieve cysteïne 
residuen te voorkomen, wordt in Hoofdstuk 3 de constructie van een basismutant 
beschreven waarin alle mogelijkerwijs reactieve cysteïnes zijn vervangen. Gestart is met 
het SOH ∆C construct waarin alle potentieel reactieve cysteïnes zijn vervangen door een 
serine, uitgezonderd cysteïne 110 en 187 die de disulfide brug vormen. Helaas 
produceerde deze SOH ∆C mutant beduidend minder functioneel eiwit dan wild-type 
rhodopsine. Geprobeerd is om de hoeveelheid functionele basismutant te verhogen door 
alternatieve cysteïne-substituties. Gezien eerdere ervaringen met enkelvoudige mutaties 
van Cys167 en Cys264 naar een serine op een wild-type achtergrond, die duidden op 
lagere hoeveelheden functioneel eiwit met een verminderde stabiliteit, is getest of 
substitutie van Cys167 en Cys264 door alanine of methionine een basismutant met 
betere functionele expressie verkregen kon worden. Echter, de productie niveaus van 
functioneel eiwit lagen zelfs lager dan die van SOH∆C. Daarom is SOH∆C verder 
onderzocht op geschiktheid als basismutant. Hieruit bleek dat deze mutant gezuiverd 
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kon worden met een redelijke opbrengst, geen noemenswaardige vrije –SH activiteit liet 
zien en, op basis van FI-IR analyse, met wild-type vergelijkbare functionele activiteit 
behield. Op grond van deze resultaten is SOH ∆C geselecteerd als basismutant voor de 
cysteïne scanning mutagenese studies. 
Aangezien een cysteïne-vrije basismutant was ontwikkeld (hoofdstuk 3) en een methode 
beschikbaar was om non-invasief lokale structurele veranderingen te bestuderen 
(hoofdstuk 2) wordt in Hoofdstuk 4 de toepassing hiervan beschreven in onderzoek 
naar de rol van de residuen in het tweede transmembraandomein van rhodopsine in de 
fotoactivatie, gebruik makend van cysteïne scanning mutagenese gecombineerd met FT-
IR verschilspectroscopie. Hierbij kwam het grote probleem naar boven dat de 
meerderheid van de enkelvoudige rhodopsine mutanten gebaseerd op SOH∆C 
nauwelijks of geen functioneel eiwit genereerde. Het geproduceerde recombinante eiwit 
was nauwelijks geglycosyleerd en werd intracellulair vastgehouden, hetgeen duidt op 
vouwings- en/of transport defecten. Enkelvoudige substitutie, op een wild-type 
achtergrond, van Cys167 en Cys264, beide structureel actief tijdens de fotoactivatie, 
leidt al tot een verminderde hoeveelheid correct gevouwen eiwit en dit werd in de 
meeste gevallen verergerd door de additionele mutatie. Opmerkelijk was dat sommige 
mutaties juist de corresponderende mutant gedeeltelijk beschermden tegen onjuiste 
vouwing. Dit is een zeer intrigerend fenomeen. Residuen die een belangrijke rol spelen 
in eiwit structuur en/of functie zijn in het algemeen door de evolutie heen goed 
geconserveerd. De natieve residuen van de “beschermende” mutaties L77C, F85C, 
F88C en G89C zijn in maximaal 30% van de familie van G-eiwit gekoppelde receptoren 
geconserveerd, een aanwijzing dat deze residuen waarschijnlijk niet van groot belang 
zijn voor de stabiliteit van rhodopsine en dat substitutie van deze residuen daarom 
mogelijk geen negatieve effecten laat zien. Een verhoogde stabiliteit van de mutant zou 
de kans kunnen vergroten dat na translatie het eiwit correct wordt gevouwen. Hoewel de 
thermische stabiliteit van deze mutanten nog niet kon worden bepaald, zou de hogere 
opbrengst van SOH ∆C/L77C na zuivering door middel van IMAC (immobilized metal 
affinity chromatography) er op kunnen wijzen dat deze mutant stabieler is dan de 
basismutant. Het lijkt echter niet waarschijnlijk dat de enkelvoudige substituties zoals 
hierboven genoemd een belangrijk verschil in stabiliteit zouden kunnen leveren. Andere 
factoren, zoals chaperone-gemedieerde processen, zullen waarschijnlijk een grotere rol 
spelen. Tot nog toe zijn alleen basismutant SOH∆C en mutant SOH∆C/L77C 
geanalyseerd op een aantal structurele en functionele eigenschappen door middel van 
UV-VIS spectroscopie, FT-IR verschilspectroscopie en de G-eiwit activerings bepaling. 
Hieruit blijkt dat residu Leu77 niet betrokken is bij structurele of katalytische 
veranderingen die ten grondslag liggen aan rhodopsine activatie. Daarbij komt dat 
volgens de kristalstructuur residu Leu77 is gelocaliseerd in de lipide matrix, hetgeen het 
plausibel maakt dat dit residu niet deelneemt aan de fotoactivatie van rhodopsine.  
Aangezien de meeste SOH ∆C-mutanten zeer lage hoeveelheden functioneel eiwit 
produceerden is naar een alternatieve benadering gezocht. In Hoofdstuk 2 van dit 
proefschrift werd aangetoond dat een verandering in vibratie-eigenschappen van een 
enkele cysteïne –SH groep gemeten kan worden op een achtergrond van natieve 
cysteïnes. Niettemin is er een reëel risico op interferentie met het geïntroduceerde 
signaal door de hoge achtergrond van natieve cysteines. Gezien de beschikbare 
gegevens leek het desondanks verantwoord cysteïne scanning mutagenese uit te voeren 
op een wild-type achtergrond. 
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De eerste resultaten van deze benadering zijn beschreven in Hoofdstuk 5. De meeste op 
wild-type rhodopsine gebaseerde mutanten produceerden hoeveelheden eiwit gelijk aan 
die van wild-type rhodopsine en eveneens vergelijkbare niveaus van glycosylering. Alle 
mutanten produceerden voldoende hoeveelheden functioneel eiwit om zuivering door 
middel van IMAC en verdere analyse mogelijk te maken. Door technische problemen 
konden de meeste mutanten echter niet in voldoende grote hoeveelheid geproduceerd 
worden om alle geplande studies uit te voeren. Tot nu toe konden de mutanten L76C, 
L79C, V81C, D83C, F85C, F88C, G89C en G90C op zijn minst gedeeltelijk worden 
geanalyseerd. Asp83 is al uitgebreid besproken in Hoofdstuk 2 waar werd aangetoond 
dat dit residu geen directe rol speelt in de signaal transductie van rhodopsine maar een 
bijdrage levert aan de structuur en de fotochemie door interactie met op H-bruggen 
gebaseerde netwerken. Onze gegevens tot nu toe wijzen niet op een belangrijke rol voor 
residuen Leu76, Val81 en Phe85 in fotoactivereing en signaaltransductie van 
rhodopsine. De mutanten F88C, G89C en G90C vertonen een vertraagde G-eiwit 
activatie. De laatste drie mutanten lijken niettemin een wild-type-achtige fotocascade te 
vertonen, hoewel de kinetiek nog niet eenduidig kon worden vastgesteld. Tevens duiden 
de resultaten er tot nog toe op dat voor alle mutanten de pKa van de Meta I → Meta II 
overgang niet veel verschilt van die van wild-type rhodopsine. De fotochemische 
eigenschappen van rhodopsine lijken daarom door deze enkelvoudige mutaties niet 
significant te zijn veranderd. Het Meta II FT-IR verschilspectrum van F88C en G89C 
vertoont wel een gereduceerd piekoppervlak van de –SH vibratie, hetgeen suggereert 
dat deze mutaties ofwel een indirect negatief effect hebben op de wild-type –SH 
activiteit of dat directe participatie van de extra cysteïne zichzelf weerspiegelt in een 
negatieve piek in het verschilspectrum en dus wordt waargenomen als een afname van 
het wild-type –SH piek oppervlak. Dit rechtvaardigt mijns inziens de conclusie dat de 
residuen Phe88, Gly89 en Gly90 direct bijdragen aan de vorming van Meta II en 
receptoractivatie, wat een verklaring zou kunnen zijn voor de lagere activiteit na 
substitutie van deze residuen door cysteïne. Na fotoactivatie treden er vectoriële 
conformatie veranderingen op die er in resulteren dat Helix II zich verwijdert van de 
cytoplasmatische lus IV en dichter naar helix IV toe beweegt. Dit wordt mogelijk 
vergemakkelijkt door aanpassingen in de eiwitketen via een rotatie rond het 
door een cysteïne zijketen de kinetiek van de roterende uitwaartse beweging zal 
beïnvloeden. Helaas is, behalve voor de D83C mutant die een aanzienlijke toename in –
SH piekoppervlakte laat zien , het –SH gebied van het FT-IR verschilspectrum van deze 
mutanten lastig te interpreteren. Dit wordt deels veroorzaakt door een relatief hoge ruis 
die gereduceerd zal kunnen worden door een behoorlijke set van onafhankelijke 
experimenten te middelen. Zelfs dan zal de aanwezigheid van de achtergrond van 
natieve cysteïnes de interpretatie van de –SH vibratie data ernstig bemoeilijken. Onze 
conclusie is dat effectieve cysteïne scanning mutagenese het beste uitgevoerd kan 
worden op een achtergrond die vrij is van endogene cysteïne activiteit. Om dit te 
bereiken zal onderzocht moeten worden hoe de productie van functioneel cysteïne-vrij 
rhodopsine verbeterd kan worden. 
Een correcte eiwitvouwing is noodzakelijk voor rhodopsine om correct te kunnen 
functioneren. Gedurende mijn onderzoek naar de bijdrage van membraan-gelocaliseerde 
residuen aan structuur en functie van rhodopsine bleek uit klinisch-genetische studies 
dat enkelvoudige mutaties in cysteïne residuen in het membraan-domein van rhodopsine 
te koppelen waren aan de autosomaal dominante ziekte retinitis pigmentosa (ADRP). In 
Hoofdstuk 6 hebben we het biochemisch fenotype bestudeerd van drie cysteïne 
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residuen die gelegen zijn in het membraan domein (C167R, C222R en C264del) en die 
betrokken zijn bij ADRP. ADRP kan onderverdeeld worden in twee klinische subtypes: 
type 1 en 2. Type 1 heeft een wat ernstiger fenotype en wordt gekarakteriseerd door 
manifestatie al op jonge leeftijd, diffuse localisatie, en/of een snelle progressie. Type 2 
wordt gekarakteriseerd door een meer regionaal voorkomen, en/of langzame progressie. 
Biochemisch gezien zijn de mutaties geclassificeerd in drie klassen gebaseerd op 
heterologe expressie: klasse I mutanten lijken op wild-type met betrekking tot vouwing, 
gericht transport naar de celmembraan en vorming van een lichtgevoelig pigment na 
toevoeging van 11-cis retinal; klasse IIa mutanten genereren het complete eiwit, maar 
vouwen niet goed, worden vastgehouden in het endoplasmatisch reticulum en vormen 
geen lichtgevoelig pigment; klasse IIb mutanten laten minder ernstige 
vouwingsdefecten zien dan IIa en produceren variabele hoeveelheden correct gevouwen 
eiwit dat in staat is om een functioneel fotopigment te vormen. De corresponderende C 
→ S mutaties van residu Cys167, Cys222 en Cys264 werden geconstrueerd als controle 
en blijken volledig functioneel, wild-type-achtig eiwit te genereren, daarmee aantonend 
dat mutatie van deze residuen op zichzelf niet leidt tot een ADRP-fenotype. Onze 
resultaten duiden er op dat de ADRP-mutaties C167R, C222R en C264del representatief 
zijn voor biochemisch drie verschillende fenotypes. C222R wordt geclassificeerd als 
klasse I: het lijkt in elk getest aspect op wild-type rhodopsine. De eigenschappen, die 
aanleiding geven tot retinitis pigmentosa komen blijkbaar niet tot expressie in een niet-
natieve omgeving.  
C167R wordt geclassificeerd als klasse IIa in overeenstemming met resultaten reeds 
eerder beschreven in een ander expressie systeem. Mutant C264del vertegenwoordigt 
een nieuwe biochemische klasse die klasse III is gedoopt en wordt gekenmerkt door 
klasse II-eigenschappen (geen vorming van functioneel pigment en geen transport naar 
de plasma membraan), maar bovendien wordt geen compleet eiwit gegenereerd. In het 
algemeen leiden ADRP-gecorreleerde mutaties in rhodopsine tot een verscheidenheid 
aan klinische beelden met variërende ernst van ADRP. Mutaties die eenzelfde 
biochemische classificatie dragen leiden niet noodzakelijkerwijs tot hetzelfde klinische 
ADRP-fenotype. Het is daarom nog niet mogelijk om alleen op basis van biochemische 
data verkregen met recombinante eiwitten de ernst van de ziekte te voorspellen. Deze 
resultaten duiden op een soortgelijk fenomeen als hetgeen is waargenomen in mijn 
cysteïne-scanning studies: subtiele mutaties in rhodopsine kunnen verstrekkende 
gevolgen hebben voor het vermogen om functioneel recombinant eiwit te genereren. De 
huidige gegevens zijn nog steeds zeer onvolledig en het inzicht in de mechanismen van 
membraaneiwit vouwing is nog steeds zeer beperkt, waardoor zelfs een voorlopige 
interpretatie van deze verschijnselen nog ondoenlijk is. 
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List of abbreviations 
 
3D three dimensional 
ADRP autosomal dominant retinitis pigmentosa 
arRP autosomal recessive retinitis pigmentosa 
Batho Bathorhodopsin 
BSA bovine serum albumin 
BSI Blue-shifted intermediate 
cGMP cyclic GMP 
CHAPS 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate 
C-I cytoplasmic loop I 
C-II cytoplasmic loop II 
C-III cytoplasmic loop III 
C-IV cytoplasmic loop IV 
d.p.i. days post infection 
DOM Dodecylmaltoside 
E.R. endoplasmic reticulum 
EDTA (ethylene-1,2-diamino)N-tetra-acetic acid 
E-I extracellular loop I 
E-II extracellular loop II 
E-III extracellular loop III 
EPR electron paramagnetic resonance 
FCS Fetal calf serum 
FT-IR Fourier Transform Infrared 
G protein GTP-binding protein 
GARPO Goat anti-Rabbit conjugated to PO 
GPCR G protein-coupled receptor 
GT transducin 
GTPγS guanosine 5’-O-(3-thiotriphosphate) 
his-tag histidine tag 
HOOP hydrogen-out-of plane 
IMAC immobilized metal affinity chromatography 
IRBP interphotoreceptor retinoid-binding protein 
LB Luria-Bertani 
LRAT lecithin:retinol acyltransferase 
Lumi Lumirhodopsin 
M.O.I multiplicity of infection 
Me ta I Metarhodopsin I 
Meta II Metarhodopsin II 
Meta III Metarhodopsin III 
NTA Ni2+-nitrilotriacetic acid 
PBS Phosphate Buffered Saline 
PDE phosphodiesterase 
RGR retinal G protein-coupled receptor 
ROS rod outer segment 
RP retinitis pigmentosa 
RPAP Rabbit Polyclonal Anti-Porc Ig 
SAR(-TRITC)  Swine anti-rabbit Ig (conjugated to rhodamine) 
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SDSL site-directed spin labeling 
SDS-PAGE  SDS Polyacrylamide gel electrophoresis 
Sf9 Spodoptera frugiperda cell line 
-SH cysteine sulfhydryl group 
SOH ∆C Synthetic Opsin His-tagged cysteine-free bovine opsin 
SOH WT Synthetic Opsin His-tagged bovine opsin 
TE Tris-EDTA 
TM transmembrane segment 
wt wild type 
x1RP X-linked retinitis pigmentosa 
 
 
 
Table 1: One and three letter code abbreviations of amino acids 
 
Amino acid Three letter code One letter code 
Alanine 
Arginine 
Asparagine 
Aspartic acid 
Cysteine 
Glutamine 
Glutamic acid 
Glycine 
Histidine 
Isoleucine 
Leucine 
Lysine 
Methionine 
Phenylalanine 
Proline 
Serine 
Threonine 
Tryptophane 
Tyrosine 
Valine 
Ala 
Arg 
Asn 
Asp 
Cys 
Gln 
Glu 
Gly 
His 
Ile 
Leu 
Lys 
Met 
Phe 
Pro 
Ser 
Thr 
Trp 
Tyr 
Val 
A 
R 
N 
D 
C 
Q 
E 
G 
H 
I 
L 
K 
M 
F 
P 
S 
T 
W 
Y 
V 
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Dankwoord 
 
Na een lange weg komt dan nu toch de afronding van mijn proefschrift in zicht. Mijn 
vader noemde mijn afstudeerscriptie ooit mijn levenswerk. Wisten wij beiden toen 
veel.... 
 
Rest mij nog het bedanken van een aantal mensen. Want, cliché, cliché, promoveren doe 
je niet alleen. Allereerst natuurlijk mijn promotor prof. Wim de Grip en co-promotor dr. 
Giel Bosman. Wim, zelf gepromoveerd van co-promotor tot promotor kon je nu mij 
optimaal begeleiden bij mijn promotie. Jouw eeuwig optimisme en droge humor 
zorgden er voor dat ik de moed niet opgaf in moeilijke tijden. Op de meest vreemde 
dagen en tijdstippen maakte je tijd voor mijn proefschrift wat het mij mogelijk maakte 
om het schrijven van mijn proefschrift en het werken in Maastricht te combineren. 
Dankjewel voor je geduld met mij. Giel, ik kon altijd op je rekenen met “de celletjes” en 
achter de confocale was het altijd leerzaam en gezellig. Als “pet”-AIO ben ik meteen 
ook jouw eerste AIO als co-promotor, spannend voor ons allebei. 
Jenny van Oostrum, ook op jou kon ik altijd rekenen met de celkweek en een peptalk als 
ik het niet meer zo zag zitten. Jenny bedankt, dankzij jou en Giel kon ik in de 
weekenden gewoon naar huis. 
Petra Bovee, onze steun en toeverlaat. Ik ben jou veel dank verschuldigd voor de vele 
experimenten die jij hebt gedaan en altijd kon ik met mijn vragen bij jou terecht. 
Bedankt Petra, zonder jou was menige figuur nog blanco.  
Arthur Pistorius, jij brengt infrarood tot leven. Zwitserland is ons beider passie, met zijn 
pieken en dalen (zou het hem daar in zitten?). 
Corné Klaassen, jij hebt mij wegwijs gemaakt in het cloneer- en baculoviruswerk. Ik 
denk dat de meeste beginnende AIO’s het zonder zo’n uitgebreide introductie moeten 
doen. Dankzij jouw basis heb ik menige mutant kunnen maken. 
Jannie Janssen, bedankt voor je zorgen als collega-aio toen ik net als groentje 
binnenkwam. Jij maakt jouw promotietraject vele malen ingewikkelder dan het mijne. 
Houd vol, jij bent gewoon de volgende! 
Micha Ummels en Heidi Willems wil ik bedanken voor hun ondersteunende 
werkzaamheden. Jullie hebben me een boel geclo(oi)neer uit handen genomen. 
Maikel Giesbers, naast aio ook onze computer vraagbaak. Met de kegeltjes heb jij een 
nog zwaardere klus dan ik met mijn mutanten. Hopelijk lukt het ook jou om een mooi 
boekje bij elkaar te pipetteren. 
En uiteraard wil ik stagiair Zan Peeters bedanken voor zijn bijdrage en voor zijn 
gezellige tijd op het mini-labje in het Trigon samen met Prasad. Ik wist niet dat mannen 
zo konden kletsen. 
Verder wil ik de collega’s van Oogheelkunde bedanken voor de gezellige tijd. Dank 
voor jullie bijdragen tijdens onze gezamenlijke werkbesprekingen en het introduceren 
van de thee- c.q. fruitpauze. 
Pap en mam, dankzij jullie ben ik kunnen gaan studeren. Jullie hebben me altijd 
gestimuleerd om er uit te halen wat er in zit en me altijd vrijgelaten en gesteund in mijn 
keuzes. Dankjewel dat jullie er altijd voor me waren en zijn, ook al hadden jullie vaak 
misschien geen idee waar ik nou precies mee bezig was. 
Last but not least, mien Frenske. Jouw geduld is misschien nog wel het meest op de 
proef gesteld. Gelukkig heb je altijd in mij geloofd, zodat we dan nu eindelijk een 
turbulente periode met een mooi feestje kunnen afsluiten. 
Datawyse
Publications 
 124
Publications 
 
Breikers, G., van Breda, S.G.J., Bouwman, F.G., van Herwijnen, M.H.M., Renes, J.W., 
Mariman, E.C.M., Kleinjans, J. and van Delft, J.H.M. Potential protein markers for 
nutritional health effects on colon cancer in the mouse as revealed by proteomics 
analysis. In preparation. 
 
Breikers G., Bovee-Geurts P.H., Van Oostrum J., Bosman, G.J.C.G.M., De Grip W.J. 
(2003). Importance of residue L77 in the structure and function of rhodopsin. In 
preparation. 
 
Bosman, G.J.C.M., Van Oostrum, J., Breikers, G., Bovee-Geurts, P.H., Klaassen, 
C.H.W., De Grip, W.J. (2003). Functional expression of his-tagged rhodopsin in Sf9 
insect cells. Methods Mol. Biol., 228, 73-86. 
 
Breikers G., Portier-Van de Luytgaarden M., Bovee-Geurts P., De Grip W. (2002). 
Retinitis pigmentosa-associated rhodopsin mutations in three membrane-located 
cysteine residues present three different biochemical phenotypes. Biochem. Biophys. 
Res. Commun., 297, 847-853.  
 
Breikers G., Bovee-Geurts P.H., De Caluwe G.L., De Grip W.J. (2001). A structural 
role for Asp83 in the photoactivation of rhodopsin. Biol. Chem., 382, 1263-1270. 
  
den Dekker E., Molin D.G., Breikers G., van Oerle R., Akkerman J.W., van Eys G.J., 
Heemskerk J.W.. Expression of transient receptor potential mRNA isoforms and Ca(2+) 
influx in differentiating human stem cells and platelets (2001). Biochim. Biophys. Acta, 
1539, 243-255.  
 
Heemskerk J.W., Siljander P., Vuist W.M., Breikers G., Reutelingsperger C.P., Barnes 
M.J., Knight C.G., Lassila R., Farndale R.W. (1999). Function of glycoprotein VI and 
integrin alpha2beta1 in the procoagulant response of single, collagen-adherent platelets. 
Thromb. Haemost., 1999, 81, 782-792. 
 
 
Datawyse
Curriculum vitae 
 125
Curriculum vitae 
 
Githa Breikers werd geboren op 9 november 1972 te Geleen. Aan de R.K.S.G. Serviam 
te Sittard werd in 1992 het Gymnasium diploma behaald waarna zij in hetzelfde jaar 
begon met de studie Gezondheidswetenschappen aan de Universiteit van Maastricht met 
als afstudeerrichting Biologische Gezondheidkunde. Haar afstudeerstage werd 
uitgevoerd bij de vakgroepen Biochemie en Moleculaire Celbiologie van de Universiteit 
van Maastricht, een tweede stage werd gelopen bij de vakgroep Pathologie van het 
Academisch Ziekenhuis Maastricht. Het doctoraaldiploma werd behaald in augustus 
1997. 
Van januari 1998 tot oktober 2002 werkte zij onder leiding van Prof. W.J. de Grip als 
Onderzoeker in Opleiding aan de Radboud Universiteit Nijmegen op de afdeling 
Biochemie van de Faculteit der Medische wetenschappen aan een door N.W.O. 
geassisteerd bij verscheidene practica voor studenten Geneeskunde en heeft zij een 
tweetal studenten begeleid tijdens hun stages. 
waar zij, naast het geven van onderwijs, onderzoek deed met behulp van Proteomics 
naar het beschermend effect van een groentedieet op dikke darm kanker bij muizen. 
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